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Abstract 
 
In recent years, an increasing desire to develop a feasible alternative to fossil fuels has led 
to an increased amount of attention in the area of bioconversion—particularly that of converting 
plant-derived lignocellulosic material into biofuels. Saccharomyces cerevisiae, also known as 
baker’s yeast, is considered one of the most promising organisms for ethanol production from 
lignocellulosic feedstock. Unfortunately, pentose sugars, which constitute up to 30% of biomass 
hydrolysate, cannot be utilized by S. cerevisiae. To this end, heterologous pentose utilization 
pathways have been introduced into S. cerevisiae in order to enable the assimilation of pentose 
sugars. However, pentose utilization of recombinant S. cerevisiae strains are inefficient due to 
the poor sugar uptake ability, the low expression level and activity of heterologous proteins, the 
redox imbalance that results from different cofactor preference in oxidation and reduction 
reactions, and a suboptimal metabolic flux through different catalytic steps. A lot of research has 
been carried out to improve pentose utilization in S. cerevisiae by targeting different aspects of 
these issues, but it is very challenging to come up with a single strategy which can solve all three 
problems at the same time.  
To address problem of inefficient pentose sugar uptake in S. cerevisiae, a collection of 
eighteen putative pentose transporters were cloned. Among them, one arabinose-specific and two 
xylose-specific transporters from Pichia stipitis and Neurospora crassa were identified. All 
transporters were functionally expressed and properly localized in S. cerevisiae as indicated by 
HPLC analysis and immunofluorescence microscopy, respectively. Overexpression of the xylose-
specific transporters under weak promoters was shown to help xylose fermentation in xylose 
assimilating S. cerevisiae.  
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To optimize the heterologous xylose utilization pathway, both an enzyme-based strategy 
and a promoter-based strategy were applied to balance the metabolic flux for xylose utilization. 
For the enzyme-based strategy, around twenty different enzyme homologues from various fungal 
species with different catalytic efficiency and cofactor preference were cloned for each catalytic 
step. These enzyme homologues were assembled into a library of xylose utilization pathways 
using our newly developed DNA assembler method. Using the library we generated, clones with 
better combinations of enzyme homologues were identified using a colony size based screening 
method. 
To fine-tune the expression level of the three genes in a heterologous xylose utilization 
pathway, enzyme homologues of xylose reductase, xylitol dehydrogenase and xylulokinase with 
the highest activity and matched cofactor specificity were selected and promoter mutants with 
varying strengths were randomly incorporated into the pathway using DNA assembler. Using this 
method, a number of xylose utilization pathways with optimized expression levels were 
identified using a high throughput screening method. Additionally, this method was also applied 
to directly search for an optimized xylose utilizing pathway for industrial yeast strains with 
different metabolic flux patterns compared to laboratory S. cerevisiae strains. Optimized xylose 
utilizing pathway mutants were also identified in industrial strains and their gene expression 
levels  were actually different from that of the laboratory strain. 
To facilitate the metabolic engineering in industrial strains with the new pathway 
assembly strategy, multiple expression and integration vectors were constructed. These vectors 
require no modification on the industrial host strains by using positive selection markers. 
Moreover, by keeping the homologous region used for pathway assembly in the laboratory 
vectors, the gene expression cassettes for pathway optimization can be directly used in the 
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industrial strains. In addition to the gene expression systems, a scar-less gene modification 
method was also investigated in the industrial strains and promising preliminary results were 
obtained. 
By introducing a new pentose-specific transporter, optimization of the heterologous 
pentose utilization pathway and the utilization of robust industrial polyploid host strains, the 
efficiency of pentose sugars in recombinant S. cerevisiae strains were significantly improved. 
More efficient utilization of pentose sugars will lead to more efficient utilization of biomass 
feedstocks and therefore lower the cost for lignocellulosic ethanol production. 
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Chapter 1 Introduction 
 
1.1 Biofuel Production from Lignocellulosic Material 
Due to environmental, economic, and energy security considerations, there is an 
increasing interest in the development of bio-derived fuel alternatives (1). Dominant biofuel 
alternatives, such as corn-derived ethanol, however, have proven to be only marginally profitable 
even with the application of governmental subsidies (2). Thus, the current biofuel production 
scheme must be modified through the use of cheaper, non-edible lignocellulosic biomass as 
feedstock or via the production of advanced biofuels (Figure 1.1). 
 
Figure 1.1 Production of biofuel and chemicals from lignocellulosic feedstock 
 
Lignocelluloses, the non-edible portion of plant-derived biomass, are considered 
preferable feedstock for biofuel production due to their low requirement for energy, fertilizer and 
pesticide input (3). Unfortunately, the recalcitrant structure of plant cell wall presents a great 
challenge for the efficient deconstruction and complete utilization of lignocellulosic feedstock. 
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Lignocellulosic biomass has a very distinctive structure, with its most abundant component, 
cellulose, tightly surrounded by a hemicellulose and lignin complex that protects the inner 
cellulose from hydrolytic enzymes (4).  
Considerable research effort has been dedicated to breaking down the crystalline structure 
of cellulose in order to release the fermentable monosaccharide glucose for use in biofuel 
production. The most recent breakthrough in this area is the development of a microorganism 
capable of consolidated bioprocessing (CBP). CBP is a process where enzyme production, 
cellulose hydrolysis, and monosaccharide fermentation for fuel production are combined into a 
single step. CBP has been proposed to significantly lower biofuel production cost as it eliminates 
the need for the large-scale production of expensive cellulases (5). One common strategy to 
develop a CBP microorganism is to introduce cellulolytic ability into ethanol producing, non-
cellulolytic organisms (6).  
Gram-negative bacterium Zymomonas mobilis is one attractive candidate for CBP 
microorganism development due to its high ethanol productivity and tolerance. Darzins and co-
workers successfully expressed two cellulolytic enzymes, E1 and GH12 from Acidothermus 
cellulolyticus, in Z. mobilis. Furthermore, both cellulolytic enzymes can be secreted 
extracellularly due to the inclusion of native Z. mobilis secretion signals. Functional expression 
and secretion of cellulolytic enzymes in Z. mobilis indicate its high potential for serving as a 
CBP platform microorganism (7).  
Another very attractive CBP organism candidate is S. cerevisiae, which has served as the 
major producer of ethanol for thousands of years (8). van Zyl and co-workers first demonstrated 
that the introduction of the endoglucanase from Trichoderma reesei and the β-glucosidase of 
Saccharomycopsis ﬁbuligera into S. cerevisiae can result in a recombinant strain with the ability 
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to grow on phosphoric acid swollen cellulose (PASC) as its sole carbon source and produce up to 
1.0 g/L of ethanol (9). Inspired by the structure of cellulosomes, Zhao and co-workers developed 
a recombinant yeast strain wherein endoglucanases, cellobiohydrolases, and β-glucosidases were 
assembled into a trifunctional minicellulosome through cohesin and dockerin. In the recombinant 
yeast strain, a miniscaffoldin composed of a cellulose-binding domain and three distinct cohesin 
modules were expressed using yeast surface display, while three cellulolytic enzymes, each fused 
with a C-terminal dockerin corresponding to a different cohesin, were co-expressed in the same 
strain. The cellulolytic enzymes were assembled into minicellulosomes through cohesin-dockerin 
interaction onto miniscaffoldings anchored onto the yeast’s surface. The recombinant yeast 
exhibited a higher cellulolytic activity due to enzyme-enzyme and enzyme-substrate synergistic 
effects. As a result, recombinant strains can simultaneously break down and ferment PASC to 
ethanol with a titer of 1.8 g/L (10). Around the same time, Chen and co-workers reported their 
work involving another CBP process that utilized a minicellulosome. In their study, instead of 
creating a single recombinant strain, a synthetic yeast consortium was used for the expression 
and assembly of its minicellulosome. This synthetic consortium is composed of four different 
recombinant yeast strains: one strain displaying a trifunctional scaffoldin and three strains that 
each express a dockerin-tagged cellulolytic enzyme. After optimization of the ratio of different 
populations in the synthetic consortium, a 1.87 g/L ethanol titer was achieved, which is 93% of 
the theoretical yield (11).  
A similar effort was carried out to tackle the problem of hemicellulose utilization. 
Hemicellulose is the second most abundant component of lignocellulosic biomass and can make 
up to 20~30% of the total feedstock. Unlike cellulose, which is composed of glucose, 
hemicellulose is primarily composed of five-carbon sugars (pentoses) such as xylose and 
 4 
arabinose (12). Unfortunately, the industrial microorganism currently used for large-scale 
production of ethanol, S. cerevisiae, cannot utilize pentoses contained within the hydrolysates of 
the hemicellulose component of biomass feedstock (13). The incomplete utilization of sugar 
substrates present in lignocellulosic biomass hydrolysates is one of the major causes of elevated 
bioethanol production cost, making this environmentally-friendly energy alternative typically far 
less economically competitive when compared to fossil fuels (14,15). To be utilized by ethanol 
producing S. cerevisiae, pentose sugars need to be first transported into the cells and then 
converted into xylulose-5-phosphate, which can then be further metabolized through the pentose 
phosphate pathway. In order to enable the efficient conversion of xylose and arabinose into 
xylulose-5-phosphate, heterologous pathways need to be introduced into S. cerevisiae and further 
optimized (15,16). For example, to improve the fermentative ability of the fungal xylose 
utilization pathway, much effort was devoted to identify heterologous enzymes with better 
catalytic efficiency and cofactor specificity (17), balance the cofactor usage of the pathway (18), 
and optimize ethanol production using more robust industrial ethanol-producing yeast strains 
(19).  
Another factor hampering efficient production of lignocellulosic ethanol in S. cerevisiae 
is the “glucose repression” that occurs during mixed sugar fermentation. Because S. cerevisiae 
preferably utilizes glucose over other carbon sources, utilization of pentose sugars is severely 
repressed before glucose is depleted (20). A novel approach was recently developed to overcome 
glucose repression by introducing a cellobiose transporter and a β-glucosidase into recombinant 
xylose-utilizing S. cerevisiae strains (21,22) (Figure 5). In these strains, cellobiose, an 
incomplete hydrolysis product of cellulose, is fermented instead of glucose in the presence of 
xylose. Since cellobiose enters S. cerevisiae cells through a dedicated cellobiose transporter, the 
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competition of glucose and xylose at the sugar uptake step is eliminated. Cellobiose is then 
hydrolyzed into glucose intracellularly and continuously consumed for the production of ethanol. 
The simultaneous hydrolysis and utilization of cellobiose avoids intracellular accumulation of 
glucose, thus alleviating glucose repression. In the engineered cellobiose and xylose co-
utilization strains, cellobiose and xylose are consumed simultaneously and synergistically with 
an ethanol productivity of 0.65 g/L·h and overall ethanol yield of 0.39 g/g glucose.  
The development of biologically-derived ethanol has achieved significant success in the 
past few decades (23,24). However, ethanol exhibits some intrinsic limitations, such as low 
energy content and corrosiveness, which hampers its large-scale application as a fuel alternative. 
In contrast, advanced biofuels, such as higher alcohols, fatty acid derived fuels, and 
hydrocarbons, are considered to be better fuel alternatives as their physiochemical properties are 
more compatible with the current gasoline-based infrastructure (25).  
Isopropanol and n-butanol are both better fuel alternatives compared to ethanol due to 
their higher energy content, higher octane number, and lower water solubility. Fortunately, unlike 
other long chain alcohols, both isopropanol and n-butanol can be produced by Clostridium 
species in nature. However, since Clostridium species are Gram-positive anaerobes with a 
relatively slow growth rate and spore-forming life cycles, it is hard to control the yield of desired 
long chain alcohols in industrial fermentation (25). To address this issue, long chain alcohols 
were produced in non-native hosts such as E. coli and S. cerevisiae (25-28). For heterologous 
production of isopropanol, various combinations of genes from different Clostridium and E. coli 
species have been introduced into E. coli for production through the coenzyme-A-dependent 
fermentative pathway. The resulting optimized recombinant strain can achieve an isopropanol 
production titer of 5 g/L with a yield of 43.5% mol/mol glucose (29). Similarly, the n-butanol 
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production pathway from a Clostridium species has also been introduced into E. coli and 
extensive metabolic engineering efforts have been dedicated to increasing the titer. However, the 
highest titer for n-butanol production only achieved 552 mg/L, most likely due to limitations 
imposed by low heterologous enzyme activity, insufficient carbon precursors, and inadequate 
reducing power (26). In recent studies, the production titer of n-butanol has been improved to  
higher levels either by using an enzymatic chemical reaction mechanism as a kinetic control 
element (4,650±720 mg/L)(30) or by introduction of driving force for the pathway (30 g/L)(31). 
At the same time, Keasling and co-workers introduced a similar pathway into S. cerevisiae and 
achieved an n-butanol production titer of 2.5 mg/L through the optimization of isozymes used in 
the pathway (28). One reason for the low efficiency in the heterologous production of long chain 
alcohols may be the cytotoxicity caused by the accumulation of intermediate metabolites as well 
as redox imbalance due to the introduction of heterologous pathways (26). To address this issue, 
Liao and co-workers investigated the production of long chain alcohols through existing non-
fermentative keto acid pathways. Using this strategy, 2-keto acids, which are intermediates in 
amino acid biosynthesis pathways, are converted into aldehydes by broad range 2-keto-acid 
decarboxylases (KDC) and then reduced to alcohols by alcohol dehydrogenases (ADH). 
Compared to fermentative pathways, only two heterologous steps need to be introduced for 
alcohol production through 2-keto-acid pathways. Through the choice of different KDCs, 2-keto 
acids from various amino acid synthesis pathways can be used to produce long chain alcohols 
including isobutanol, 1-butanol, 2-methy1-butanol, 3-methy1-butanol and 2-phenylethanol 
(27,32,33).  
Aliphatic hydrocarbons, such as alkenes and alkanes, are highly attractive targets for 
advanced biofuel production as they are currently the major constituents of jet fuel, gasoline, and 
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diesel. Though alkenes are naturally produced by many species, the genetic and biochemical 
mechanism for alkene synthesis remains unclear. Keasling and co-workers achieved long-chain 
alkene production through the expression of a three-gene cluster from M. luteus in a fatty acid 
overproducing E. coli strain. After a series of biochemical characterizations of the strain, a 
metabolic pathway for alkene biosynthesis was proposed involving acyl CoA thioester and 
decarboxylative Claisen condensation catalyzed by OleA (34). In another report, del Cardayre 
and co-workers elucidated an alkane biosynthesis pathway from cyanobacteria (35). In this 
pathway, intermediates of fatty acid metabolism are converted to alkanes and alkenes by an acyl 
carrier protein reductase and an aldehyde decarbonylase. Heterologous production of C13 to C17 
mixtures of alkanes and alkenes was achieved in E. coli by the expression of this pathway. 
In addition to alcohols and aliphatic hydrocarbons, fatty acid derived fuel alternatives 
such as fatty acid esters and fatty alcohols are also potential fuel alternatives. In a recent study by 
Keasling and co-workers (36), recombinant E. coli strains were engineered to overproduce free 
fatty acid through cytosolic expression of a native E. coli thioesterase and the deletion of fatty 
acid degradation genes. Furthermore, the chain length and saturation of the fatty acid chain can 
be controlled by simply altering the thioesterase used in the pathway. The recombinant strain was 
further modified to directly produce fatty acid ethyl esters (FAEEs) via the introduction of 
ethanol production genes from Z. mobilis and overexpression of endogenous wax-ester synthase. 
Finally, hemicellulases from various species were expressed in recombinant fatty acid derivative 
producers and secreted into the medium to realize consolidated bioprocessing of hemicellulose 
biomass directly into biodiesels.  
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1.2 Pentose Sugar Utilization in Saccharomyces cerevisiae 
Biofuels are under intensive investigation due to increasing concerns about energy 
security, sustainability, and global climate change (1). Biological conversion of plant-derived 
lignocellulosic materials into biofuels has been regarded as an attractive alternative to the 
chemical production of fossil fuels (3,37). Saccharomyces cerevisiae, also known as baker’s 
yeast, has been used for bioconversion of hexose sugars into ethanol for thousands of years. It is 
also the most widely used microorganism for large scale industrial fermentation of glucose into 
ethanol. S. cerevisiae is an excellent organism for bioconversion of lignocellulosic biomass into 
biofuels (38). This microorganism has a well-studied genetic and physiological background, 
ample genetic tools, and high tolerance to ethanol and inhibitors present in lignocellulosic 
hydrolysates (39). Moreover, the low fermentation pH of S. cerevisiae can also prevent bacterial 
contamination.  
Lignocellulosic biomass is composed of cellulose, hemicellulose, and lignin. The 
hemicellulose component comprises 20~30% of lignocellulosic biomass, and it is primarily 
composed of five-carbon sugars (pentoses) such as xylose and arabinose (40). Complete 
substrate utilization is one of the prerequisites to render cellulosic ethanol processes 
economically competitive (14,41). Unfortunately, the most widely used ethanol producing 
microorganism, baker’s yeast (Saccharomyces cerevisiae), cannot ferment pentose sugars into 
ethanol (13). On the other hand, there are many naturally existing fungal and bacterial species 
which can utilize pentose sugars efficiently. However, these microorganisms are not compatible 
with industrial ethanol fermentation due to their complicated physiology and low ethanol 
productivity (42). 
To overcome this limitation, pentose utilization pathways from pentose-assimilating 
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organisms have been introduced into S. cerevisiae, allowing fermentation of xylose and 
arabinose (43-52). Over the past few decades, pentose utilization pathways from various species 
have been transferred into S. cerevisiae allowing fermentation of xylose and arabinose (43-47). 
However, pentose utilization of recombinant S. cerevisiae strains are inefficient due to the low 
expression level and activity of heterologous proteins, the redox imbalance that results from 
different cofactor preference for oxidation and reduction reactions, and suboptimal metabolic 
flux through different catalytic steps (13). A lot of research has been carried out to improve the 
pentose utilization in S. cerevisiae by targeting different aspects of these issues (53,54), but it is 
very challenging to come up with a single strategy which can solve all three problems at the 
same time. 
1.2.1 Sugar Uptake 
Sugar uptake through corresponding sugar transporters is the first step of sugar 
utilization. S. cerevisiae has a complicated glucose uptake system composed of seventeen hexose 
transporters and several sensors and regulators. The hexose transporters family consists of both 
high-affinity and low-affinity transporters. Expression of different kind of transporters are 
regulated by sensors and regulators according to various sugar concentrations in the environment 
(55). In contrast, S. cerevisiae lacks an efficient transport system for the uptake of pentose 
sugars. Pentose sugars can only enter S. cerevisiae cells through the hexose uptake system but 
with two orders of magnitude lower affinity (52). As a result, xylose uptake in xylose-
assimilating yeast strains is very slow and inhibited by glucose present in the environment.  
Xylose uptake has been found to be the limiting step in some recombinant xylose 
assimilating S. cerevisiae strains (42). Significant improvement of xylose uptake activity has also 
been found in an engineered S. cerevisiae strain obtained through evolutionary engineering 
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aimed for efficient xylose fermentation (56). Therefore, improving xylose uptake activity 
through the introduction of more efficient xylose transporters can be a viable strategy to facilitate 
xylose utilization in recombinant S. cerevisiae strains (48,57). 
Nature has evolved many pentose assimilating fungal strains in which both low-affinity 
and high-affinity sugar transport systems are present for pentose uptake (43,58,59). To improve 
xylose uptake, heterologous xylose transporters were introduced into recombinant S. cerevisiae 
strains. Leandro and coworkers discovered one high-affinity xylose/glucose symporter (GXS1) 
and one low-affinity xylose/glucose facilitator (GXF1) from Candida intermedia and 
characterized them in S. cerevisiae at the molecular level (58). It has also been observed that 
overexpression of the Gxf1 transporter can improve fermentation performance in recombinant 
xylose-utilizing S. cerevisiae (60). Strains expressing heterologous xylose transporters from 
Arabidopsis thaliana showed up to a 2.5-fold increase in xylose consumption rate and a 70% 
increase in ethanol production rate (13). Overexpression of a glucose transporter Sut1 from 
Pichia stipitis was also shown to improve ethanol productivity during xylose and glucose co-
fermentation by a xylose-assimilating S. cerevisiae strain(61). 
Recently, a functional survey has been done on a group of twenty-six known and putative 
monosaccharide transport proteins by Young and coworkers using S. cerevisiae as a host. These 
known and putative transporter proteins were cloned from a wide collection of species such as 
Arabidopsis thaliana, Candida intermedia, Cryptococcus neoformans, Debaryomyces hansenii, 
E. coli, and Pichia stipitis. The transporters proteins were introduce separately into a transporter 
knockout S. cerevisiae strain hosting a P. stipitis-based oxidoreductase pathway. The function of 
the transporter proteins were assayed using a growth rate based approach on different 
monosaccharide substrate. In all the known and putative transporter proteins they cloned, ten 
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were found to be functional as a transporter of sugars. However, all assayed transporters showed 
board substrate ranges and preferred glucose as a substrate. (62) 
Neurospora crassa and Pichia stipitis, two organisms which have complete genomic 
sequence data available, can utilize pentose sugar very efficiently (63,64). In Pichia stipitis, three 
glucose/xylose transporters (SUT1-3) were cloned and characterized at the molecular level (65). 
Overexpression of SUT1 has been shown to facilitate xylose consumption and ethanol 
production in recombinant xylose assimilating S. cerevisiae (66). However, as a xylose 
assimilating filamentous fungus species, no pentose transporter has been identified from 
Neurospora crassa so far. 
Molecular characterization of the glucose/xylose-H+ symporter from Candida intermedia 
unveiled a group of putative, previously uncharacterized, fungal sugar transporters (66). With the 
sequence of the characterized xylose symporter, it is also possible to discover new sugar 
transporters based on sequence homology from genome-sequenced fungal species such as 
Neurospora crassa and Pichia stipitis. 
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1.2.2 Heterologous Pentose Utilization Pathways 
 
Figure 1.2 Oxidoreductases-based and isomerases-based pathways for pentose utilization 
 
To be utilized by ethanol producing S. cerevisiae, pentose sugars need to be first 
transported into cells and then converted into D-xylulose-5-phosphate which can be further 
metabolized through the pentose phosphate pathway. In order to enable the efficient conversion 
of xylose and arabinose into xylulose-5-phosphate, heterologous pathways need to be introduced 
into S. cerevisiae. There are two types of pentose metabolic pathways that can be introduced into 
yeast, the fungi-originated oxidoreductases based pathways and the bacteria-originated 
isomerases based pathways (Figure 1.2) (67)  
The fungal-originated oxioreductases based pathways require the use of cofactors to be 
functional, whereas the isomerases based pathways operate independently of cofactors. In 
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contrast to the co-factor dependent oxidoreductases based pathways, isomerases based pathways 
appeared to be a more attractive option because of its lack of cofactor imbalance. In isomerases 
based pathways, xylose is converted into D-xylulose through the use of a single xylose 
isomerase, while arabinose is converted into D-xylulose-5-phosphate by an arabinose isomerase, 
a ribulokinase and an L-ribulose-5-phosphate-4-epimerase through the intermediate of L-ribulose 
and L-ribulose-5-phosphate. Recently, both isomerases based xylose and arabinose utilization 
pathways have been constructed in S. cerevisiae. However, most isomerases based pathways 
suffered from poor performance due to the difficulty of heterologous expression in bacteria-
originated enzymes within yeast, the lack of thermodynamic driving force, and an insufficient 
metabolic flux through the pathways without evolutionary engineering.(44,45,68,69) Researchers 
are currently actively working on improving expression of isomerases based pathway related 
genes from rare fungal sources as well as understanding the recombinant strains that have been 
obtained through evolutionary engineering (70,71). 
Although the oxidoreductases based pentose utilization pathways suffered from several 
disadvantages, such as the potential cofactor imbalance issue and a low ethanol yield compared 
to the isomerases based pathways, they did exhibit a number of obvious advantages such as a 
much higher growth rate as well as an increased consumption and ethanol production rates both 
under aerobic and anaerobic conditions. In oxidoreductases based pathways, xylose is reduced to 
xylitol by aldose reductase and xylitol is oxidized by xylitol dehydrogenase. The resultant D-
xylulose is then converted into D-xylulose-5-phosphate by xylulokinase. The oxidoreductases 
based pathway from native xylose assimilating yeast Pichia stipitis has been the best studied 
heterologous xylose utilization pathway so far. The major problems for the fungal xylose 
pathway were low metabolic flux through the heterologous pathway, redox imbalance due to 
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different co-factor preference of the reductase and the dehydrogenase, and suboptimal metabolic 
flux due to the fact that D-xylose was not a recognizable fermentable substrate (72). To improve 
the fermentative ability of the fungal xylose utilization pathway, researchers have been actively 
working on finding heterologous enzymes with better catalytic efficiency and cofactor specificity 
(17), to balance the cofactor usage of the pathway (18), and to optimize ethanol production using 
more robust industrial ethanol producing strains (73).   
The oxidoreductase based arabinose utilization pathway is a little more complicated 
compared to the xylose utilization pathway, because two additional enzymes, L-arabitol 4-
dehydrogenases and L-xylulose reductases, are required to convert L-arabitol into L-xylulose and 
L-xylulose into D-xylulose, respectively. Recently, several research groups have achieved ethanol 
production on arabinose by the introduction of a fungal arabinose pathway from different fungal 
species into S. cerevisiae (74,75). The heterologous arabinose pathways usually exhibit a low 
activity and prolonged evolutionary engineering was sometimes needed to improve strain 
performance (76). 
1.2.3 Metabolic Engineering of Fungal Xylose Utilization Pathway in S. cerevisiae 
Over the past several decades, numerous efforts from many excellent research groups 
have been invested to develop a recombinant S. cerevisiae for the efficient conversion of xylose 
into ethanol. To enable xylose assimilation in S. cerevisiae, a xylitol dehydrogenase has to be 
introduced to convert xylitol into D-xylulose. At the same time, due to the insufficient activity of 
endogenous aldose reductase and xylulokinase, heterologous or endogenous xylose reductase 
and xylulokinase are usually overexpressed to enable fast consumption of xylose (77). 
One key problem for oxidoreductase xylose utilization pathway is the cofactor imbalance 
issue caused by the different cofactor preference of xylose reductase (XR) and xylitol 
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dehydrogenase (XDH). Many XRs from various species have been investigated and most of the 
naturally occurring XRs exclusively prefer to use NADPH as a cofactor. On the contrary, most 
XDHs characterized so far only use NAD+ as a cofactor (41,78-80). To address this issue, a large 
amount of effort has been spent on heterologous expression of new XR and XDH homologous as 
well as engineering existing enzymes. XRs from various fungal species such as Candida 
shehatae (81), Candida tenuis (82), Candida tropicalis (83), and Aspergillus oryzae (84) have 
been introduced into S. cerevisiae.  At the same time, XDHs from different sources, such as 
Aspergillus oryzae (84) and Pichia angusta (85), were also characterized. More effort has also 
been spent on engineering a matching pair of XR and XDH by altering their cofactor specificities 
(86). Zeng and coworkers applied site-directed mutagenesis on the XR from P. stipitis and 
achieved complete reversal of coenzyme specificity towards NADH coupled with an 
improvement of catalytic efficiency at the same time (87).  Using this type of engineered XR, the 
cofactor imbalance issue could be solved by making XR and XDH use NADH and NAD+ as the 
cofactor pair for the oxidoreductases based xylose pathway. Concurrently, some researchers have 
been tackling this problem from the complete opposite direction by engineering a NADP+ 
specific XDH and a strict NADPH specific XR (88-90).  
Aside from the cofactor imbalance issue, the relative activity of XR, XDH, and XKS is 
also a crucial factor on efficient xylose assimilation (91). Eliasson and coworkers used a kinetic 
model to determine that a 1:≥10:≥4 relation of the XR/XDH/XKS activity ratio was optimal for 
xylose utilization by minimizing xylitol formation. The theory was tested in XR-, XDH- and 
XKS- expressing S. cerevisiae strains and the stain with a XR/XDH/XKS ratio corresponding to 
the theoretical optimal exhibited the highest efficiency in xylose fermentation (91). In a later 
study, Matsuchika and coworkers investigated the expression ratio of XR/XDH/XKS by varying 
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the promoter strength of XR and the copy number of XKS in XDH expressing recombinant S. 
cerevisiae strains. The highest ethanol yield and lowered xylitol yield were observed in a strain 
with high activity of both XR and XDH and a moderate activity of XKS (92). Jin and coworkers 
also studied the flux change of xylose metabolites by altering the copy number of the XDH gene. 
They found out that higher XDH activity and aeration resulted in less xylitol and more xylulose 
accumulation. This result also supported the hypothesis that XKS limits the metabolic flux in 
recombinant xylose fermenting stains (53). In a later study, a genomic fragment library from P. 
stipitis was introduced into recombinant S. cerevisiae expressing both XR and XDH. After 
enrichment of the library, ten out of sixteen library mutants were found to contain the XKS gene, 
which further proved the XKS was a very important gene for increasing xylose utilization (93). 
In addition to engineering the XR, XDH, and XKS genes, some other modifications have 
also been made to improve the xylose fermentation ability of recombinant S. cerevisiae strains.  
Träff-Bjerre and coworkers found that deletion of endogenous NADPH-dependent aldose 
reductase GRE3 decreased the xylitol yield and increased ethanol yield in a XR, XDH, and XKS 
expressing S. cerevisiae strain. It has also been shown by Johansson and coworkers that 
simultaneous overexpression of the four non-oxidative pentose phosphate pathway (PPP) 
enzymes together with the overexpression of XR, XDH, and XKS would improve the xylulose 
fermentation ability in recombinant strains (94). Karhumaa and coworkers also successfully 
constructed a fast xylose assimilating strain: a recombinant strain with XR and XDH 
overexpression on a multicopy plasmid in a strain background with PPP and XKS 
overexpression (95). Previous studies indicated that overly high XKS activity will result in 
growth inhibition in recombinant strains growing on xylose (54). Ni and coworkers performed a 
transposon mutagenesis study on the XKS overexpression strain and found that the deletion of 
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para-nitrophenyl phosphatase PHO13 or overexpression of transaldolase TAL1 can relieve the 
growth inhibition caused by XKS overexpression (96). Van Vleet and coworkers further proved 
the PHO13 deletion can improve the xylose utilization rate and reduce glycerol production by 
altering redox levels in XKS overexpressing strains (97). 
To further improve the xylose fermentation ability of recombinant strains, different strain 
background was also tested for ethanol production on xylose. A good host strain for industrial 
xylose fermentation must have good tolerance toward inhibitors present in lignocellulosic 
hydroglysate, and high productivity and tolerance of ethanol (98). More importantly, the host 
strain must have an effective PPP pathway.  It has been previously shown that different S. 
cerevisiae strains have distinct xylulose fermentation abilities due to their inherent capacities for 
pentose sugar metabolism (73). Matsushika and coworkers constructed five different 
recombinant S. cerevisiae strains using different laboratory and industrial parental strains. After 
comparison of these recombinant strains, the xylose utilizing strain, constructed by chromosomal 
integration of XR and XDH from P. stipitis together with endogenous XKS, exhibited the most 
efficient xylose-to-ethanol fermentation ability (73). Another major advance was performed by 
Ho and coworkers, who used the polypoid Saccharomyces sp. strain 1400 as a host strain. The 
XR and XDH from P. stipitis and S. cerevisiae endogenous XKS were introduced into this strain 
using a high copy number plasmid. The resulting recombinant strain was able to conferment 
most of the 8% glucose and 4% xylose to ethanol within 48 hours (99). 
1.3 Strategies for Balancing Metabolic Flux 
Introduction of metabolic pathways consisting of more than one gene are usually required 
for production of value-added compounds in microbial cell factories (100). To facilitate 
commercially viable production of target compounds, the metabolic flux in the heterologous or 
 18 
endogenous pathways need to be optimized to avoid metabolic burden resulted from 
overexpression of certain genes, redox imbalance from unmatched cofactor specificity, and 
accumulation of unstable or toxic intermediates (101,102). Although traditional metabolic 
engineering approaches involving identification of bottlenecks in metabolic pathways and 
debottlenecking the pathway through overexpression and deletion of key metabolic gene yielded 
limited success in balancing metabolic flux, simultaneous operation of several metabolic genes 
remained highly desirable yet overwhelming (103). Many new techniques have been recently 
developed to enable optimization of metabolic pathways through either perturbation of global 
transcription machinery (104), genomic-scale mapping of fitness altering genes (105,106), or 
multiplex genome engineering to optimize metabolic flux at a global level (107). At the same 
time, a lot of efforts have also been spent to balance metabolic flux within the target pathway 
through tuning of expression level of certain genes through engineering of the strengths of 
promoters (104), ribosome binding sites (108), and intergenic regions (101).  
Due to the drastic advances in metabolic engineering and combinatorial design and 
synthetic biology, there is an increasingly urgent need for the development of genetic tools that 
enable the rapid assembly of large DNA molecules (109). For example, for biofuel production 
from lignocellulosic feedstock via chemicals, heterologous pathways involved in breaking down 
polysaccharide, utilizing pentose sugars, and producing these advanced biofuels need to be 
sequentially introduced into microbial factories. Each catalytic step consists of separate parts 
including the open reading frame of the catalytic gene, promoters, terminators, and the regulation 
elements themselves. For construction of these heterologous pathways, the conventional multi-
step sequential cloning method involving iterative steps of restriction digestion and ligation 
would prove to be exceptionally time consuming as well as extraordinarily inefficient, if not 
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altogether impossible, due to the limited availability of unique restriction sites (110). 
To tackle the problem of synthesizing large metabolic pathways using a traditional 
cloning method, a homologous recombination-based in vivo assembly method was developed by 
Dr. Zengyi Shao from our research group. Taking advantage of the in vivo homologous 
recombination in S. cerevisiae, DNA fragments that shares identical sequence with neighboring 
fragments can be simply assembled into a desired construct through a single step of yeast 
transformation. Using this new approach, metabolic pathways up to around 19 kb of size were 
assembled from nine DNA fragments in one step(111) (Figure 1.3). 
 
Figure 1.3 Scheme of pathway assembly using DNA assembler. A. Assembling pathways into a plasmid 
using DNA assembler. B. Assembling pathways into a chromosome using DNA assembler 
 
Compared to the conventional restriction-digestion-based cloning method, the DNA 
assembler method exhibits several advantages. First and foremost, the cloning work done with 
the DNA assembler method is completely independent of the availability of restriction sites. The 
feature is extremely valuable when the sequences of the genes involved in the pathway are not 
completely clear. Second, the DNA assembler method enables the construction of long and 
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complicated pathways consisting of multiple genetic elements via a single step of yeast 
transformation. Taking advantage of this feature, plasmids bearing multi-step metabolic 
pathways or multi-component gene expression cassettes were constructed very rapidly and 
efficiently. Third, the DNA assembler method is very efficient when a reasonable length of DNA 
sequence was used as an overlap region for pathway assembly. With the high efficiency provided 
by the assembler method, in vivo assembly and screening of a pathway library became a feasible 
approach for optimization of metabolic pathways.  
1.4 Project Overview 
 
This thesis focuses on metabolic engineering of S. cerevisiae for efficient ethanol 
production from pentose sugars. Pentose sugars can make up to 5~30% of lignocellulosic 
hydrolysate. Unfortunately, S. cerevisiae, which is the most widely used microorganism for large 
scale production of ethanol from bio-derived feedstock, cannot utilize pentose sugars as a carbon 
source for ethanol production. Introduction of heterologous genes from pentose-assimilating 
species enabled the consumption of pentose sugars in S. cerevisiae at a slow rate. The main 
challenges for pentose utilization of recombinant S. cerevisiae strains remain in inefficient 
pentose sugar uptake, low expression level and activity of heterologous proteins, redox 
imbalance resulting from different cofactor preference for oxidation and reduction reactions, and 
suboptimal metabolic flux through the different catalytic steps (13). 
In the second chapter of this thesis, we attempted to address the inefficient pentose uptake 
issue for pentose utilization in S. cerevisiae. As wild type S. cerevisiae could not utilize pentose 
sugars as its sole carbon source, it also lacks an efficient pentose uptake system for assimilation 
of pentose sugars. Pentose sugars can only enter S. cerevisiae through the hexose transport 
systems with two orders of magnitude lower affinity. The inefficient uptake of pentose sugars 
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could be one of the main reasons for “glucose repression,” where the utilization of pentose 
sugars only starts after the glucose in the environment has been depleted. Taking advantage of 
the sequence information of the newly characterized glucose/xylose symporter and 
glucose/xylose facilitator in Candida intermedia (58), and the recently available genomic 
sequence of pentose assimilating strain Pichia stipitis (64) and Neurospora crassa (63), a group 
of putative pentose transporters have been identified based on protein sequence similarity. These 
putative pentose transporters were cloned into a transporter knockout strain with no pentose 
uptake activity and their xylose and arabinose uptake ability was tested using a HPLC-based 
approach. After testing of eighteen putative transporters, two xylose-specific transporters and one 
arabinose-specific transporter were discovered. The expression and localization of these 
transporters were studied using confocal imaging of transporter-GFP fusion proteins. The kinetic 
parameters of the pentose-specific transporters were then determined using a 14C-labled sugar 
uptake assay. Finally, the xylose-specific transporters were overexpressed in xylose utilizing 
recombinant strains to facilitate the xylose utilization. 
Chapter 3 and Chapter 4 mainly focus on the optimization of a heterologous fungal 
xylose utilization pathway for xylose fermentation. In Chapter 3, a serial of enzyme homologues 
were cloned from various fungal species for each of the three catalytic steps in xylose utilization. 
These enzyme homologous include enzymes previously reported in literature, enzyme 
homologues annotated in online databases, and putative enzymes identified based on protein 
sequence similarity. This collection of enzyme homologues with different enzymatic activity, 
cofactor specificity, kinetic parameters, and substrate preference were assembled into a pathway 
library using our newly developed DNA assembler method. Characterization of the resulting 
pathway library confirmed the high efficiency and diversity within the library assembly. Various 
 22 
strategies were then applied to identify fast xylose utilizing pathways from the library. Finally, a 
pathway mutant with improved xylose utilization ability was identified using a colony size-based 
screening method. 
In Chapter 4, a promoter-based pathway optimization strategy was applied for 
optimization of xylose fermentation in S. cerevisiae. Enzyme homologues with the highest 
activity and matched cofactor specificities were identified through activity measurement of all 
the enzyme homologues cloned from various species. A three gene pathway consisting of the 
xylose reductase from Candida shehatae, the xylitol dehydrogenase from Candida tropicalis,  
and the xylulokinase from Pichia pastoris were used to fine-tune the expression level of the 
xylose utilization pathway for efficient fermentation. Promoter mutant libraries were created 
using S. cerevisiae native promoter TEF1, PDC1 and ENO2 as templates via nucleotide analogue 
mutagenesis (112,113). Promoters with varying strengths were incorporated with a fixed set of 
catalytic enzymes to create a library of xylose utilization pathways with different expression 
profiles using the DNA assembler method. The resulting library was screened using a colony-
size-based screening method in laboratory and industrial strains. Fast mutants identified from 
different strain backgrounds exhibited a much higher xylose fermentation ability when compared 
to the xylose pathways driven by wild type promoters.  
In Chapter 5, a variety of genetic tools were developed for metabolic engineering in 
polyploid S. cerevisiae strains. First, several positive selection markers were tested in various 
industrial strains and single copy shuttle vectors based on functional markers were constructed 
for introduction and direct pathway assembly in industrial strains. Second, a collection of 
expression vectors for site-specific and delta-integration in polyploid yeast chromosomes were 
constructed for chromosomal integration of heterologous pathways into industrial yeast. Last, a 
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scar-less gene modification method was adapted for use in polyploid industrial strains for the 
genetic deletion, insertion, and modification of industrial strains.  
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Chapter 2 Discovery and Characterization of Pentose-Specific 
Transporters 
2.1 Introduction 
Pentose uptake is the first step of pentose utilization in Saccharomyces cerevisiae. 
Currently, pentose sugars can only enter yeast cells through hexose transporters which have two 
orders of magnitude lower affinity and capacity (1), suggesting that pentose uptake can be a 
limiting step for pentose utilization. In contrast, native D-xylose utilizing yeasts have been shown 
to use both low-affinity and high-affinity pentose sugar transport systems for D-xylose and L-
arabinose uptake (2,3). To address this problem, researchers have tried to overexpress different 
sugar transporters in S. cerevisiae to facilitate pentose uptake. Recent studies have shown that 
introducing D-xylose transporters can improve D-xylose utilization in S. cerevisiae (4-6) (Table 
2.1). Despite the significance of pentose transporters for pentose utilization in S. cerevisiae, very 
limited research has been done so far to characterize novel pentose transporters in S. cerevisiae 
(7). In one notable example, Leandro and coworkers discovered two new D-glucose/D-xylose 
transporters from Candida intermedia and characterized them at the molecular level. Of the two 
D-glucose/D-xylose transporters, one is a D-xylose-H
+
 symporter while the other is a D-xylose 
facilitator (2).  
There are a number of properties that contribute the different performance of sugar 
transporters. First, since sugar transporter has to be correctly folded and localized into the cell 
membrane to be active, transporter localization is very important when introducing a sugar 
transporter into another species. Second, there are two types of transporters in S. cerevisiae, 
including symporters and facilitators. For symporters, sugar uptake is coupled with proton uptake 
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and ATP is needed in order to generate the proton gradient for sugar uptake. In contrast, sugar 
uptake is not coupled with proton uptake for facilitators; therefore, no ATP is required for sugar 
uptake with facilitator transporters. Usually, symporters exhibit higher sugar uptake affinity 
when  compared to facilitators (2). Third, similar to enzymatic reaction kinetics, the kinetics of 
sugar uptake can be described using a non-linear model; when sugar transport rate is plotted 
against extracellular sugar concentrations, the maximum sugar uptake rate is defined as Vmax for 
a certain sugar transporter and the sugar concentration at which the uptake rate is half of the 
maximum sugar uptake rate is defined as Km (8). 
 
Table 2.1 Recent developments in characterization of pentose transporters 
 
Microorganism  Transporter Characterization 
Candida intermedia  High affinity glucose/xylose-proton symporter  
 Low affinity glucose/xylose facilitator 
 Characterized at molecular level 
Trichoderma reesei   Trxlt1: transport xylose but not glucose after 
adaptive mutation 
Candida arabinofermentans and 
Pichia guilliermondii 
 L-arabinose transporters characterized (not at 
molecular level) 
Pichia stipitis  Low affinity xylose transporter SUT1~3 
 Heterologous expression of SUT1 can improve 
ethanol production on xylose 
Pichia stipitis, Saccharomyces 
cerevisiae, Arabidopsis thaliana, 
Cryptococcus neoformans, 
Debaryomyces hansenii,  
and E. coli 
 Ten active transporters were identified 
 Broad substrate ranges  
 Always prefer glucose as a substrate 
 
Based on the gene sequence of GXS1 and the recently available genome sequences of 
pentose-assimilating fungal species Neurospora crassa and Pichia stipitis, I identified 17 
putative pentose transporters using BLAST search based on sequence homology. These putative 
transporters were cloned and introduced into a sugar transporter knockout strain and tested for 
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their pentose uptake activity. Seven active transporters were identified through a HPLC-mediated 
sugar uptake assay. Among the active transporters, two D-xylose-specific and one L-arabinose-
specific transporters were discovered. The D-xylose-specific transporters, An25 and Xyp29, 
together with the L-arabinose-specific transporter Xyp32, were characterized for their cellular 
localization, type, and kinetic parameters.  
2.2 Results 
2.2.1 Genome Mining for Putative Pentose Transporters 
Characterization of D-glucose/D-xylose symporter GXS1 revealed a very important piece 
of information regarding the sequence/function relationship of D-xylose transporters in yeast. 
Comparison of the amino acid sequence of GXS1 with recently available genome sequence 
information of N. crassa and P. stipitis may lead to discovery of additional D-xylose transporters 
active in S. cerevisiae (2). To search for candidates for pentose transporter research, proteins 
sharing high sequence identity with Gsx1 were investigated using BLAST 
(http://www.ncbi.nlm.nih.gov/). In order to identify more candidates, uncharacterized putative L-
arabinose-proton symporter from Pichiaa stipitis (AUT1, locus tag PICST_87108) was also used 
as a template for the BLAST search. The BLAST searches for putative transporters in N. crassa 
and P. stipitis were performed separately. 
The results of the BLAST searches were screened to eliminate any protein with known 
activity of D-glucose uptake or activity other than sugar uptake. Using a cut-off of 25% 
minimum identity, 17 putative transporters were identified from the BLAST searches (Table 
2.2). Together with AUT1 from P. stipitis, 18 putative transporters were cloned. These putative 
transporters shared 25~50% identity with either GSX1 from Candida intermedia or AUT1 from 
Pichia stipitis. All 17 putative transporters were annotated to be either sugar uptake proteins or 
 42 
hypothetical proteins with unknown activity. D-glucose transporter SUT1 and SUT2 from P. 
stiptis were also cloned for comparison.  
 
Table 2.2 Putative pentose transporters from BLAST search  
 
BLAST search result using AUT1 (Locus tag PICST_87108) from Pichia stipitis as a probe 
Name Origin % identity 
with AUT1 
Annotation Length 
(cDNA) 
Locus Tag 
Ap31 
(SUT2) 
P. stipitis 31 Sugar UpTake (tentative) 1653 ABN66266 
Ap26 P. stipitis 26 Sugar transporter 1404 XP_001387242 
AN49 N. crassa 49 hypothetical protein NCU01494 
similar to MFS sugar transporter 
2025 EAA26691 
AN41 N. crassa 41 hypothetical protein NCU09287 
similar to galactose-proton symport 
1968 EAA28903   
AN29-2 N. crassa 29 hypothetical protein NCU04963 
similar to MFS monosaccharide 
transporter 
1584 EAA30175 
AN28-3 N. crassa 28 hypothetical protein NCU02188 
conserved hypothetical protein 
1458 EAA30346 
AN25 N. crassa 25 sugar transporter 1653 EAA35128 
 
BLAST search result using GSX1 from Candida intermedia as a probe 
Name Origin % identity 
with GSX1 
Annotation Length 
(cDNA) 
Locus Tag 
Xy50 N. crassa 50 hypothetical protein NCU04537 1620 EAA26741 
Xy31 N. crassa 31 hypothetical protein NCU06138 
similar to MFS monosaccharide 
transporter" 
1752 EAA30764 
Xy33 N. crassa 33 hypothetical protein NCU00988 
similar to MFS quinate transporter" 
D-xylose transporter; PRK10077 
Sugar (and other) transporter; 
pfam00083 
1614 EAA34662 
Xyp37 
(SUT3) 
P. stipitis 37 Sugar UpTake (tentative) 1653 ABN67990   
Xyp33 
(XUT3) 
P. stipitis 33 sugar transporter, putative 
Xylose UpTake (tentative) Predicted 
transporter (major facilitator 
superfamily) with sequence similarity to 
similar; 
1656 EAZ63115 
Xyp32 
(XUT1) 
P. stipitis 32 sugar transporter, high affinity, putative 
"Xylose UpTake (tentative); 
D-xylose transporter; PRK10077 
1701 ABN67554 
Xyp30 
(STL1) 
P. stipitis 30 sugar transporter, strongly conserved; 
no transcript evident 
1587 ABN65745 
Xyp31 
(XUT2) 
P. stipitis 31 Sugar transporter, xylose transporter 
(tentative) similarity to GXS1 (STL1); 
1404 AAVQ01000002 
Xyp29 
(STL12) 
(XUT6) 
P. stipitis 29 Sugar transporter, putative (STL12) 
xylose uptake (tentative) 
1635 ABN68560 
Xyp30-1 
(HGT3) 
P. stipitis 30 high affinity xylose transporter 
(putative) 
1587 ABN68686 
Xyp28 
(XUT7) 
P. stipitis 28 xylose transporter, high affinity, 
putative 
1251 EAZ63044 
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2.2.2 Cloning of Putative Pentose-Specific Transporters 
N. crassa and P. stipitis were cultivated in rich media supplemented with D-xylose or L-
arabinose as the sole carbon source. Next, total RNA was isolated from the fungal strains and 
reverse transcribed into cDNA using a Transcriptor First Strand cDNA Synthesis Kit (Roche 
Applied Science, Mannheim, Germany). Putative transporters were amplified directly from 
cDNA through polymerase chain reaction (PCR), if possible. Because the regulation mechanism 
and expression pattern were not clear for pentose transporters in fungal species, cDNAs encoding 
for putative transporters were not always obtainable despite alteration of cultivation conditions. 
In this case, primers were designed according to the corresponding cDNA sequence from 
GenBank and were used to amplify gene sequences using genomic DNA as a template (Table 
2.3). Overlap-extension PCR was then used to get the corresponding full-length gene without 
introns. 
The above-mentioned PCR products were then cloned into a pRS424 shuttle vector (New 
England Biolabs, Beverly, MA) with a HXT7 promoter and a HXT7 terminator using the DNA 
assembler method (9). Yeast plasmids isolated from transformants were retransferred into E. coli 
DH5α. Isolated E. coli plasmids were first checked by diagnostic PCR using the primers 
originally used to amplify the transporter genes. The entire open reading frames were then 
submitted for sequencing to confirm the correct construction of plasmids.  
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Table 2.3 List of primers for putative pentose transporters cloning 
 
Name Forward Primer Reverse Primer 
SUT2 caaaaagtttttttaattttaatcaaaaaatgtcctcacaagatttacc gatcatgaattaataaaagtgttcgcaaactaaacttgctcttgctcttttgc 
Ap26 caaaaagtttttttaattttaatcaaaaaatgaagtattttcaaatctgg gatcatgaattaataaaagtgttcgcaaatgagaacaaatcgtcaatggc 
AN49 caaaaagtttttttaattttaatcaaaaaatggcgtcgaacccaacgaac gatcatgaattaataaaagtgttcgcaaactacaccttcccagcagcatcc 
AN41 caaaaagtttttttaattttaatcaaaaaatgggccacaatccagacctg gatcatgaattaataaaagtgttcgcaaactaagaattaggagcattaac 
AN29-2 caaaaagtttttttaattttaatcaaaaaatgaagccatttctggggctc gatcatgaattaataaaagtgttcgcaaactacgactcccgattacctcc 
AN28-3 caaaaagtttttttaattttaatcaaaaaatgtccgccatcgtcgtgaccg gatcatgaattaataaaagtgttcgcaaactaaaccttctcatgctcatgc 
AN25 caaaaagtttttttaattttaatcaaaaaatggcgcctccaaagttcctgg gatcatgaattaataaaagtgttcgcaaattaacgtgtttccttggtg 
Xy50 caaaaagtttttttaattttaatcaaaaaatggagcacgatcactccgcctcc gatcatgaattaataaaagtgttcgcaaagaattcttactcgctatcgctgcggttc 
Xy31 caaaaagtttttttaattttaatcaaaaaatggaattcggtggcggaggcggctc
cggc 
cgcccatgtgtttctgaaaggctggcatggc 
cagcctttcagaaacacatgggcgaatacgatccg cacccatacccgtgataaaccgtccggcaag 
cggtttatcacgggtatgggtgtcggatcc ggtcagcttctggattgactacggaaccaac 
cttggaagagatggacatgatcttcggatccg gatcatgaattaataaaagtgttcgcaaagaattcttagacatgctgagaatagtg 
Xy33 caaaaagtttttttaattttaatcaaaaaatgggtctttcgataggaaatagg gatcatgaattaataaaagtgttcgcaaagaattcttagacatgctgagaatagtg 
Xyp37 caaaaagtttttttaattttaatcaaaaaatgtcctcacaagatttaccctcg gatcatgaattaataaaagtgttcgcaaagaattcctaaacttgctcttgctc 
Xyp33 caaaaagtttttttaattttaatcaaaaaatgagagaagttggtattcttg gatcatgaattaataaaagtgttcgcaaagaattcttattctgacatttcaatc 
Xyp32 caaaaagtttttttaattttaatcaaaaaatgcacggtggtggtgacggtaac gatcatgaattaataaaagtgttcgcaaagaattcttatttttcaacgtggtagac 
Xyp30 caaaaagtttttttaattttaatcaaaaaatggcatatcttgattggttaac gatcatgaattaataaaagtgttcgcaaagaattcttaagagctgctggatgcgttttc 
Xyp31 caaaaagtttttttaattttaatcaaaaaatgaagtattttcaaatctgg gatcatgaattaataaaagtgttcgcaaagaattcttatgagaacaaatcgtcaatgg 
Xyp29 caaaaagtttttttaattttaatcaaaaaatgtccagtgttgaaaaaagtgctc gatcatgaattaataaaagtgttcgcaaagaattcttagctgatgttttcgacatg 
Xyp30-1 caaaaagtttttttaattttaatcaaaaaatgtcttcgttattgactaacg gatcatgaattaataaaagtgttcgcaaagaattctcattccatctcattcaacttg 
Xyp28 caaaaagtttttttaattttaatcaaaaaatgacttttgcagttaacttgtat gatcatgaattaataaaagtgttcgcaaagaattcttagtccaaatcgtccaaatcg 
AUT1 caaaaagtttttttaattttaatcaaaaaatgagtgctgacgaaaaagtcgctg gatcatgaattaataaaagtgttcgcaaagaattcctactcgacataagagacttc 
 
2.2.3 Transporter Activity Assay for Putative Pentose Transporters 
To determine the pentose uptake ability of yeast strains expressing putative pentose 
transporters, intracellular accumulation of D-xylose and L-arabinose was measured using high 
performance liquid chromatography (HPLC) (10).  It was reported that a S. cerevisiae strain 
without the D-xylose assimilating pathway is still able to uptake and accumulate D-xylose within 
the cell, though it cannot metabolize it further for growth or fermentation (11). D-xylose 
accumulated within yeast cells will be partially converted to xylitol due to the presence of 
endogenous aldose reductase (12). This work also revealed that L-arabinose can be accumulated 
in S. cerevisiae strain. Similar to D-xylose, a portion of the L-arabinose accumulated will also be 
converted into L-arabitol by an endogenous aldose reductase. D-xylose, xylitol, L-arabinose, and 
L-arabitol can all be extracted using osmosis followed by HPLC analysis (10).  
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In this study, the sugar transporter deletion strain EBY.VW4000 was used for the pentose 
sugar uptake assay. The EBY.VW4000 strain has concurrent knockout of more than 20 sugar 
transporters and sensors including HXT1-17 and GAL2 (13). Growth on D-glucose as the sole 
carbon source was completely abolished in this strain, while uptake of maltose through a 
different sugar transport system is retained. EBY.VW4000 also exhibits minimal D-xylose and L-
arabinose uptake under current assay conditions, which makes it a suitable strain for pentose 
uptake assay. Plasmids expressing putative transporters were transferred into the EBY.VW4000 
strain using a standard lithium acetate method (14) and single colonies were used for 
measurement of sugar uptake activity. EBY.VW4000 strains harbouring putative pentose 
transporters were first grown up in SC-Trp media supplemented with 2% maltose. Cells were 
then harvested and washed before transferring into fresh YPA media supplemented with 2% D-
xylose or L-arabinose. Samples of cell culture were collected after incubation with pentose 
sugars for 24 hours. Cell pellets were washed to remove extracellular sugars and resuspended in 
water and then shook at 37 °C for two days in order to extract intracellular sugars via osmosis. 
Supernatants of cell suspension were filtered and analyzed using a HPLC (Shimadzu, Kyoto, 
Japan) equipped with an HPX-87C column (Bio-Rad Laboratories, Hercules, CA) and an ELSD-
LTII detector (Shimadzu). The pentose uptake ability of putative pentose transporters was 
determined by summation of the concentration of intracellular pentose sugars and corresponding 
sugar alcohols. (Notebook #2, page 289; Notebook #3, page 80&81; Notebook#5, page 137-
139) 
Since D-glucose will be metabolized once it enters a yeast cell, D-glucose transport 
activity cannot be determined by measuring the intracellular D-glucose concentration. However, 
the fact that the EBY.VW4000 strain cannot grow on media with D-glucose as the sole carbon 
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source linked the D-glucose uptake ability with cell survival. If the putative pentose transporter 
has D-glucose uptake activity, it should complement the transporter knockout in the 
EBY.VW4000 strain, resulting in cell survival on media with D-glucose as the sole carbon 
source. 
Using HPLC in combination with the functional assay, several putative pentose 
transporters were identified to have uptake activity towards D-glucose, D-xylose, and L-
arabinose. Introduction of Xyp37, Xyp33, An29-2, and Xy31 restored cell growth of the 
EBY.VW4000 strain on D-glucose. At the same time, Xyp37, Xyp33, and An29-2 also exhibited 
a D-xylose uptake activity, while AN29-1 and Xy31 showed L-arabinose uptake activity at the 
same time (Figure 2.1). 
 
Figure 2.1 Putative pentose transporters with glucose uptake activity. Transporter-expressing plasmids 
were introduced into transporter knockout strains to analyze the intracellular accumulation of D-xylose 
and L-arabinose. After one day incubation of D-xylose or L-arabinose, sugar accumulated in the cells were 
extracted via osmosis. The sugar uptake activity of sugar transporters were determined as mg/mL sugar 
extracted from 1 mL of cell suspension of OD~10. D-Glucose uptake activity of transporters is 
determined by the ability of survival on media containing D-glucose as the sole carbon source. This figure 
showed the pentose sugar uptake activity of cloned transporters with confirmed D-glucose uptake activity. 
 
The rest of putative pentose transporters failed to enable D-glucose uptake in the 
EBY.VW4000 strain. However, the EBY.VW4000 strains harbouring Xyp29 and An25 were 
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able to uptake and accumulate D-xylose within the cells, indicating that they are D-xylose-
specific transporters. Similarly, the EBY.VW4000 strain harbouring Xyp32 was able to 
accumulate L-arabinose, indicating that it may be an L-arabinose-specific transporter (Figure 
2.2). 
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Figure 2.2 Putative pentose transporters without glucose uptake activity. Transporter-expressing plasmids were introduced into transporter 
knockout strains to analyze the intracellular accumulation of D-xylose and L-arabinose. After one day incubation of D-xylose or L-arabinose, sugar 
accumulated in the cells were extracted via osmosis. The sugar uptake activity of sugar transporters were determined as mg/mL sugar extracted 
from 1 mL of cell suspension of OD~10. D-Glucose uptake activity of transporters is determined by the ability of cell survival on media containing 
D-glucose as the sole carbon source. This figure showed the pentose sugar uptake activity of cloned transporters without D-glucose uptake activity. 
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2.2.4 Cellular Localization of Pentose-Specific Transporters 
Sugar transporters are trans-membrane proteins, and correct folding and localization in 
the cell membrane is required for functionality. Since no signal peptide was specifically added 
when the putative pentose transporters were cloned, it is important to ensure that the pentose-
specific transporters are correctly localized in the cell membrane. This is particularly true for 
putative transporters like An25 cloned from filamentous fungi N. crassa, which exhibits a very 
different physiology when compared to S. cerevisiae.  
To study the cellular localization of pentose-specific transporters in S. cerevisiae, An25, 
Xyp29, and Xyp32, were fused with a green fluorescent protein (GFP) at their C-terminus via a 
GS-linker (Gly-Gly-Gly-Gly-Ser-Gly-Gly-Gly-Gly-Ser) (Table 2.4). The resulting plasmids 
were transferred into wild-type S. cerevisiae strain CEN.PK2-1c and fluorescent images were 
taken using a  confocal microscope (Core Facilities, Institute for Genomic Biology, University of 
Illinois at Urbana-Champaign, Urbana, IL).  
Table 2.4 List of Primers for Construction of Transporter-GFP Fusion 
Name  Forward primer Reverse primer 
AN25 AN25 caaaaagtttttttaattttaatcaaaaaatggcgcctccaaagttcct
gg 
ctcatagaacctccacctccagaacctccacctccacgtgtttcctt
ggtgttaatac 
GFP cacgtggaggtggaggttctggaggtggaggttctatgagtaaag
gagaagaacttttc 
gaattaataaaagtgttcgcaaagaattcctatttgtatagttcatcca
tg 
Xyp29 AN29 caaaaagtttttttaattttaatcaaaaaatgtccagtgttgaaaaaag
tgctc 
ctcatagaacctccacctccagaacctccacctccgctgatgttttc
gacatgctc 
GFP cagcggaggtggaggttctggaggtggaggttctatgagtaaagg
agaagaacttttc 
gaattaataaaagtgttcgcaaagaattcctatttgtatagttcatcca
tg 
Xyp32 Xyp32 caaaaagtttttttaattttaatcaaaaaatgcacggtggtggtgacg
gtaac 
ctgatgtctaccacgttgaaaaaggaggtggaggttctggaggtg
gaggttctatgag 
GFP gaaaaaggaggtggaggttctggaggtggaggttctatgagtaaa
ggagaagaacttttc 
gaattaataaaagtgttcgcaaagaattcctatttgtatagttcatcca
tg 
 
 As shown in Figure 2.3, yeast strains expressing D-xylose-specific transporters showed a 
distinctive fluorescent halo at the cell periphery. For An25 and Xyp32, almost all the GFP 
fluorescence appeared in the cell membrane, while a large portion of fluorescence of Xyp29 
expressing cells remained in the cytoplasma. This may indicate inefficient export of the 
 50 
transporter due to an elevated expression of the membrane protein. It has also been noticed that 
not all the cells showed fluorescence (data not shown), indicating that expression of the 
transporter is not optimized or stable. (Notebook #4, page 52-55,;Notebook#5, page 137-139) 
 
 
Figure 2.3 GFP fluorescence images of transporter localization. Fluorescence image of transporter-GFP 
fusion protein (upper row) and cell nuclei dyed with Hoechst 33342 (lower row) are shown of S. 
cerevisiae strain CEN.PK2-1C harboring transporter-GFP fusion protein expressing plasmids. 
 
2.2.5 Type of Pentose-specific Transporters 
There are two types of sugar transporters in S. cerevisiae, symporters and facilitators. For 
symporters, sugar uptake is coupled with proton uptake. Sugar symporters usually exhibit high 
affinities for sugars. Alternatively, sugar uptake through facilitators is not coupled with proton 
transport, and facilitators usually exhibit low sugar uptake affinities (2). Symporter assays were 
performed for An25, Xyp29, and Xyp32 in the EBY.VW4000 strain. No elevation of pH in un-
buffered cell suspensions was observed for any of the pentose transporters, indicating that 
pentose sugar uptake through these transporters were not coupled with proton transport (Figure 
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2.4). In other words, An25 and Xyp29 are D-xylose facilitators while Xyp32 is an L-arabinose 
facilitator. (Notebook #3, page 196-199, page 206-207, page 230-231)  
  
 
  
Figure 2.4 Symporter assay of AN25, Xyp29 and Xyp32. pH change in un-buffered cell 
suspension of S. cerevisiae EBY.VW4000 strains harboring pentose-specific transporter 
expressing plasmids. The arrows in the figures indicated when the sugar solution is added into 
the system. As it shown the figures above, none of the transporter expressing strains showed 
elevated pH with the sugar uptake. 
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2.2.6 Intracellular Accumulation of Pentose Sugars 
Intracellular accumulation of both D-xylose and L-arabinose in the EBY.VW4000 strain 
expressing Xyp29, An25, and Xyp32 was also measured using HPLC. Cell cultures with 30 min, 
60 min, 120 min, and 24 hour incubation with pentose sugars were sampled and analyzed using 
HPLC. As shown in Figure 2.5, EBY.VW4000 strains expressing Xyp29 and An25 exhibited  D-
xylose uptake activity during 24 hour incubation, while EBY.VW4000 strains expressing Xyp32 
only exhibited L-arabinose uptake activity. (Notebook#5, page 137-139) 
 
Figure 2.5 Pentose uptake of AN25, Xyp29 and Xyp32. S. cerevisiae stains EBY.VW4000 harboring 
pentose-specific transporter expressing plasmids are used to test the pentose uptake activity of 
transporters. After various length of incubation with D-xylose or L-arabinose, sugar accumulated in the 
cells was extracted via osmosis. The sugar uptake activity of sugar transporters were determined as 
mg/mL sugar extracted from 1 mL of cell suspension of OD~10. 
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2.2.7 Kinetic Parameters of Pentose-specific Transporters 
To further confirm that Xyp29, An25, and Xyp32 are actually pentose-specific 
transporters with no D-glucose uptake activity, 
14
C-labeled sugar uptake assays were performed 
using 
14
C-labeled D-glucose, D-xylose, and L-arabinose as substrates. As a result, D-glucose and 
L-arabinose uptake activity in the EBY.VW4000 strain expressing only Xyp29, An25, and 
Xyp32 were too low to measure under assay conditions used to determine pentose sugar uptake 
kinetics of both transporters (data not shown). 
Using 
14
C-labeled sugar uptake assay, kinetic parameters of pentose transport through 
An25, Xyp29, and Xyp32 were determined. It has been tested that under the assay condition, 
sugar uptake is within a linear range for the first 60 seconds (data not shown). The 
EBY.VW4000 strains expressing An25, Xyp29, or Xyp32 were incubated with D-xylose or L-
arabinose for 40 or 60 seconds (exactly timed), and sugar uptake was stopped by the addition of 
ice-cold water. The reaction mixture was then filtered and washed before counting with a liquid 
scintillation counter. Sugar uptake rate and substrate concentration were fitted into a Michaelis–
Menten equation by non-linear regression using OriginPro 8.1 (OriginLab Corporation, 
Northampton, MA). The Km towards D-xylose for the transporter knockout strain expressing only 
An25 or Xyp29 were 175.7±21.4 mM and 56.0±9.4 mM, respectively. The Vmax of 
EBY.VW4000 strains harboring An25 and Xyp29 were 0.037±0.0029 mmol/h/gram dry cell 
weight and 0.041±0.0023 mmol/h/gram dry cell weight, respectively. For the EBY.VW4000 
strain harboring Xyp32, the Km and Vmax towards L-arabinose were determined to be 48.0±13.2 
mM and 0.0056±0.0016 mmol/h/gram dry cell weight. (Notebook#4 page 143) 
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2.2.8 Overexpression of Pentose-Specific Transporters 
The overexpression of active heterologous D-xylose-specific transporters in S. cerevisiae 
strains containing the D-xylose utilization pathway was also investigated. Unfortunately, the 
advantage of D-xylose-specific transporter overexpression could not be observed despite 
alteration of expression strategies, cultivation conditions, and choice of the D-xylose utilization 
pathway (data not shown). After engineering of D-xylose utilization pathways in S. cerevisiae, 
we are revisiting this problem using our newly discovered fast xylose utilizing strains as well as 
optimizing expression level of transporters using promoter mutants with varying strength. In this 
study, an INVSc1 strain with a single copy integration of D-xylose utilization pathway from 
Pichia stipitis at the URA3 site was used as a host strain (Figure 2.6). 
 
Figure 2.6 Xylose fermentation by INVSc1 strain with P. stipitis xylose utilization pathway (psXR-
psXDH-psXKS) integrated into the URA3 site. Red squre: xylose concentration, blue diamond: cell 
density measured by optical density at 600 nm, green triangle: ethanol concentration  
 
Helper plasmids were constructed for optimizing expression level of D-xylose-specific 
transporters. On a single copy expression vector pRS414, a unique restriction site was 
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engineered in front of the open reading frame of An25 or Xyp29 followed by a HXT7 terminator. 
The promoter mutants generated using nucleotide analogue mutagenesis were assembled with 
linearized An25 or Xyp29 helper plasmid using DNA assembler in INVSc1 strain with P. stipitis 
D-xylose utilization pathway integrated (Figure 2.7). (Notebook #7, page 251, Notebook #8, 
page 3) 
 
Figure 2.7 Strategy for D-xylose-specific transporter overexpression with optimization of promoter 
strength. A library of ENO2 promoter mutants created through nucleotide analogue mutagenesis was 
assembled with linearized helper plasmid with the open reading frame of the D-xylose-specific 
transporter and a HXT7 terminator with DNA assembler in xylose utilizing S. cerevisiae strain. The 
resulted library was screened using xylose as sole carbon source. 
 
The resultant library was spread on SC-Trp-Ura plate supplemented with 2% xylose and 
ten mutants with colony size bigger than the control plate (INVSc1 strain with no transporter 
overexpression) were selected for each transporter and the inoculated into tube culture. To screen 
for the fast growing transporter overexpression strain, the big colonies were inoculated into SC-
Trp-Ura liquid media supplemented with 2% glucose. The saturated seed cultures were then used 
to inoculate both YP media and SC-Trp-Ura media complemented with 2% xylose to compare 
the xylose consumption rate with the control strains. The samples analyzed using HPLC and the 
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mutants with a higher xylose consumption rate in both YP media and SC media were identified. 
(Figure 2.8). (Notebook #9, page 28) 
 
Figure 2.8 Screening of transporter overexpression mutants in different media with xylose as the sole 
carbon source. Strains #1 to #10 are An25 overexpression constructs, while strains #11 to #20 are Xyp29 
overexpression mutants. Strain #21 and strain #22 are control strains (INVSc1 strain URA3::psXR-
psXDH-psXDH harboring a pRS414 empty plasmid). The strains marked with red stars showed faster 
xylose consumption compared to control strain in both YP and SC media. All the data shown are just a 
single sample of preliminary tube screening. 
 
The ENO2 promoter mutants in these mutants were re-cloned into pRS415-GFP helper 
plasmid and the strength of promoter mutants were determined using flowcytrometry (Figure 
2.9). The strength of promoter mutants isolated from the five fast growing strains were all under 
30% of that of the wild type ENO2 promoter. This result supported the assumption that a high 
overexpression of transporter would hamper cell growth by affecting the integrity of cell 
membrane.  (Notebook #9, page 29-30) 
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Figure 2.9 Promoter strength measured by flow cytometry. S2, S3, S7 and S10 are An25 transporter 
overexpressing strains. S13 is Xyp29 overexpressing strain. The promoter strengths are shown as the 
relative strength when compared with TEF1 wild type promoter. (Relative strength of TEF1 promoter 
wild type as 100.) Data shows average of four replicate samples, and error bars are standard deviation of 
the replicate samples. 
 
2.3 Discussions 
Using the Gxs1 from C. intermedia and Aut1 from P. stipitis as probes, 17 putative 
transporters were identified using BLAST searches based on protein sequence identity. These 
putative pentose transporters shared 50-25% sequence identity with either Gxs1 or Aut1. 
Interestingly, Aut1, which was annotated as an L-arabinose transporter, failed to show any sugar 
uptake activity in the sugar uptake assay. However, among putative pentose transporters found 
using Aut1 as a probe, both An29-2 and An25 exhibited a D-xylose uptake activity. Similarly, 
using the D-xylose transporter Gxs1 as a probe, both D-xylose transporter and L-arabinose 
transporters can be identified. All the active transporters shared less than 40% identity with the 
probes, indicating the pentose transporter family is not highly conserved.  
Sugar transport activity exhibited by the cloned putative pentose transporters indicated 
that the constructs of sugar transporters under the HXT7 promoter on the multicopy pRS424 
shuttle plasmid are functional. The fact that sugar transporters were active without adding any 
additional signal peptide suggested some inherent sequence may exist within the encoding region 
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of sugar transporters to direct expressed sugar transporters to localize in the cell membrane and 
fold in a functional manner. Interestingly, several putative transporters from filamentous fungus 
N. crassa also showed sugar uptake activity in S. cerevisiae. Note that it is not surprising that D-
xylose transporters from other fungal species can be correctly expressed and localized in S. 
cerevisiae, given the fact that several transporters from various fungal species have already been 
introduced into S. cerevisiae (2,6). In fact, sugar transporters from more distinct species like A. 
thaliana can also be expressed and correctly localized in the S. cerevisiae cell membrane (4). 
This fact indicates that different species may use a similar mechanism for directing transporter 
proteins into the cell membrane. 
After the first round of the sugar uptake activity assay using HPLC, seven putative 
transporters were found to be functionally expressed in S. cerevisiae. Among these seven 
transporters, two appear to be potentially D-xylose-specific while the other could be L-arabinose-
specific.  
The correct localization of pentose-specific transporters was confirmed by using 
fluorescence imaging of the transporter-GFP fusion proteins. The correct localization of pentose-
specific transporters from N. crassa and P. stipitis further confirmed the addition of an extra 
signal peptide is not required for heterologous expression of sugar transporters. As it was shown 
in Figure 2.1, most of An25 and Xyp32 fusion proteins are localized in the cell membrane of S. 
cerevisiae while a large portion of Xyp29-GFP fusion proteins are retained in the cytoplasm. 
This result indicated further improvement of expression and localization of Xyp29 may be 
necessary for it to function efficiently. The fact that not all the cells with transporter-GFP fusion 
proteins were visible during the fluorescence imaging suggested the expression level of 
transporters were not stable and optimized. This problem may be solved by altering the 
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expression level and/or integrating the transporter genes into the genome of recombinant S. 
cerevisiae. 
14
C-labeled sugar uptake assays, together with HPLC analysis of intracellular sugar 
accumulations, confirmed that among the three most abundant monosaccharides in 
lignocellulosic hydrolysates (D-glucose, D-xylose, and L-arabinose), Xyp29 and An25 are 
responsible only for D-xylose uptake, while Xyp32 is only responsible for L-arabinose uptake. Of 
note, most sugar transporters studied in yeast for D-xylose uptake still have higher uptake 
activity towards D-glucose than D-xylose (2). Only Trxlt1 from Trichoderma reesei exhibited D-
xylose-specific uptake activity after its adaptive evolution (15). Our data indicates that Xyp29 
and Xyp32, from P. stipitis, together with An25, from N. crassa, are the first three 
experimentally confirmed naturally occurring pentose-specific transporters introduced to S. 
cerevisiae. 
In naturally occurring D-xylose-assimilating fungal species, both high-affinity D-xylose-
proton symport systems and low-affinity D-xylose facilitated diffusion systems were present. The 
Km value of these two systems were determined to be 0.4~4 mM for the symport system and 
around 140 mM for the facilitate diffusion system (2,16). These values are close to the affinity of 
the D-glucose uptake system in S. cerevisiae, with a Km of 1.5 mM for the high-affinity system 
and 20 mM for the low-affinity system. Unfortunately, the D-xylose uptake affinity of wild-type 
S. cerevisiae is two orders of magnitude lower compared to D-glucose. The Km values of D-
xylose uptake in S. cerevisiae are only 190 mM for the high-affinity system and 1.5 M for the 
low-affinity system (1). The affinities of our newly discovered pentose-specific transporters are 
lower when compared to the high-affinity D-xylose uptake system in naturally occurring D-
xylose-assimilating yeast. However, when compared with the D-xylose uptake system in wild-
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type S. cerevisiae, the newly discovered pentose-specific transporters still showed higher 
affinities towards D-xylose. Especially for Xyp29 and Xyp32, the Km towards pentose sugars 
were only one-fourth of the value for wild-type S. cerevisiae. 
All three pentose-specific transporters were determined to be sugar facilitators. This 
result is consistent with the fact that kinetic parameters of these three pentose-specific 
transporters is similar to those of the low-affinity D-xylose facilitated diffusion system in 
naturally occurring pentose-assimilating yeasts (2,3). Despite the fact symporters have higher 
affinities towards D-xylose, overexpression of symporters may not always facilitate the sugar 
utilization by D-xylose assimilating strains due to the ATP requirement to create the proton 
gradient. In fact, most of the transporters shown to be beneficial for D-xylose fermentation are 
facilitators (5,6). Furthermore, The Km values of D-xylose-specific transporters are also close to 
those of Gxf1 (Km = 88 mM) and Sut1(Km = 145 mM), which have been shown to improve D-
xylose fermentation in recombinant S. cerevisiae (5,6). It is very possible that D-xylose 
fermentation can be improved by introducing these newly characterized D-xylose-specific 
transporters.  
Pentose-specific transporters are very useful for creation of recombinant S. cerevisiae 
capable of simultaneously utilizing pentose sugars with high efficiency. Many researchers have 
been working very hard to increase the efficiency of pentose utilization in S. cerevisiae. 
Matsushika et al. reported the construction of a recombinant industrial yeast strain which can 
completely ferment a mixture of 45 g/L D-glucose and 45 g/L D-xylose within 24 hours (17). As 
the pentose utilization pathway becomes more and more efficient in S. cerevisiae, the insufficient 
uptake of pentose sugars will be the limiting step in pentose utilization. Since the pentose-
specific sugar transporters are highly specific towards pentose sugars, it would be less likely for 
 61 
them to be inhibited by D-glucose in the cell media. The introduction of pentose-specific 
transporters may provide a pentose transport system that is independent of D-glucose 
concentration. 
Furthermore, it was shown that D-glucose serves as a very important signaling compound 
in the regulation of metabolic fluxes in S. cerevisiae in addition to being a preferred carbon 
source. In the presence of D-glucose, pathways involved in utilization of pentose sugars will be 
down regulated. This regulation event made S. cerevisiae to utilize D-glucose prior to other 
carbon sources, such as pentose sugars. As part of the regulation process, the presence of D-
glucose represses the uptake of D-xylose (18). By introducing an independent pentose-specific 
sugar uptake system, the down regulation of pentose uptake in the presence of D-glucose may be 
eliminated, and glucose repression on pentose sugar utilization may be alleviated.  
The putative pentose transporters with both glucose and pentose transport activities can 
be considered candidates for engineering mutants of pentose transporters with increased activity 
towards pentose sugar uptake via directed evolution. Mutations can be introduced into these 
transporters through error-prone PCR, resulting in the creation of a library that can be transferred 
to transporter knockout strains capable of pentose utilization. The library can be enriched in 
pentose media, after which fast growth mutants can be isolated and analyzed (Figure 2.10). 
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Figure 2.10 Strategy for transporter engineering using directed evolution. Using a transporter with 
pentose uptake activity as a template, mutations were introduced via error-prone PCR. The resulting PCR 
products were cloned into plasmid and transferred into a yeast transporter knockout strain with a pentose 
utilization pathway. The population with improved transporter efficiency can be enriched in media with 
pentose sugar as sole carbon source. After several rounds of enrichment, the culture can be plated and the 
plasmids can be isolated from single colonies and transferred into transporter knockout strain to be 
assayed for sugar uptake activity. The resultant mutants with improved sugar uptake efficiency can be 
used as templates for the next round of library creation and directed evolution. The process can be 
repeated till the efficiency of the mutant is satisfactory or no more improvement can be observed. 
 
The overexpression of active heterologous xylose-specific transporters in S. cerevisiae 
strains with a D-xylose utilization pathway was also investigated. Unfortunately, the advantage of 
a pentose-specific transporter overexpression cannot be observed despite alteration of expression 
strategies, cultivation conditions, and choice of the pentose utilization pathway (data not shown). 
There are several possible reasons. First, the overexpression of membrane proteins, such as sugar 
transporters, could affect the integrity of the cell membrane and consequently hamper cell 
growth (19). It has been observed that transporter overexpression strains display a slower growth 
rate even when D-glucose is used as a carbon source (data not shown). Second, the pentose 
uptake activity of wild-type S. cerevisiae through hexose transporters is much higher than 
pentose uptake activity of a certain pentose transporter overexpressed in the hexose transporter 
knockout strain. The low sugar transport activity of newly discovered pentose transporters may 
make it hard to observe the improvement of sugar uptake ability. Third, even if the introduction 
of new pentose transporters could improve the uptake of pentose sugars into S. cerevisiae cells, 
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the benefit of pentose sugar utilization can only be observed when the pentose utilization 
pathway is efficient enough to make the sugar uptake the limiting step. It has been shown that the 
effect of overexpression of sugar transporters depends on the strain background and cultivation 
conditions (20). 
The overexpression of D-xylose-specific transporters was investigated again after a fast 
xylose utilizing strain was identified from pathway optimization work performed by Byoungjin 
Kim. The library of ENO2 promoter mutant with varying strength was also introduced in front of 
transporters to optimize the expression level of sugar transporters. After one round of 
preliminary screening of transporter overexpressing mutants, fast xylose consuming mutants 
were identified. These mutants exhibited fast xylose consumption rate compared to control 
strains with no transporter overexpression in both rich and minimal media. After checking the 
promoter strength of the fast xylose consuming strains, we found that all the promoters in these 
constructs exhibited a less than 30% of the strength of wild type ENO2 promoter. The low 
expression level in fast growing  strain supported our previous assumption that a high level 
overexpression of sugar transporters might hamper the cell growth by affecting the integrity of 
cell membrane. 
2.4 Conclusions and Outlook 
 
Pentose uptake is the first step of pentose utilization by S. cerevisiae. Pentose sugars 
enter S. cerevisiae cells through hexose transporters at an affinity two orders of magnitude lower 
than hexose sugars. In order to facilitate pentose utilization in S. cerevisiae by the introduction of 
pentose transporters, eighteen putative transporters from N. crassa and P. stipitis were identified 
based on sequence homology with GXS1 and AUT1. 
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Open reading frames of putative transporters were amplified and cloned into the pRS424 
multicopy shuttle plasmid under the HXT7 promoter and terminator using the DNA assembler 
method. Resultant constructs were first confirmed using diagnostic PCR and then the whole open 
reading frames were sequenced.  
Correct constructs of plasmid-encoding putative pentose transporters were then 
transferred into the transporter knockout strain EBY.VW4000 for the assessment of sugar uptake 
activities. These assays checked intracellular sugar accumulation using HPLC. Among 18 cloned 
putative transporters, Xyp37, Xyp33, An29-2, Xy31 were identified to have glucose transport 
activity. Xyp37, Xyp33 and An29-2 also had D-xylose transport activity, while An29-1 and 
Xy31 displayed L-arabinose uptake activity at the same time. In addition, two D-xylose-specific 
transporters, An25 and Xyp29, were identified together with one L-arabinose-specific transporter 
Xyp32. 
The cellular localization of pentose-specific transporters was studied by using 
transporter-GFP fusion proteins and confocal microscopy. All three pentose-specific transporters 
were expressed, correctly folded, and localized in the cell membrane. 
To determine the type of pentose specific transporters, transporters were expressed in the 
EBY.VW4000 strains.  Any changes in pH of the un-buffered solution during sugar uptake were 
recorded using a pH meter equipped with data collection software. None of the three pentose-
specific transporters showed elevated pH together with sugar uptake, indicating that they are all 
pentose facilitators. 
The specificities of the three newly cloned sugar transporters were further confirmed 
using a 
14
C-labeled sugar uptake assay. The Km and Vmax values for all three pentose specific 
transporters were determined using a 
14
C-labeled sugar uptake assay. All three transporters are 
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low-affinity transporters, but their affinity towards pentose sugars are still higher compared to 
endogenous hexose transporters in S. cerevisiae.  
The overexpression of D-xylose-specific transporters was studied using fast xylose 
assimilating strains. When the expression levels of transporters were optimized at a low level, the 
overexpression of transporters facilitated xylose utilization in both rich and synthetic media. 
Pentose-specific transporters may be more beneficial for mixed sugar fermentation by pentose-
assimilating recombinant S. cerevisiae, as the strict substrate specificity may eliminate the 
inhibition of D-xylose uptake when D-glucose is present and thus alleviate the D-glucose 
repression. 
When this research project was initiated, only limited information was available on the 
pentose transporters. GXS1 was the only D-xylose-H
+
 symporter characterized at the molecular 
level in S. cerevisiae. Through sequence homology with the newly available genomic sequence 
of N. crassa and P. stipitis, seven novel pentose transporters were identified. Using the identified 
transporters as probes, more pentose-specific transporters could be discovered from various 
species. These pentose-specific transporters could aid in the systematic analysis of this important 
family of sugar transporters in S. cerevisiae. 
2.5 Materials and Methods 
 
2.5.1 Strains, Media and Cultivation Conditions 
S. cerevisiae CEN.PK2-1C (MATα leu2-3,112 ura3-52 trp1-289 his3-Δ1 MAL2-8c) was 
purchased from Euroscarf (Frankfurt, Germany), and was used for manipulation of 
recombinant DNA in yeast. Sugar transporter knockout strain EBY.VW4000 (CEN.PK2-1c 
Δhxt1-17 Δstl1 Δagt1 Δydl247w Δyjr160c Δgal2) was a gift from Eckhard Boles (13). 
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Escherichia coli DH5α (cell media facility, University of Illinois at Urbana-Champaign, 
Urbana, IL) was used for recombinant DNA manipulation. Yeast strains were cultivated in 
synthetic dropout media to maintain plasmids (0.17% of Difco yeast nitrogen base without 
amino acids and ammonium sulfate, 0.5% of ammonium sulfate, 0.05% of amino acid drop 
out mix). YPA media supplemented with 2% of sugar was used to grow yeast strain 
harboring no plasmids (1% yeast extract, 2% peptone, 0.01% adenine hemisulfate). E. coli 
strains were grown in Luria broth (Fisher Scientific, Pittsburgh, PA). S. cerevisiae strains 
were cultured at 30 °C and 250 rpm for aerobic growth. Yeast strains were grown under 
aerobic condition for cell multiplation if not specified. E. coli strains were cultured at 37 °C 
and 250 rpm if not specified. All restriction enzymes were purchased from New England 
Biolabs (Ipwich, MA). All chemicals were purchased from Sigma Aldrich (St. Louis, MO) or 
Fisher Scientific (Pittsburgh, PA).  
 
2.5.2 Cloning of Putative Pentose-specific Transporters Using the DNA Assembler Method 
 
Most of the cloning work was done using the DNA assembler method via the yeast 
homologous recombination mechanism (9). pRS424-HXT7-GFP plasmids were used for 
cloning of putative pentose-specific transporters. In this plasmid, a HXT7 promoter, a GFP 
gene flanked with EcoRI sites at both ends, and a HXT7 terminator were assembled into the 
pRS424 shuttle vector (New England Biolabs) linearized by ClaI and BamHI. PCR products 
of the putative pentose-specific transporters flanked with DNA fragments sharing sequence 
identity to the HXT7 promoter and terminator were co-transferred into CEN.PK2-1C with 
EcoRI digested pRS424-HXT7-GFP using the standard lithium acetate method (14). (See 
Table 2.3 for list of primers used for the cloning of putative pentose-specific transporters). 
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The resulting transformation mixture was plated on SC-Trp plates supplemented with 2% D-
glucose (Figure 2.11).  
 
 
Figure 2.11 Cloning of putative pentose transporters using the DNA assembler method. pRS424-
HXT7-GFP plasmids were used for cloning of putative pentose-specific transporters. In this 
plasmid, a HXT7 promoter, a GFP gene flanked with EcoRI sites at both ends, and a HXT7 
terminator were assembled into the pRS424 shuttle vector linearized by ClaI and BamHI. PCR 
products of the putative pentose-specific transporters flanked with DNA fragments sharing 
sequence identity to the HXT7 promoter and terminator were co-transferred into CEN.PK2-1C 
with EcoRI digested pRS424-HXT7-GFP using the standard lithium acetate method. 
 
  To confirm the proper construction of plasmids using the DNA assembler method, 
yeast plasmids were isolated using Zymoprep Yeast Plasmid Miniprep II (Zymo Research, 
Orange, CA). Yeast plasmids were then transferred into E. coli DH5α, which were plated on 
LB plates containing 100 mg/L ampicillin. Single colonies of E. coli transformants were then 
inoculated in LB liquid media. Plasmids were isolated from E. coli using the QIAprep Spin 
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Miniprep Kit (QIAGEN, Valencia, CA) and checked by diagnostic PCR. All constructs of 
heterologous pentose transporters were submitted for DNA sequencing to confirm the correct 
sequence (UIUC Core Sequencing Facility, Urbana, IL). The DNA sequencing results were 
compared with gene sequences from NCBI using Sequencher 4.7 (Gene Codes Corporation, 
Ann Arbor, MI). 
2.5.3 Plasmid Construction of Transporter-GFP Fusion Using the DNA Assembler Method 
C-terminal fusions of D-xylose-specific transporters with the GFP were constructed for 
the transporter localization study. A GS-linker consisting of amino acid sequence Gly-Gly-
Gly-Gly-Ser-Gly-Gly-Gly-Gly-Ser was introduce between the transporter and the GFP. The 
GS-linker was added to the N-terminus of the GFP open reading frame by a PCR primer, 
resulting in a PCR product of GS-linker-GFP flanked with nucleotide sequence homologous 
with the transporters at the 5’-end and the HXT7 terminator at the 3’-end (See Table 2.3 for 
primer sequences for construction of transporter-GFP fusions). Transporter genes were 
amplified from the original pRS424-HXT7-transporter constructs to generate DNA fragments 
of the transporters flanked with nucleotide sequence identical to the HXT7 promoter at the 
5’-end and the GS-linker-GFP at the 3’-end. These two fragments were then co-transferred 
into CEN.PK2-1C with pRS424-HXT7-GFP digested with EcoRI.  The resulting 
transformation mixture was plated on SC-Trp supplemented with 2% D-glucose (Figure 
2.12). 
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Figure 2.12 Construction of plasmids containing transporter-GFP fusion proteins using the DNA 
assembler method. The GS-linker was added to the N-terminus of the GFP open reading frame 
by a PCR primer, resulting in a PCR product of GS-linker-GFP flanked with nucleotide sequence 
homologous with the transporters at the 5’-end and the HXT7 terminator at the 3’-end. 
Transporter genes were amplified from the original pRS424-HXT7-transporter constructs to 
generate DNA fragments of the transporters flanked with nucleotide sequence identical to the 
HXT7 promoter at the 5’-end and the GS-linker-GFP at the 3’-end. These two fragments were 
then co-transferred into CEN.PK2-1C with pRS424-HXT7-GFP digested with EcoRI. The 
resulting transformation mixture was plated on SC-Trp supplemented with 2% D-glucose. 
 
  To confirm the proper construction of plasmids using the DNA assembler method, 
yeast plasmids were isolated using Zymoprep Yeast Plasmid Miniprep II (Zymo Research, 
Orange, CA). Yeast plasmids were then transferred into E. coli DH5α, which were plated on 
LB plates containing 100 mg/L ampicillin. Single colonies of E. coli transformant were then 
inoculated into the LB liquid media. Plasmids were isolated from E. coli using the QIAprep 
Spin Miniprep Kit (QIAGEN, Valencia, CA) and checked by diagnostic PCR. All constructs 
containing heterologous transporters were submitted for DNA sequencing to confirm the 
correct construction (UIUC Core Sequencing Facility, Urbana, IL). The DNA sequencing 
results were compared with gene sequences in the NCBI database using Sequencher 4.7 
(Gene Codes Corporation, Ann Arbor, MI). 
2.5.4 Analysis of Intracellular Accumulation of Pentose Sugars 
 
Single colonies of the EBY.VW4000 strain expressing a target transporter was inoculated 
in a culture tube with 2 mL SC-Trp medium supplemented with 2% maltose. Seed culture was 
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then used to inoculate a 50 mL culture in a 250 mL flask. Cell culture was harvested by 
centrifugation after 2 days of growth and resuspended in YPA medium supplemented with 2% D-
xylose or L-arabinose to a final OD600 of 10. At 30 min, 60 min, 120 min, and 24 hours, 5 mL of 
culture samples were taken for measuring intracellular sugar concentrations. Culture samples 
were washed twice with ice-cold water and resuspended in 3 mL of deionized water. Cell 
suspensions were incubated at 37 °C with 250 rpm agitation for 2 days to extract intracellular 
sugars. The resulting cell suspension was filtered through a 0.22 μm PES filter (Corning, Lowell, 
MA) before HPLC analysis. Sugar and corresponding sugar alcohol concentrations were 
determined using a Shimadzu HPLC equipped with a Bio-Rad HPX-87C column (Bio-Rad 
Laboratories, Hercules, CA) and Shimadzu ELSD-LTII low temperature-evaporative light 
scattering detector (Shimadzu) following the manufacturer’s protocol. The sugar uptake activity 
was calculated to be mg sugar extracted through osmosis per mL of cell culture at OD~10. 
 
2.5.5 Determination of Type of Transporters 
  
To determine the transporter type, pH change of the EBY.VW4000 strain expressing D-
xylose-specific transporters was measured in un-buffered cell suspension containing D-xylose, L-
arabinose, or maltose using a Seven Multi pH meter equipped with an USB communication 
module and Direct pH software (Mettler Toledo, Columbus, OH). Plasmids encoding pentose-
specific transporters were transferred into the EBY.VW4000 strain followed by plating on the 
SC-Trp plates supplemented with 2% maltose. Single colonies were inoculated with 2 mL SC-
Trp medium supplemented with 2% maltose. Seed culture was then used to inoculate a 400 mL 
culture in 2 L flask. The culture was harvested at OD~1 and washed twice with ice-cold water. 
The cell pellet was resuspended in 4 mL of water and kept on ice before use. For the symporter 
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assay, the pH electrode was immersed in a 50 mL water-jacketed beaker kept at 25 °C and 
provided with magnetic stirring. To the beaker, 23 mL of deionized water and 1 mL of yeast cell 
suspension equilibrated at 25 °C was added. The pH was adjusted to 5 and a base line was 
obtained. The pH change was recorded with addition of 1 mL 50% sugar solution at pH 5. An 
elevation of pH following the addition of the sugar solution suggests a sugar-proton symport 
behaviour of the target sugar transporter. As it was reported that pH in un-buffered S. cerevisiae 
cell suspension should go up with the addition of maltose, 1 mL of 50% maltose solution was 
added to the un-buffered cell suspension to make sure the pH recording system is functional (3). 
pH elevations of all the constructs were observed, indicating that the pH recording system can 
monitor the transient pH change in the experimental setting (Figure 2.13). (Notebook #3, page 
198, page 199, page 206) 
 
Figure 2.13 pH changes in the un-buffered cell suspension after the addition of maltose. As it 
was reported that pH in un-buffered S. cerevisiae cell suspension should go up with the addition 
of maltose, 1 mL of 50% maltose solution was added to the un-buffered cell suspension to make 
sure the pH recording system is functional. The arrows indicated when maltose solution was 
added to the system. pH elevations of all the constructs were observed, indicating that the pH 
recording system can monitor the transient pH change in the experimental setting. 
 
2.5.6 GFP Fluorescence Imaging of Transporter Expressing Live Cells 
 
Plasmids encoding D-xylose-specific transporters with C-terminal GFP fusion were 
transferred into the CEN.PK2-1C strain and the cells were plated on the SC-Trp plates with 2% 
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maltose. Single colonies were inoculated in 2 mL of SC-Trp liquid medium supplemented with 
2% maltose. Cell culture was harvested at the exponential phase. In a centrifuge tube, 250 μL of 
cell culture was stained with 10 μL Hoechst 33342 nuclei dye (Invitrogen, Carlsbad, CA) for 10 
min at room temperature. A small droplet of cell culture was then transferred onto a piece of 
cover glass and florescence images were taken using an Andor Technology Revolution System 
Spinning Disk Confocal Microscope (Core Facilities, Institute for Genomic Biology, University 
of Illinois at Urbana-Champaign, Urbana, IL). Images were processed using Imaris image 
analysis and visualization software (Bitplane, Saint Paul, MN). 
2.5.7 
14
C-labeled Sugar Uptake Assay 
 
14
C-labeled D-glucose, L-arabinose, and D-xylose were purchased from American 
Radiolabeled Chemicals (St. Louis, MO) as solutions in 90% ethanol. Radio-labelled sugars 
were first dried in a chemical hood and then resuspended in water. Sugar solutions at a 
concentration of 1.33 M, 1 M with specific radioactivity of approximately 40,000 dpm/μL, and at 
concentrations of 500 mM, 350 mM, 250 mM, 100 mM, and 50 mM with specific radioactivity 
of about 20,000 dpm/μL were used for the sugar uptake assay. Cell cultures at the exponential 
phase were harvested and washed twice with ice-cold water and resuspended to about 60 mg dry 
cell weight per mL in 100 mM Tris-Citrate buffer at pH 5. Three aliquots of 160 μL cell 
suspension were dried at 65 °C for 24 hours to determine the cell dry weight. The rest of cell 
suspension was kept on ice before use. For sugar uptake assay, cell suspension was equilibrated 
at 30 °C for 5 min before the assay. In a 50 mL conical tube, 160 μL of cell suspension was 
mixed with 40 μL of radio-labeled sugar solution for 40 or 60 seconds (accurately timed). 
Reaction was stopped by addition of 10 mL ice-cold water delivered by a syringe. The zero time 
point sample was obtained by adding ice-cold water and cell suspension simultaneously into a 
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culture tube containing the radio-labeled solution. The mixture was filtered immediately through 
a Whatman GF/C filter (Whatman, Florham Park, NJ) pre-soaked in 40% sugar solution, and 
washed with 15 mL of ice-cold water. The filter was then placed in 3 mL of Econo I scintillation 
cocktail (ThermoFisher Scientific) and counted using a Beckman LS6500 scintillation counter 
(Beckman Coulter, Brea, CA) for 1 min. All data points were measured by three independent 
experiments. Sugar uptake rate was calculated to be mmol sugar transported per hour per gram of 
dry cell weight. 
 
. 
  
 74 
2.6 References 
 
1. Kotter, P. and Ciriacy, M. (1993) Xylose fermentation by Saccharomyces cerevisiae. 
Applied Microbiology and Biotechnology, 38, 776-783. 
2. Leandro, M.J., Goncalves, P. and Spencer-Martins, I. (2006) Two glucose/xylose 
transporter genes from the yeast Candida intermedia: first molecular characterization of a 
yeast xylose-H+ symporter. Biochemical Journal, 395, 543-549. 
3. Fonseca, C., Romao, R., de Sousa, H.R., Hahn-Hagerdal, B. and Spencer-Martins, I. 
(2007) L-Arabinose transport and catabolism in yeast. FEBS Journal, 274, 3589-3600. 
4. Hector, R.E., Qureshi, N., Hughes, S.R. and Cotta, M.A. (2008) Expression of a 
heterologous xylose transporter in a Saccharomyces cerevisiae strain engineered to utilize 
xylose improves aerobic xylose consumption. Applied Microbiology and Biotechnology, 
80, 675-684. 
5. Runquist, D., Fonseca, C., Radstrom, P., Spencer-Martins, I. and Hahn-Hagerdal, B. 
(2009) Expression of the Gxf1 transporter from Candida intermedia improves 
fermentation performance in recombinant xylose-utilizing Saccharomyces cerevisiae. 
Applied Microbiology and Biotechnology, 82, 123-130. 
6. Kondo, A., Katahira, S., Ito, M., Takema, H., Fujita, Y., Tanino, T., Tanaka, T. and 
Fukuda, H. (2008) Improvement of ethanol productivity during xylose and glucose co-
fermentation by xylose-assimilating S. cerevisiae via expression of glucose transporter 
Sut1. Enzyme and Microbial Technology, 43, 115-119. 
7. Alper, H., Young, E., Poucher, A., Comer, A. and Bailey, A. (2011) Functional Survey 
for Heterologous Sugar Transport Proteins, Using Saccharomyces cerevisiae as a Host. 
Applied and Environmental Microbiology, 77, 3311-3319. 
 75 
8. Bertilsson, M., Andersson, J. and Liden, G. (2008) Modeling simultaneous glucose and 
xylose uptake in Saccharomyces cerevisiae from kinetics and gene expression of sugar 
transporters. Bioprocess and Biosystems Engineering, 31, 369-377. 
9. Shao, Z., Zhao, H. and Zhao, H. (2009) DNA assembler, an in vivo genetic method for 
rapid construction of biochemical pathways. Nucleic Acids Research, 37, Article No.: 
e16. 
10. Sedlak, M. and Ho, N.W.Y. (2004) Characterization of the effectiveness of hexose 
transporters for transporting xylose during glucose and xylose co-fermentation by a 
recombinant Saccharomyces yeast. Yeast, 21, 671-684. 
11. Barnett, J.A. (1976) The utilization of sugars by yeasts. Advances in Carbohydrate 
Chemistry & Biochemistry, 32, 125-234. 
12. Traff, K.L., Cordero, R.R.O., van Zyl, W.H. and Hahn-Hagerdal, B. (2001) Deletion of 
the GRE3 aldose reductase gene and its influence on xylose metabolism in recombinant 
strains of Saccharomyces cerevisiae expressing the xylA and XKS1 genes. Applied and 
Environmental Microbiology, 67, 5668-5674. 
13. Wieczorke, R., Krampe, S., Weierstall, T., Freidel, K., Hollenberg, C.P. and Boles, E. 
(1999) Concurrent knock-out of at least 20 transporter genes is required to block uptake 
of hexoses in Saccharomyces cerevisiae. FEBS Letters, 464, 123-128. 
14. Gietz, R.D. and Woods, R.A. (2002), Guide to Yeast Genetics and Molecular and Cell 
Biology. Academic Press Inc, San Diego, Vol. 350, pp. 87-96. 
15. Saloheimo, A., Rauta, J., Stasyk, O.V., Sibirny, A.A., Penttila, M. and Ruohonen, L. 
(2007) Xylose transport studies with xylose-utilizing Saccharomyces cerevisiae strains 
 76 
expressing heterologous and homologous permeases. Applied Microbiology and 
Biotechnology, 74, 1041-1052. 
16. Stambuk, B.U., Franden, M.A., Singh, A. and Zhang, M. (2003) D-xylose transport by 
Candida succiphila and Kluyveromyces marxianus. Applied Biochemistry and 
Biotechnology, 105, 255-263. 
17. Matsushika, A., Inoue, H., Murakami, K., Takimura, O. and Sawayama, S. (2009) 
Bioethanol production performance of five recombinant strains of laboratory and 
industrial xylose-fermenting Saccharomyces cerevisiae. Bioresource Technology, 100, 
2392-2398. 
18. Salusjarvi, L., Kankainen, M., Soliymani, R., Pitkanen, J.P., Penttila, M. and Ruohonen, 
L. (2008) Regulation of xylose metabolism in recombinant Saccharomyces cerevisiae. 
Microbial Cell Factories, 7, 16. 
19. Wagner, S., Bader, M.L., Drew, D. and de Gier, J.W. (2006) Rationalizing membrane 
protein overexpression. Trends in Biotechnology, 24, 364-371. 
20. Runquist, D., Hahn-Hagerdal, B. and Radstrom, P. Comparison of heterologous xylose 
transporters in recombinant Saccharomyces cerevisiae. Biotechnol Biofuels, 3, 5. 
 
*  Part of this chapter was reproduced by permission of The Royal Society of Chemistry from 
previously published paper “Discovery and characterization of novel D-xylose-specific 
transporters from Neurospora crassa and Pichia stipitis”, Molecular BioSystems, 2010, 6, 2150-
2156 (http://pubs.rsc.org/en/Content/ArticleLanding/2010/MB/c0mb00007h). 
 
  
 77 
Chapter 3 Optimization of the Xylose Utilization Pathway Using 
Heterologous Enzyme Homologues from Various Fungal Species 
3.1 Introduction 
Increasing concerns about energy security, sustainability, and global climate change  have 
led to an increase in the investigation of alternative energy sources (1). Biological conversion of 
plant-derived lignocellulosic materials into biofuels is commonly regarded as an attractive 
alternative to the chemical production of fossil fuels (2,3). Saccharomyces cerevisiae, also 
known as baker’s yeast, has been used for bioconversion of hexose sugars into ethanol for 
thousands of years (4). It is also the most widely used microorganism for large-scale industrial 
fermentation of glucose into ethanol. Due to this, S. cerevisiae is an excellent organism for 
bioconversion of lignocellulosic biomass into biofuels (5). In addition, S. cerevisiae has a well-
studied genetic and physiological background, an ample supply of available genetic tools, and a 
high tolerance to ethanol and inhibitors typically present in lignocellulosic hydrolysates (6). 
Moreover, the low fermentation pH of S. cerevisiae can also prevent bacterial contamination.  
Lignocellulosic biomass is composed of cellulose, hemicellulose, and lignin. The 
hemicellulose component comprises 20~30% of lignocellulosic biomass, and it is primarily 
composed of five-carbon sugars (pentoses) such as xylose and arabinose (7). Unfortunately, wild 
type S. cerevisiae cannot utilize pentose sugars (8). In order to overcome this limitation, pentose 
utilization pathways from pentose-assimilating organisms have been introduced into S. 
cerevisiae, allowing for the fermentation of xylose and arabinose (9-15).  
Unfortunately, the current inefficiency of pentose utilization within recombinant S. 
cerevisiae strains makes them ill-suited for large-scale ethanol production. Factors such as the 
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low expression level and activity of heterologous genes, the redox imbalance that results from a 
dissimilar cofactor preference for oxidation and reduction reactions, as well as the overall 
suboptimal metabolic flux through the individual steps of catalysis limit the ultimate potential of 
contemporary recombinant S. cerevisiae strains (8). Although a great deal of research has 
focused on the improvement of the aforementioned issues that hinder pentose utilization in S. 
cerevisiae (16,17), no single strategy with the potential to alleviate the inefficiency imposed by 
these detrimental factors has yet been discovered.  
 
Figure 3.1 Scheme for the combinatorial pathway assembly strategy. Homologues responsible for the 
same catalytic steps were cloned under the same combination of promoters and terminators. Enzymes 
responsible for different catalytic steps were randomly assembled into a three-gene-pathway through 
homologous recombination. Since different combinations of promoters and terminators were used for 
different catalytic steps, the resulting pathway library consists of pathways that all contain three catalytic 
enzymes for xylose utilization, while the selection of the enzyme homologue for the same catalytic step 
remains completely random. 
 
In this chapter，we explored a combinatorial approach for developing highly efficient 
pentose utilization pathways in S. cerevisiae. Specifically, we chose the fungal three-step xylose 
utilization pathway as our target pathway. In each target pathway, ten to twenty different enzyme 
homologues from various fungal species with different expression level, catalytic efficiency, and 
cofactor preference were cloned for each catalytic step. The resulting enzymes were randomly 
assembled into a library of full pathways using our recently developed DNA assembler method 
(18). Figure 1 displays the combinatorial pathway design strategy for the three-step xylose 
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utilization pathway. After random assembly of enzyme homologues from different fungal 
species, a library will contain a combination of three gene xylose utilization pathways consisting 
of one xylose reductase gene, one xylitol dehydrogenase gene, and one xylulokinase gene from 
various sources. In a test run using a subset of enzyme homologues involved in a xylose 
utilization pathway, the corresponding library exhibited a high efficiency of correct assembly of 
the complete multi-gene pathway as well as a high degree of diversity. This enzyme-based 
pathway assembly strategy was then applied for optimization of the xylose utilization pathway. 
Various strategies for library enrichment based on cellular growth rate using xylose as the sole 
carbon source were tested for identification of fast pathway mutants. Finally, an agar plate-based 
prescreening method complemented with culture tube and shake flask screening was developed 
and pathway mutants with improved xylose fermentation ability were selected and characterized. 
Of note, Dr. Byoungjin Kim should be considered as a major contributor of this chapter. 
His aid in the development of the combinatorial pathway assembly strategy, the search for 
enzyme homologue candidates, and the acquirement of fungal strains from various culture 
collections was essential for the completion of this work. He spent a lot of time growing fungal 
strains and isolating total RNA for the cloning of enzyme homologues. Dr. Kim was also 
responsible for the cloning of all the xylose reductase homologues as well as a portion of the 
xylose reductase and xylulokinase homologues. He tested different enrichment methods and 
helped screen the pathway library and characterize the mutants. The construction of this chapter 
would have been impossible without Dr. Kim’s help and guidance; I was lucky to have the 
chance to work side by his side on this project and to have the chance to design and create the 
constructs for the enzyme cloning and final assembly. I was involved in the cloning of xylose 
reductase and xylulokinase homologues and performed the pathway assembly in different host 
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strains. Together with Dr. Kim, I also tried different enrichment methods for library enrichment. 
Using the same method for screening the enzyme-based library, I screened the promoter-based 
xylose utilization pathway library. The results of this promoter-based pathway assembly project 
will be discussed more comprehensively in Chapter 4. 
3.2 Results 
3.2.1 Genome Mining of Enzyme Homologues for Pentose Utilization in Various Species   
To identify enzyme homologues for pathway assembly, an intensive literature search was 
first performed to identify known xylose reductases (XRs), xylitol dehydrogenases (XDHs), and 
xylulokinases (XKSs). This group of enzyme homologues includes wild type enzyme 
homologues that have been characterized elsewhere, such as XR, XDH and XKS from Pichia 
stipitis (19), XR, XDH and XKS from Neurospora crassa, and XKS from Saccharomyces 
cerevisiae. In addition to previously characterized enzyme homologues, engineered enzyme 
homologues with altered cofactor specificity, such as the NADH-specific XR mutant from P. 
stipitis, were also included (20). Moreover, genome mining was also performed in databases 
such as NCBI (http://www.ncbi.nlm.nih.gov/) and the BRENDA Enzyme database 
(http://www.brenda-enzymes.org/) in order to identify genes encoding those enzymes based on 
their annotation. Finally, BLAST searches were performed using the NCBI BLAST search tools 
using known enzyme homologues as templates. Sequences and sources of all enzyme 
homologues cloned are listed in Table 3.1(table of enzyme homologues). 
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Table 3.1 Enzyme homologues of xylose reductase, xylitol dehydrogenase and xylulokinase cloned in 
this study 
Abbreviation Source LOCUS Annotation 
aoXR Aspergillus oryzae XP_001819987 NAD(P)H-dependent D-xylose reductase 
xyl1 
pgXR Pichia guilliermondii* AAD09330 xylose reductase 
ctrXR Candida tropicalis ABX60132 xylose reductase 
ncXR Neurospora crassa AAW66609   xylose reductase 
klXR Kluyveromyces lactis AAA99507 xylose reductase 
csXR Candida shehatae ABK35120 xylose reductase 
psXR Pichia stipitis CAA42072 xylose reductase 
cpXR Candida parapsilosis ABK32844 xylose reductase 
afXR Aspergillus flavus XYL1_ASPFN xylose reductase 
MoXR Magnaporthe oryzae XP_363305 conserved hypothetical protein 
ZrXR Zygosaccharomyces 
rouxii 
XP_002494646 hypothetical protein 
 
tsXR Talaromyces stipitatus XP_002484051 
 
D-xylose reductase (Xyl1), putative 
 
paXR Podospora anserina XP_001912586   hypothetical protein 
ppXR Pichia pastoris XP_002492973 
 
Aldose reductase involved in 
methylglyoxal, D-xylose and arabinose  
metabolism 
pnXR Phaeosphaeria nodorum XP_001803042 
 
hypothetical protein 
 
pcXR Penicillium chrysogenum XP_002561272  
 
hypothetical protein 
 
mgXR Meyerozyma 
guilliermondii 
ABB87188  
 
putative gamma-butyrobetaine 
hydroxylase 
  
anXR Aspergillus niger XP_001388804 NAD(P)H-dependent D-xylose reductase 
xyl1 
anidXR Aspergillus nidulans XP_658027 hypothetical protein 
psXR_m (21) Pichia stipitis N.A. K270R mutant of psXR 
Abbreviation Source LOCUS Annotation 
aoXDH Aspergillus oryzae XP_001825523 D-xylulose reductase 
anidXDH Aspergillus nidulans XP_682333 hypothetical protein 
caXDH Candida albicans XP_719434   hypothetical protein 
cdXDH Candida dubliniensis XP_002422539 xylitol dehydrogenase, putative 
hjXDH Hypocrea jecorina AF428150_1 xylitol dehydrogenase 
ncXDH Neurospora crassa   XP_964807 hypothetical protein 
nhXDH Nectria haematococca XP_003053965 predicted protein 
paXDH Pichia angust BAD32688 glycerol dehydrogenase 
pcXDH Penicillum chrysogenum XP_002568185 hypothetical protein 
pnXDH Phaeosphaeria nodorum XP_001801634 hypothetical protein 
ppXDH Pichia pastoris XP_002489933 hypothetical protein 
zrXDH Zygosaccharomyces 
rouxii 
XP_002497308 Sorbitol dehydrogenase 
baXDH Blastobotrys 
adeninivorans 
CAG34729 xylitol dehydrogenase 
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Table 3.1 (cont’d) Enzyme homologues of xylose reductase, xylitol dehydrogenase and xylulokinase 
cloned in this study 
Abbreviation Source LOCUS Annotation 
psXDH Pichia stipitis** XP_001386982 Xylitol dehydrogenase 
anXDH Aspergillus niger XP_001395093 D-xylulose reductase A 
pgXDH Pichia guilliermondii* XP_001481963 hypothetical protein 
ctXDH Candida tropicalis XP_002546318 D-xylulose reductase 
klXDH Kluyveromyces lactis XP_453306 hypothetical protein 
csXDH Candida shehatae ACI01079 xylitol dehydrogenase 
tsXDH Talaromyces stipitatus XP_002488234 xylitol dehydrogenase 
ptXDH Pachysolen tannophilus ACD81475 alcohol dehydrogenase 
ncXDH_m Neurospora crassa N.A. ARS mutant of ncXDH 
Abbreviation Source LOCUS Annotation 
anXKS Aspergillus niger XP_001391397 D-xylulose kinase A 
caXKS Candida albicans XP_711437 potential xylulokinase Xks1p 
ctXKS Candida tropicalis XP_002549576 hypothetical protein 
pcXKS Penicillium 
chrysogenum 
CAP80202 strong similarity to D-xylulokinase 
Xks1Saccharomyces cerevisiae 
psXKS Pichia stipitis** AAF72328 D-xylulokinase 
scXKS Saccharomyces 
cerevisiae 
EDN61781 xylulokinase 
ppXKS Pichia pastoris XP_002489935 Xylulokinase, converts D-xylulose and 
ATP to xylulose 5-phosphate 
cdXKS Candida dubliniensis CAX42363 xylulokinase, putative 
ncXKS Neurospora crassa XP_001728137 hypothetical protein 
klXKS Kluyveromyces lactis XP_454390 hypothetical protein 
mgXKS Meyerozyma 
guilliermondii 
XP_001482343 hypothetical protein 
paXKS Podospora anserine XP_001907775 hypothetical protein 
afXKS Aspergillus flavus XP_002383697 D-xylulose kinase 
afuXKS Aspergillus fumigatus XP_753656 D-xylulose kinase 
tsXKS Talaromyces stipitatus XP_002484260 D-xylulose kinase 
anidXKS Aspergillus nidulans XP_682059 hypothetical protein 
aoXKS Aspergillus oryzae XP_001824894 D-xylulose kinase A 
zrXKS Zygosaccharomyces 
rouxii 
XP_002498508 hypothetical protein 
nhXKS Nectria haematococca XP_003048965 predicted protein 
* Meyerozyma guilliermondii 
**Scheffersomyces stipitis 
 
To obtain the open reading frames (ORFs) encoding enzyme homologues, strains 
carrying corresponding genes were obtained from various culture collections such as the ARS 
(Agricultural Research Service) culture collection (NRRL) (http://nrrl.ncaur.usda.gov/cgi-
bin/usda/, Peoria, IL), ATCC (American Type Culture Collection, http://www.atcc.org/), and 
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DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH aka.German 
Collection of Microorganisms and Cell Cultures, http://www.dsmz.de/). (Table 3.1 table of 
enzyme homologues) The strains were cultivated in YP media supplemented with 2% xylose. 
Total RNA was subsequently isolated using an RNeasy mini kit (Qiagen, Valencia, CA). The 
total RNA was then reverse transcribed into cDNA using a First Strand cDNA Synthesis Kit 
(Roche, Branford, CT) using oligo-dT primer. Primers were designed based on known gene 
sequences from GenBank to amplify the ORFs. At the same time, genomic DNA was also 
generated from the same collection of strains for cloning of enzyme homologues with no intron 
within the ORFs.  
In total, twenty xylose reductase homologues, twenty-two xylitol dehydrogenase 
homologues, and nineteen xylulokinase homologues were successfully amplified by PCR. All 
these genes were then included in the combinatorial library for pathway optimization. 
3.2.2 Cloning of Gene of Enzyme Homologues Involved in Xylose Utilization 
In order to facilitate the assembly of the pentose utilization pathways consisting of 
different combinations of enzyme homologues from various fungal species, a general scaffold for 
the three-gene xylose utilization pathway was constructed. To construct the scaffold for the three 
gene xylose utilization pathways, xylose reductase and xylitol dehydrogenase from Neurospora 
crassa as well as xylulokinase from Pichia stipitis were assembled into the pRS416 single copy 
shuttle vector using DNA assembler (18). Specifically, the N. crassa xylose reductase ORF was 
assembled with an ADH1 promoter and an ADH1 terminator using overlapping extension PCR 
(22) to generate the gene expression cassette, while N. crassa xylitol dehydrogenase was 
assembled with a PGK1 promoter and a CYC1 terminator, and P. stipitis xylulokinase was 
assembled with a PYK1 promoter and an ADH2 terminator. The resultant gene expression 
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cassettes were then assembled using the DNA assembler method into a linearized pRS416 
plasmid to generate pHZ981 (Figure 3.2). 
 
Figure 3.2 Scaffold for combinatorial engineering of the xylose utilization pathway. The scaffold for 
pathway assembly consists of a xylose reductase gene from N. crassa flanked with an ADH1 promoter 
and an ADH1 terminator, followed by a xylitol dehydrogenase gene from N. crassa flanked with a PGK1 
promoter and a CYC1 terminator, and, finally, a xyulokinase gene from Pichia stipitis flanked with a 
PYK1 promtoer and an ADH2 terminator. 
 
To facilitate the cloning of enzyme homologues for pathway assembly, helper plasmids 
were constructed for each catalytic step of the pentose utilization pathway. In each helper 
plasmid, a promoter with a DNA fragment (~500 bp) homologous to the upstream adjacent 
sequence and a terminator with a DNA fragment (~500 bp) homologous to the downstream 
adjacent sequence were assembled into a pRS414 single copy plasmid using DNA assembler. A 
unique XhoI site was engineered between the promoter and the terminator to facilitate the 
linearization of the helper plasmids for the cloning of enzyme homologue ORFs for the assembly 
of gene expression cassettes. In total, three helper plasmids were constructed for cloning of XR, 
XDH and XKS enzyme homologues. For the cloning of XR homologues, an ADH1 promoter, a 
unique XhoI cutting site, an ADH1 terminator, and the first 480 bp of a PGK1 promoter were 
assembled into a pRS414 single copy shuttle vector. Similarly, an ADH1 terminator, a PGK1 
promoter, a unique XhoI site, a CYC1 terminator, and the first 404 bp of a PYK1 promoter were 
assembled into a pRS414 vector for the cloning of XDH homologues. For the cloning XKS 
homologues, a CYC1 terminator, a PYK1 promoter, a unique XhoI site, and an ADH2 terminator 
were assembled into a pRS414 vector. Primers were designed according to the gene sequences in 
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GenBank for the amplification of the ORFs of enzyme homologues. A DNA sequence of 
approximately 45 bp in length was introduced at the 5’ end of the ORF to be homologous to the 
3’ end of the promoter sequence as well as at the 3’ end of the ORF in order to be homologous to 
the 5’ end of the terminator sequence for the homologous recombination-based cloning.  
The PCR products were purified by gel extraction and then cloned into the corresponding 
pRS414 helper plasmids linearized with XhoI using yeast homologous recombination based 
cloning. The correctly assembled enzyme homologue expression cassettes were confirmed by 
diagnostic PCR using primers annealing to the end of the promoter and the beginning of the 
terminator. In total, twenty homologues of xylose reductase, twenty-two homologues of xylitol 
dehydrogenase, and nineteen homologous of xylulokinase were successfully cloned. Constructs 
yielding the correct size of PCR product were used as templates to generate gene expression 
cassettes in later assembly (Figure 3.3).  
 
Figure 3.3 Assembly of gene expression cassettes on the pRS414 helper plasmids. The helper plasmids 
were first linearized at the unique XhoI site, and then co-transformed into S. cerevisiae with the PCR 
fragments of the enzyme homologue genes flanked with promoter and terminator sequences. The 
resulting constructs were used for amplification of gene expression cassettes consisting of a promoter, an 
enzyme homologues open reading frame, a terminator, and the upstream and downstream homologous 
regions. 
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To obtain the gene expression cassettes for random pathway assembly, PCR was used to 
amplify the whole gene expression cassette including the homologous region upstream of the 
promoter, the promoter itself, the target ORF, the terminator, and the homologous region 
downstream of the terminator. The sizes of the resultant fragments were confirmed using agarose 
gel electrophoresis. The concentrations of purified DNA fragments were then determined using 
Nanodrop (Thermo Scientific, Wilmington, DE). Finally, DNA fragments of gene expression 
cassettes were mixed together and co-transferred with the linearized pRS416 shuttle vector for 
assembly of pathway libraries. 
3.2.3 Optimization of Combinatorial Assembly of Pathway Libraries 
To create a library of pentose utilization pathways, DNA fragments encoding different 
enzyme homologues were mixed together and co-transferred into S. cerevisiae competent cells 
with a linearized pRS416 plasmid. Since approximately ten to twenty enzyme homologues were 
involved in the assembly of the library for each catalytic step, the number of different DNA 
fragments involved in the assembly was quite large. Specifically, for a three-gene xylose 
utilization pathway, twenty homologues of xylose reductase, twenty-two homologues of xylitol 
dehydrogenase, and nineteen homologous of xylulokinase were used for the assembly of the full 
size library. Together with the linearized backbone, there were a total of sixty-two DNA 
fragments involved in library creation.  
To ensure a high efficiency of correct assembly in the DNA assembler method, a large 
quantity of DNA for each fragment is often desirable. However, as there is a limit to the amount 
of DNA yeast cells can uptake, introducing too much DNA into the yeast cells will only result in 
an inefficient assembly and wasted DNA fragments. In order to determine the optimal amount of 
DNA fragments for pathway assembly, varying amounts of DNA fragments were used for library 
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creation. Equal amounts of DNA (in ng) of all the DNA fragments were mixed and transferred 
into yeast using either electroporation or heat-shock transformation and the resulting library size 
was investigated. (Notebook#6, page 131). 
 
Figure 3.4 Optimal amounts of DNA fragments for library creation. The efficiency of transformation in 
terms of number of transformants per microgram of DNA verses total amount of DNA used in the 
transformation are plotted above. The optimal total amount of DNA used in the transformation was 
around 5000 nanograms for both heat-shock transformation and electroporation. 
 
As shown in Figure 3.4, the optimal amounts of DNA fragments for library creation was 
determined to be around 5000 ng in total and the resulting library size was around 1.3x104. The 
transformation efficiency showed a similar trend independent of the transformation method. 
When a larger library size was needed, multiple transformations were performed and the final 
transformants were combined. 
 
3.2.4 Characterization of a Small Size Random Library Resulted from Combinatorial 
Pathway Assembly 
To characterize the efficiency and diversity of the random pathway assembly method, a 
small library of yeast strains containing the three-gene xylose utilization pathways were created 
and evaluated. Specifically, eight homologues of xylose reductase, ten homologues of xylitol 
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dehydrogenase, and six homologues of xylulokinase were assembled using DNA assembler. 
After DNA transformation using either heat-shock or electroporation, transformants were spread 
upon a SC-Ura plate supplemented with 2% glucose. Twenty single colonies were randomly 
picked from the electroporation library for subsequent analysis. These twenty transformants were 
first grown in liquid SC-Ura medium supplemented with 2% glucose. Next, the yeast plasmids 
were isolated using a Zymoprep II yeast plasmid isolation kit (Zymo Research, Irvine, CA). The 
resultant yeast plasmids were transferred into E. coli DH5α and the corresponding plasmids were 
isolated from E. coli using a QIAprep Spin Miniprep kit (QIAGEN, Valencia, CA). The correct 
assembly of the three-gene xylose utilization pathway was checked using diagnostic PCR with 
primers annealing to both the promoter and the terminator regions. It was found that all twenty 
constructs had the correct assembly of the three-gene pathway. To further study the diversity 
within the library, the twenty constructs were submitted for DNA sequencing to identify the 
enzyme homologues assembled into the pathways. It was found that the twenty constructs all had 
distinct combinations of different enzyme homologues and the choice of enzyme homologues for 
the same catalytic step did not appear to be biased (Figure 5). Similar experimentation was also 
performed on mutants randomly picked from a pathway library obtained through heat-shock 
transformation. Twenty randomly picked mutants from the heat-shock library also showed a 
100% efficiency of correct assembly, good library diversity, and an unbiased choice of enzyme 
homologues in an assembled pathway. (Notebook #6, page 83). 
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Figure 3.5 Sequence analysis of the genetic diversity within the library. For the twenty randomly picked 
constructs, number of appearance of certain enzyme homologues is plotted in this figure. 
 
3.2.5 Construction of the Xylose Utilization Pathway Libraries Using DNA Assembler 
To create a library of yeast strains containing the three-gene xylose utilization pathway, 
DNA fragments of enzyme homologue cassettes were mixed and transferred into S. cerevisiae 
with a linearized pRS416 shuttle plasmid. In the assembly of the xylose utilization pathway 
using all sixty-one enzyme homologues, eighty nanograms of DNA were used for each DNA 
fragment including the linearized pRS416 vector. After DNA transformation, a small amount of 
transformants were spread upon a SC-Ura plate supplemented with glucose in order to determine 
the size of the library. The rest of the transformants were first cultivated in the liquid SC-Ura 
medium supplemented with glucose overnight and then glycerol frozen stocks were made for the 
pathway libraries.  
As previously mentioned, twenty xylose reductase homologues, twenty-two xylitol 
dehydrogenase homologues, and nineteen xylulokinase homologues were introduced into the 
pathway library. The corresponding theoretical library size should be 8,360 different pathways. 
For pathway assembly in laboratory strains such as L2612 and INVSc1, a library size of 1.3x10
4
 
transformants per transformation can be achieved.  
 90 
3.2.6 Enrichment of a Xylose Utilization Pathway Library 
In theory, after the xylose utilization pathway library is constructed, a pathway consisting 
of any given combination of the enzyme homologues used in the assembly should exist in the 
library. However, identification and isolation of a desired pathway remains a particularly 
challenging endeavor. To identify advantageous pathway mutants, three strategies can be used: 
selection, screening, and enrichment. Selection is the most powerful and high throughput method 
for isolating mutants with desired characteristics if those characteristics themselves can be linked 
with the cell’s growth or survival. Unfortunately, since a good portion of the mutants in the 
pathway library retain their functionality, it is hard to select for a good mutant on media with 
xylose as the sole carbon source. Enrichment is a good alternative strategy that could possibly 
work for selection of desirable xylose pathways. Since strains bearing highly productive xylose 
utilization pathways should grow faster when xylose is utilized as the sole carbon source, the 
population of strains bearing the highly productive xylose utilization pathways should become 
bigger and bigger during the serial transfer of cell culture. After several rounds of serial transfer, 
strains harboring the most efficient xylose utilization pathways could be enriched to the point 
where only a relatively small number of mutants need to be examined in order to identify the 
desired pathway mutants.  
To test the enrichment strategy, the library was inoculated in YP media containing 2% 
xylose (YPX) and grown under oxygen-limited conditions. When the culture reached the late 
exponential growth phase (OD10), a portion of the culture (1%) was used to inoculate fresh 
medium. This sequential culture transfer was repeated three times in order to enrich clones able 
to yield a high amount of ethanol when grown on xylose under oxygen-limited conditions. At 
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each round of enrichment, ten microliters of culture was plated on SC-Ura plates supplemented 
with glucose.  
Table 3.2. Sequence analysis of randomly selected yeast clones from the second and third round of 
enrichment. For species names, use full names when they are first used.  
 XR XDH XKS 
E2.1
a
 P. guilliermondii N. crassa P. chrysogenum 
E2.6 A. oryzae N. crassa P. chrysogenum 
E2.7 A. oryzae N. crassa P. chrysogenum 
E2.8 A. oryzae N. crassa P. chrysogenum 
E2.9 A. oryzae N. crassa P. chrysogenum 
E3.2
b
 A. oryzae N. crassa P. chrysogenum 
E3.3 A. oryzae N. crassa P. chrysogenum 
E3.5 A. oryzae n.d.
c
 P. chrysogenum 
E3.6 A. oryzae N. crassa P. chrysogenum 
E3.8 A. oryzae N. crassa P. chrysogenum 
  a E2.# indicates clones from second round of enrichment 
  
b
 E3.# indicates clones from the third round of enrichment 
  
c
 n.d.: not determined 
 
Ten clones were randomly selected from the second (E#2) and third round (E#3) of 
enrichments and then grown in culture tubes containing SC-Ura supplemented with 2% glucose. 
Five clones from E#2 and five clones from E#3 were randomly picked and submitted for 
sequencing to identify the pathway genes. The growth rate and metabolism of these ten clones 
were determined and compared with a control strain containing three well-studied genes: XR, 
XDH, and XKS from Pichia stipitis (pRS416-psXP).  
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Figure 3.6 Cell growth and metabolism of the control strain and the yeast clones isolated through 
enrichment. a) Comparison of the cell growth of the control strain and ten clones from the second and 
third round of enrichment. b), c), and d) OD (solid diamond), xylose (solid rectangle), xylitol (solid 
triangle), glycerol (cross), acetate (solid circle), and ethanol (empty circle) concentrations in the culture of 
control (b), clone E2.1 (c), and E3.2 (d). The data shown was the mean of duplicate experiments and the 
standard deviation is less than 20%.  
 
However, after isolation of the plasmid from E2.1 and E3.2 strains, and transformation of 
these plasmids into fresh host cells, the advantage of the enriched pathway significantly 
decreased (data not shown). As a control experiment, serial transfer experiments were carried out 
for the control pathway and the pathway library in parallel. Surprisingly, the growth and 
fermentation ability of the control pathway was also significantly improved after the serial 
transfer experiment. It appeared that the improvement of the strain performance was more likely 
to be from host strain adaptation rather than pathway mutant selection (Figure 3.7). 
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Figure 3.7 Enrichment of the control pathway with the pathway library itself in parallel (right). Blue 
diamond: final OD after every 48 hours of culture for the strain with psXR-psXDH-psXKS single copy 
integration in the genome, green triangle: final OD after every 48 hours for E3.2 pathway on single copy 
plasmid, red square: final OD after every 48 hours for E3.2 pathway on single copy chromosomal 
integration. 
 
In order to remove the host cell adaptation that resulted from prolonged culture time due 
to serial transfer, two strategies were implemented for pathway library enrichment. In the first 
strategy, additional cultivation step in the SC-Ura media supplemented with 2% glucose was 
introduced after every two rounds of enrichment in the YP media supplement with 2% xylose to 
remove the host cell adaptation in xylose media. In the second strategy, yeast plasmids were 
isolated after every couple rounds of enrichment in the YP media and then retransferred into 
fresh host cells to eliminate the host adaptation. Using the first strategy, the pathway library was 
continuously enriched for nine rounds. Unfortunately, after retransformation, only marginal 
improvement was observed for the enriched mutant (Figure 3.7). For the second strategy, the re-
transformation step was initially introduced after every two rounds of enrichment. As shown in 
Figure 3.8, yeast plasmids were isolated after two serial transfers of culture. The yeast plasmid 
was then transferred into E. coli. After propagating in E. coli, the library of plasmids were 
isolated and retransferred into fresh host cells. The final OD after two days of growth in shake 
flasks with xylose as the sole carbon source is shown in the figure. Obviously, though only two 
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serial transfers happened before every retransformation, the host cells were adapted to the xylose 
media that resulted in faster cell growth.  Unfortunately, this kind of improvement cannot be 
transferred with re-transformation of the mutant pathway into fresh host strains, and after every 
round of retransformation the growth rate of the library dropped back to the level before 
enrichment. (Notebook #7,  page 94) 
 
Figure 3.8 Enrichment with re-transformation after every two rounds of enrichment. A. Scheme of the 
library enrichment strategy, B. Final OD of each culture in the YP media supplemented with xylose. 
Before even round numbers, the yeast plasmids were isolated and retransferred into fresh host cells. C. 
Plot of the final OD of the culturse right after re-transformation displaying that the cell growth rate didn’t 
improve after rounds of enrichment. 
 
In an attempt to addres the host adaptation problem within the enrichment process to the 
greatest extent, the second serial transfer was eliminated so that after every round of serial 
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plasmid transfer of the pathway library would be first isolated from the yeast culture, propagated 
into E. coli, and then re-transferred into fresh yeast cells. Figure 3.8 shows the final cell density 
and the xylose consumption in the (which media) after every round of enrichment. After four 
rounds of enrichment, the growth rate of the mutant library remained at the same level while the 
xylose utilizing ability dramatically dropped. Consequently, after four rounds of re-
transformation, the strains that were better at utilizing other nutrients in the rich media but not 
xylose were enriched. Since the main purpose of this study is to isolate mutant xylose ultilization 
pathways that utilize xylose efficiently, this enrichment method was deemed to be ineffective. 
(Notebook #7, page 140-142) 
 
Figure 3.9 Enrichment with re-transformation after every round of enrichment. Cell density (left) and 
xylose consumption (right) at the end of each round of enrichment. 
 
3.2.7 Screening of an Enzyme-Based Pathway Library 
Since the enrichment method failed to identify more efficient xylose utilization pathways 
from the pathway library, a screening method was developed to facilitate the isolation of more 
efficient xylose utilization pathways. In order to reduce the amount of mutant pathways to be 
screened, an agar plate-based pre-screening method was used to identify the more efficient 
xylose utilizing pathways. To growth rate of the strain in xylose liquid medium with the colony 
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size of the yeast strain containing that xylose utilization pathway on the agar plates with xylose 
as the sole carbon source, five yeast strains that harbored mutant xylose utilization pathways 
which exhibited different growth rates in liquid culture were spread upon SC-Ura plates 
supplemented with 2% xylose at the same colony density. The colony size distribution on these 
plates was then examined use a microscope. The microscope images were analyzed using the 
Image J software (NIH). Finally, colony size distributions were plotted with the growth rates in 
liquid culture under oxygen limited conditions . 
 
Figure 3.10 Relationship between growth rate and colony size distribution. Left: Growth rate of yeast 
strains harboring different pathway mutants. Inv.lib.1 to inv.lib.8 are the eight random picked strains with 
different growth rate. Inv.lib.1 to inv.lib.5 are the five strains plated on xylose plate for colony size check. 
Right: Distribution of colony size of 50 random picked yeast colonies. Plate 1 to plate 5 correspond to the 
colony size of inv.lib.1 to inv.lib.5. 
 
As shown in Figure 3.10, yeast strains with higher growth rates tend to have larger 
colonies (except for the situation on plate #5 as indicated by the question mark in the right figure 
of Figure 3.10). Therefore, we hypothesized that picking larger colonies on the agar plates will 
likely enable us to find strains with a higher growth rate. This hypothesis was then incorporated 
into the new colony size based screening strategy to identify strains with high growth rate on 
xylose. Agar plates containing rich media supplemented with 2% xylose were also tested for the 
prescreening. Unfortunately, although cellular growth on agar plates containing rich media was 
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faster compared to the synthetic drop-out media (SC-Ura), the differences in colonies size were 
not as obvious as those in the SC-Ura media. When the pathway library was spread on synthetic 
drop-out media plates, the size difference between the big colonies and small colonies could be 
readily identified by naked eyes. Yet, when the same library was spread on the rich media plates, 
the size differences among the strains harboring different mutant pathways were very small. 
More importantly, no colonies sized larger than the biggest colonies of the reference plate could 
be identified on the rich media plate with naked eyes. The selection of the host strain was also 
very crucial for the colony size-based pre-screening strategy. The L2612 strain was used for the 
development for the pathway assembly strategy and for the primary characterization of the 
pathway libraries. However, when spread on agar plates, the colony size distribution of the 
L2612 strain harboring the same mutant pathway was too large. In this case, the colonies’ sizes 
were not well correlated with the growth rates in liquid media. Fortunately, we were able to find 
an alternative host strain which has also been proven to be suitable for xylose fermentation (23). 
In subsequent studies, the INVSc1 strain (Invitrogen, Carlsbad, CA) was used as the host strain 
for pathway optimization. The colony size distribution of the INV.Sc1 strain hosting the same 
utilization pathway was quite uniform, making it convenient for the identification of strains that 
harbor more efficient mutant xylose utilizing pathways. 
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Figure 3.11. Screening strategy based on colony size. Screening strategy based on colony size. The 
pathway library is spread on an agar plate containing 2% xylose as the sole carbon source together with a 
reference pathway consisting of a xylose utilization consisting of psXR, psXDH and psXKS. Colonies on 
the library plate that have grown to a size bigger than that of the largest colonies on the reference plate are 
picked and inoculated in media supplemented with 2% and the necessary selection pressure for 
maintaining the pathway bearing plasmids. The seed cultures are then used to inoculate tubes containing 
YP media supplemented with 2% xylose to a similar initial OD. Mutant strains bearing fast xylose 
utilizing pathways are identified by measuring the cell growth rates of the mutant strains. The top ten 
mutant strains identified using tube cultures are screened again in 50 mL flasks containing 10 ml YP 
media supplemented with 2% xylose. Flask cultures are analyzed using HPLC and the top mutant strain 
with the fastest xylose utilization rate and the highest ethanol productivity is identified.  
 
To identify more efficient mutant xylose utilization pathways, the pathway library was 
assembled using DNA fragments amplified from the helper plasmids. A small aliquot of the 
transformants were plated onto SC-Ura plates supplemented with 2% glucose in order to 
determine the library size. The rest of the transformants were used to inoculate a twenty-five 
milliliter liquid media of SC-Ura supplemented with 2% glucose. Frozen cell stocks were made 
from the liquid culture for later analysis. A small aliquot of the liquid culture was then washed 
with ddH2O. Around 10
5
 cells were plated onto 24.5 cm by 24.5 cm square agar plates of SC-Ura 
supplemented with 2% xylose. At the same time, around 10
4
 cells harboring a reference pathway 
consisting of XR, XDH and XKS from P. stipitis were plated on regular fifteen centimeter round 
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agar plates with the same media. The library plate and the reference plate were then incubated 
together and the colony sizes on both plates were checked daily. After around three days of 
incubation at 30 °C, the differences among the colony sizes on the library plate and the reference 
plate gradually became obvious. Colonies on the library plate that were larger than the biggest 
colonies on the reference plate were then picked and inoculated first in one milliliter of SC-Ura 
liquid media supplemented with glucose for thirty-six hours. The liquid media was then used to 
inoculate a three milliliter liquid media of YP supplemented with 2% xylose to an initial OD of 
approximately 0.2. The tube cultures were then cultivated at 30 °C with 250 rpm agitation. The 
cell densities of the strains were measured after around 24 hours, 36 hours and 48 hours. The 
first two time points were used to determine the specific growth rate of mutant strains. The top 
ten strains with the highest growth rate were next subjected to another round of screening using 
fifty milliliter shake flask containing ten milliliter YP media supplemented with 2% xylose at 
30 °C and 100 rpm agitation (oxygen limited condition). The flask cultures were then sampled at 
various time points and the strains found to display the highest xylose consumption and ethanol 
production rate were isolated. 
Using this method, more efficient mutant xylose utilization pathways were identified 
using INVSc1 as the host strain. Stains with faster growth rate were identified through culture 
tube screening. Among the ten fast growers identified from culture tube screening, one fast 
grower named S2 was isolated (Figure 3.12).  
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Figure 3.12 Culture tube and shake flask screening of enzyme-based xylose utilization pathway library in 
the INVSc1 strain. All data shown are from a single experiment, no replication was taken for the 
preliminary screening experiment due to the large number of samples. 
 
Sequencing of the top ten mutant xylose utilization pathways revealed the combination of 
enzyme homologues (Table 3.3). The optimized pathway S2 consisted of the xylose reductase 
from Aspergillus nidulans (anXR), the xylitol dehydrogenase from Candida albicans (caXDH), 
and the xylulokinase from Saccharomyces serevisiae (scXKS). 
Table 3.3 Sequence analysis of top 10 xylose utilization pathway mutants from enzyme-based xylose 
utilization pathway screening in the INVSc1 strain. 
  XR XDH XKS 
S1 Aspergillus nidulans Pichia stipitis Podospora anserina 
S2 Aspergillus nidulans Candida albicans Saccharomyces serevisiae 
S3 Pichia stipitis Pichia pastoris Podospora anserina 
S4 Neurospora crassa Zygosaccharomyces rouxii Apergillus niger 
S5 Zygosaccharomyces rouxii Arxula adeninivorans Kluyveromyces lactis 
S6 Aspergillus nidulans Pichia stipitis Podospora anserina 
S7 Neurospora crassa Arxula adeninivorans Saccharomyces serevisiae 
S8 Neurospora crassa Neurospora crassa Apergillus niger 
S9 Zygosaccharomyces rouxii Zygosaccharomyces rouxii Aspergillus nidulans 
S10 Pichia stipitis Aspergillus oryzae Nectria haematococca 
 
The mutant xylose utilization pathway S2 was then compared with the reference pathway 
consisting of XR, XDH and XKS from P. stipitis in shake flask fermentation under oxygen 
limited conditions using rich media containing 4% xylose as sole carbon source. As shown in 
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Figure 3.13, the S2 pathway consumes xylose at a rate of 0.39 g/L/hour, while the reference 
pathway consumes xylose at a rate of 0.21 g/L/hour. The mutant pathway also exhibited a three-
fold improvement at ethanol production rate and a 1.6-fold improvement in ethanol. 
 
Figure 3.13 Xylose fermentation of S2 (anXR-caXDH-scXKS) pathway and the control pathway 
(psXR-psXDH-psXKS). Red square: xylose concentration, blue diamond: cell density (measured 
by optical density at 600 nm), green triangle: ethanol concentration. The date shown is the mean 
of the duplicates, and the standard deviation is within 20%. 
3.3 Discussions  
In this chapter, a pathway assembly strategy was developed for optimization of xylose 
utilization in S. cerevisiae. The three step xylose utilization pathway was randomly assembled on 
a single copy vector using enzyme homologues from various fungal species. We choose to 
assemble our pathway library on plasmids for their inherent mobility as well as their ease of 
transformation and handling. A single copy vector was chosen as the backbone for pathway 
assembly in this study instead of a multicopy vector in order to ensure that every mutant cell 
within the resultant pathway library would only contains a certain mutant pathway. If a 
multicopy vector had been used as a backbone in the pathway assembly—as 2 micro origin of 
replication would allow multiple plasmids to co-exist in a single mutant cell—the pathway 
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responsible for the improved xylose utilization would have been much harder to identify. In this 
case, the mutant exhibiting faster xylose utilization would quite possibly have resulted from a 
collection of mutant pathways within the strain, a result which is very hard to analyze and 
transfer.  
For the cloning of enzyme homologues and assembly of the pathway library, a 
recombination-based DNA assembler approach was used instead of the traditional restriction 
digestion and ligation-based method. For the cloning of enzyme homologues, application of the 
DNA assembler method eliminated the need to find restriction sites. Additionally, it should be 
noted that the strains used in this study as sources for cloning of enzyme homologues were not 
always identical to the strain specified in the database where the gene sequences were obtained 
due to the availability of strains in culture collections. When necessary, strains of the same 
species isolated from wood or agricultural waste were ordered as the target organisms for DNA 
cloning. Consequently, it is not guaranteed that the gene sequences of the enzyme homologues in 
these particular strains are identical to the gene sequences in databases—in fact, DNA 
sequencing results of the cloned enzyme homologues usually differ from the database. (Please 
refer to the example of the cloned sequence of XKS from Pichia pastoris discussed in Chapter 4.)  
In this situation, a restriction digestion-ligation-based approach would fail even when restriction 
sites were chosen based on the DNA sequence of enzyme homologues found in the database, 
since the actual sequence of the amplified gene could very likely be different. For the assembly 
of the pathway library, the DNA assembler method was chosen due to its innate advantages in 
the rapid assembly of multi-step pathways. As shown in the assembly of a xylose utilization 
pathway consisting of a small subset of enzyme homologues, the efficiency of correct pathway 
assembly (~100%) and the diversity of the resultant library generated from the DNA assembler-
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based method was satisfactory. 
For efficient assembly of the xylose utilization pathway library, the scaffold for the 
xylose utilization pathway — namely the combination of promoters and terminators for each 
catalytic step — remained consistent throughout this study. A fixed scaffold provides many 
advantages for subsequent investigation. First of all, all three promoters used in this study have 
been tested in various nutrition and aeration conditions and the expression levels have been 
proven to be both similar and constitutive (unpublished data, please refer to the strengths of 
constitutive promoters in Chapter 4). As such, the difference in the expression level and enzyme 
activity should be mainly dependent upon the properties of the different enzyme homologues. 
Second, the fixed scaffold ensures that during the random assembly of the pathway, shuffling of 
different enzyme homologues only occurs within the homologues that correspond to the same 
catalytic step. In other words, all the resultant variant pathways in the library should have the 
complete three-gene pathway. Third, due to the fact that the length of yeast promoters and 
terminators have an average length of around 400 to 1000 bp, the promoter and terminator of the 
adjacent enzyme provides a fixed DNA sequence of around 1000 bp in length. In later steps, 
these fixed DNA sequences were included in both of the neighboring gene expression cassettes 
to generate longer homologous ends, which resulted in higher assembly efficiency for the library 
creation. 
Different backbone vectors were used for the helper plasmid construct and the final 
assembly intentionally to reduce the amount of work involved in material preparation for 
pathway assembly. Since gene expression cassettes were amplified from pRS414 helper 
plasmids, which contain a different selection marker than the backbone vector pRS416 used in 
the final assembly, it is very unlikely that the trace amount of helper plasmids in the PCR 
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mixture would result in false positive colonies in the assembly. Due to this, the DNA fragments 
with the correct size could be purified using simple PCR cleanup rather than a gel extraction. 
This design greatly reduced the amount of labor required for preparation of gene expression 
cassettes. 
DNA fragments of the gene expression cassettes amplified from helper plasmids were 
then mixed together with linearized pRS416 shuttle vector at an equal DNA amount (in 
nanograms) for the combinatorial assembly of the pathway library. In this experiment, a lower 
molar amount of backbone was used in comparison to the amount used for enzyme homologues 
for two reasons. First, like in regular cloning work, more insert DNA was used than backbone 
DNA in order to ensure a high cloning efficiency. Second, less backbone was also used to avoid 
cyclization of the backbone by itself, inevitably decreasing the overall likelihood of false positive 
colonies and thus increasing the overall efficiency of assembly for all three catalytic steps. 
After the screening, a heterologous xylose utilization pathway consisting of anXR, 
caXDH and scXKS was identified from a library. The activity and cofactor preference of the 
enzyme homologues in the selected pathway on single copy vector was determined later. (Please 
refer to Chapter 4, “4.2.1 Activities of Enzyme Homologous in the Xylose Utilization Pathway” 
for enzyme activity with different cofactors.) The anXR in the selected pathway showed 
moderate activity (about 1/3 of the enzyme homologue with the highest activity) when NADPH 
was used as a cofactor. When NADH was used as a cofactor, the anXR activity decreased to 
about half of that with NADPH as a cofactor. The caXDH and the scXKS were both among the 
enzyme homologues with the highest activity. Considering the relative strength of the ADH1, 
PGK1 and PYK1 promoters previously characterized by Jie Sun and Zengyi Shao (unpublished 
data, please refer to Chapter 4), a relatively low activity of XR together with high activity of 
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XDH and XKS was shown to be the best combination of enzyme activities for xylose utilization 
in INVSc1 strain on single copy centromeric vector. Previous study has shown that a relatively 
low xylose reductase activity was desired for xylose utilization pathway to reduce the formation 
of xylitol (24). This result of the enzyme-based pathway optimization is consistent with finding 
from previous metabolic engineering study for oxidoreductase xylose utilization pathway.  
One key problem of metabolic engineering for oxidoreductase xylose utilization pathway 
is the cofactor imbalance issue caused by the different cofactor preference of xylose reductase 
(XR) and xylitol dehydrogenase (XDH). To address this issue, a large amount of effort has been 
spent on heterologous expression of new XR and XDH homologous as well as engineering 
existing enzymes. (20,25-30) The experiment result of this kind of approach differed due to the 
different strain backgrounds and cofactor pairs used in the study (20,21,31,32). Aside from the 
cofactor imbalance issue, the relative activity of XR, XDH, and XKS is also a crucial factor on 
efficient xylose assimilation (24). Although a lot of efforts have been invested to optimized the 
activity level of the three enzymes, results of a best balance of the activity of XR, XDH and XKS 
also heavily depend on different strain background and pathway construction strategies (24,33). 
This study is the first attempt of surveying a large collection of enzyme homologues for all three 
genes of the heterologous oxidoreductase xylose utilization pathway in S. cerevisiae. All enzyme 
homologues with different activity and cofactor preference were assayed in the same host strain 
on same expression vector under a same group of promoters. In contrast to the previous 
metabolic engineering strategies where a single enzyme was replaced or engineered at a time 
(20,25-30), a library of random assembly of all three catalytic enzymes was examined at one 
single trial. Since expression of enzyme homologous with the same catalytic activity from 
various species has been a general metabolic engineering approach for optimization of 
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heterologous pathways (34,35), the enzyme-based pathway assembly strategy has the potential to 
be applied for engineering of various heterologous pathways for production of value-added 
compounds (36-38). 
3.4 Conclusions and Outlook 
      In this chapter, a DNA assembler-based pathway assembly strategy was developed for the 
optimization of a xylose utilization pathway in S. cerevisiae. Twenty xylose reductase 
homologues, twenty-two xylitol dehydrogenase homologues, and nineteen xylulokinase 
homologues were successfully cloned and included in the pathway library. After optimizing the 
amount of DNA to be used in the pathway assembly, a library size of 1.3x10
4
 was achieved for 
the assembly of the xylose utilization pathways. Pathway assemblies with a novel combination of 
enzyme homologues for xylose utilization were identified. The fastest mutants consist of anXR, 
caXDH and scXKS. 
Unlike the traditional pathway optimization strategy, which relies on identifying the 
limiting step and then engineering a certain enzyme in that metabolic pathway (16,20,25-30,33), 
our newly developed combinatorial pathway assembly method provides a novel strategy for 
pathway optimization. Instead of switching a certain enzyme within the pathway, a collection of 
enzyme homologues were shuffled and randomly assembled as building blocks for a library of 
pathways. Using this method, all enzyme homologues that had been shown to improve the xylose 
utilization was evaluated under the same scaffold in the same host strains.  
Many complicated metabolic pathways can be optimized by applying the strategy 
presented in this chapter given a proper screening or selection method. Moreover, this newly 
developed strategy can also enable host strain-specific pathway optimization for tailor-making 
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pathways for special strains with a particular metabolic background. 
In the process of optimizing these pathways, a library of pathway assembly with 
diversified behavior was also generated. Given the well-defined scaffold using fixed promoters 
and terminators, the diversity of the pathway mutants mainly relies on the choice of different 
enzyme homologues. In other words, the pathway libraries generated using the strategy described 
in this chapter exhibit a controlled diversity. These kinds of libraries are very useful in the 
understanding of metabolic pathways. Regulation and interaction of metabolic pathways can be 
studied through approaches such as metabolic flux analysis and DNA microarray. The pathway 
library consisting of the different pathway enzymes under same group of promoters can also be 
used to study the effect of the activity and cofactor specificity of a certain enzyme on the overall 
pathway performance. Models of metabolic pathways can be generated using the data collected 
by studying mutants from the pathway library to understand and predict the response of the 
metabolic pathway to different enzyme homologous. 
3.5 Materials and Methods 
3.5.1 Strains, Media and Cultivation Conditions 
S. cerevisiae L2612 (MATα leu2-3 leu2-112 ura3-52 trp1-298 can1 cyn1 gal+) is a gift 
from Professor Yong-su Jin (17). S. cerevisiae strain INVSc1 (MATa his3D1 leu2 trp1-289 ura3-
52 MATAlpha his3D1 leu2 trp1-289 ura3-52) was purchased from Invitrogen (City, State). 
Escherichia coli DH5α (Cell Media Facility, University of Illinois at Urbana-Champaign, 
Urbana, IL) was used for recombinant DNA manipulation. Yeast strains were cultivated in either 
synthetic dropout media (0.17% Difco yeast nitrogen base without amino acids and ammonium 
sulfate, 0.5% ammonium sulfate, 0.083% amino acid drop out mix) or YPA media supplemented 
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with sugar as a carbon source (1% yeast extract, 2% peptone, 0.01% adenine hemisulfate). E. 
coli strains were cultivated in Luria broth (LB) (Fisher Scientific, Pittsburgh, PA) at 37 °C and 
250 rpm unless specified otherwise. S. cerevisiae strains were cultivated at 30 °C and 250 rpm 
for aerobic growth, and 30 °C and 100 rpm for the oxygen limited condition. All restriction 
enzymes were purchased from New England Biolabs (Ipswich, MA). All chemicals were 
purchased from either Sigma Aldrich or Fisher Scientific. 
3.5.2 Plasmid and Strain Construction 
Most of the cloning work was done using a yeast homologous recombination mediated 
DNA assembler method (18). DNA fragments flanked with regions homologous to adjacent 
DNA fragments were generated with polymerase chain reaction (PCR) and all the DNA 
fragments were purified and co-transferred into S. cerevisiae along with the backbone. To 
confirm the correct clones from transformants, yeast plasmids were isolated using a Zymoprep II 
yeast plasmid isolation kit (Zymo Research, Irvine, CA) and transferred into E. coli. Plasmids 
from E. coli were then isolated and confirmed using diagnostic PCR. 
3.5.3 Synthesis of cDNA from Various Species 
Lyophilized cells purchased from various culture collections were inoculated in YP media 
supplemented with 2% glucose and made into frozen stock for later use. For cloning of enzyme 
homologues involved in xylose utilization, the strains were cultivated in YP media supplemented 
with 2% xylose at 30 °C and 250 rpm. The cell cultures were then harvested and total RNA was 
isolated using an RNeasy mini kit (Qiagen, Valencia, CA) following the manufacturer’s manual. 
Specifically, the cell cultures were pelleted using a microcentrifuge and cell pellets were frozen 
in liquid nitrogen and ground into fine powder. The broken cells were resuspended in buffer, 
loaded into RNeasy columns, washed and digested with RNAse free DNAse I (Qiagen, Valencia, 
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CA) and then the total RNA was finally eluted with RNAse free water. The resulting total RNA 
was immediately subjected to cDNA synthesis or stored at -80 °C for later usage. To obtain 
cDNA for the cloning of enzyme homologues, the total RNA was reverse transcribed into cDNA 
using a First Strand cDNA Synthesis Kit (Roche, Branford, CT) following the manufacturer’s 
manual using Oligo-dT primers. 
3.5.4 Fermentation and HPLC Analysis 
Most shake flask fermentation was performed in un-baffled flasks at 30 °C under 100 
rpm agitation. A single colony was inoculated into media with selection (e. g. SC drop out media 
or rich media supplemented with antibiotic drugs as selection pressure) supplemented with 2% 
glucose within 15 mL round bottom culture tubes filled with 3 mL media at 30 °C with 250 rpm 
agitation. If a high initial OD is desired for the fermentation, a secondary seed culture was 
inoculated with the primer seed culture in a 125 mL baffled shake flask at 30 °C under 250 rpm 
agitation. The seed culture was then used to inoculate a fermentation culture to a certain initial 
OD either in a 250 mL un-baffled shake flask fill with 50 mL of media or 125 mL un-baffled 
shake flask filled with 25 ml media. The media in the shake flask for fermentation was YPA 
media supplemented with sugar as carbon source (1% yeast extract, 2% peptone, 0.01% adenine 
hemisulfate). The fermentation culture was cultivated at 30 °C under 100 rpm agitation and 
samples were taken periodically and analyzed. Cell densities of samples were measured using a 
Cary 300 UV-Visible Spectrophotometer (Agilent Technologies, Santa Clara, CA) after a proper 
dilution at a wave length of 600 nm. The sample was then centrifuged and the supernatant was 
diluted 5 to 10 times before HPLC analysis. An HPLC system equipped with a reflex index 
detector (Shimadzu Scientific Instruments, Columbia, MD) was used to analyze the 
concentration of glucose, xylose, xylitol, ethanol, acetate, and glycerol concentration within the 
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broth. To separate all the metabolites mentioned above, a HPX-87H column (BioRad, Hercules, 
CA) was used following the manufacturer’s manual using 5 mM sulfuric acid as the mobile 
phase. The HPLC chromotograph was analyzed using LCsolution Software (Shimadzu Scientific 
Instruments, Columbia, MD). 
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Chapter 4 Optimization of a Xylose Utilization Pathway Using 
Promoter Mutants with Varying Strengths 
4.1 Introduction 
In order to be converted into ethanol, pentose sugars need to be taken into S. cerevisiae 
cells via sugar transporters and then converted into xylulose via heterologous fungal or bacterial 
pentose utilizing pathways (1). Xylulose was first converted into xylulose-5-phosphate by 
xylulokinase. Xylulose-5-phosphate was then introduced into glycolysis through the non-
oxidative pentose phosphate pathway (PPP) for the production of ethanol. In this process, 
multiple catalytic steps need to be either introduced from heterologous hosts or overexpressed. 
For xylose utilization, targets of gene overexpression include xylose-specific transporters, xylose 
reductases, xylitol dehydrogenases, xylulokinases, and genes involved in PPP such as 
transaldolases and transketolases.  
It has been shown in numerous metabolic engineering studies that strong overexpression 
of a gene is not always beneficial for metabolic pathways as it can cause “metabolic burden” on 
the cell (2). For example, the overexpression of membrane proteins, such as sugar transporters, 
could affect the integrity of the cell membrane and consequently hamper cell growth (3). At the 
same time, the relative activity of xylose reductase and xylitol dehydrogenase is also important 
as it affects the redox balance and byproduct (such as xylitol) formation (4). Additionally, it has 
also been shown that the expression level of xylulokinase is crucial for efficient xylose 
utilization due to its requirement for ATP (5). Similarly, researchers have also observed that 
optimal expression levels of endogenous transaldolases and transketolases are required for 
efficient metabolic flux and ethanol production (6).  
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Traditional approaches for balancing metabolic flux, which involve identifying 
bottlenecks in metabolic pathways and debottlenecking the pathways through overexpression or 
deletion of key metabolic genes, have met with limited success (7). Recently, a number of 
innovative approaches have been developed that optimize metabolic flux at a global level 
through either perturbation of global transcription machinery (8), genomic-scale mapping of 
fitness altering genes (9,10), or multiplex automated genome engineering (11). In addition, new 
strategies have been developed to balance the metabolic flux within a target pathway by tuning 
pathway gene expression through engineering of the promoters (8), ribosome binding sites (12), 
and intergenic regions (13). Despite these impressive efforts, however, balancing the metabolic 
flux in a pathway of interest remains an overwhelming challenge (7). 
To address this limitation, we developed a method called “Customized Optimization of 
Metabolic Pathways by Combinatorial Transcriptional Engineering (COMPACTER)” that is 
capable of simultaneously optimizing multiple genes in a metabolic pathway and tailoring the 
target pathway to a production host of interest. In this approach, a metabolic pathway is 
introduced into a host strain on a single copy vector with each gene under the control of a distinct 
promoter and terminator pair. The three step xylose utilization pathway was used as a proof of 
concept to demonstrate the utility of the COMPACTER method. For pathway optimization of the 
xylose utilization pathway using enzyme homologues from different sources, around twenty 
different enzyme homologues from various fungal species with different expression levels, 
catalytic efficiencies, and cofactor preferences were cloned for each catalytic step (Please refer to 
Chapter 3). All these homologous enzymes were then assayed for their catalytic activities. 
Following this, the ones with high enzyme activity and matching cofactor specificity were 
chosen as the enzymes for each catalytic step for further optimization of the xylose utilization 
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pathways. In previous work done by Alper and coworkers, nucleotide analogue mutagenesis was 
applied to create a series of promoter mutants with varying strength for the fine-tuning of gene 
expression (14). In this chapter, the same approach was adopted to generate six groups of 
promoter mutants for engineering of multi-step pathways in S.cerevisiae. To optimize the 
expression profile of the xylose utilization pathways, mutants of yeast promoters PDC1p, 
TEF1p, and ENO2p with varying strengths were randomly incorporated into a library of xylose 
utilization pathways consisting of a fixed group of enzyme homologues using our recently 
developed DNA assembler method (15). Figure 4.1 shows the combinatorial pathway design 
strategy for the optimization of the three-step xylose utilization pathway using promoter mutants 
with varying strength. In principle, this library should contain mutant pathways with all possible 
combinations of expression levels presented in the promoter mutants. A high throughput 
screening or selection method is then used to identify a mutant pathway with a balanced 
metabolic flux from the library in the target host. The COMPACTER method was applied to 
optimize pathways in several laboratory and industrial yeast strains. In all of the cases, pathways 
with improved xylose utilization efficiency were identified. 
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Figure 4.1 General scheme of the COMPACTER method for pathway optimization. Promoter mutants 
with varying strength were cloned in front of identical catalytic enzymes. Different groups of promoter 
mutants were used for each catalytic step. Promoter mutants corresponding to the same catalytic step were 
assembled randomly. The resulting pathway library consists of pathways that all contain the same three 
catalytic enzymes for xylose utilization, while the promoter mutant incorporated in front of each catalytic 
step remains completely random. As the enzyme-based pathway assembly strategy yields a library of 
pathways consisting of random choice of enzyme homologues, the COMPACTER method yields a library 
of pathways consisting of the same catalytic enzymes but with different expression profiles. The pathway 
library was then introduced in to different host strains of Saccharomyces cerevisiae. The mutants bearing 
fast xylose utilizing pathway were then identified using a colony-size-based screening method. 
 
4.2 Results and Discussion 
4.2.1 Activities of Enzyme Homologues in the Xylose Utilization Pathway 
As shown previously in Chapter 3, twenty homologues of xylose reductase (XR), twenty-
two homologues of xylitol dehydrogenase (XDH), and nineteen homologous of xylulokinase 
(XKS) were cloned for enzyme-based pathway optimization of the xylose utilization pathway. 
All enzyme homologues were cloned into a pRS414 single copy shuttle vector via DNA 
Target pathway
Gene3Promoter3 Terminator3Gene2Promoter2 Terminator2Gene1Promoter1 Terminator1
Screening/selection of mutant pathways with desired phenotype
Combinatorial assembly of a library of mutant pathways
Gene1
Terminator2
Terminator2 Terminator3Gene3Terminator1
Terminator1 Gene2
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assembler. An enzyme activity check was then performed by Dawn Eriksen using the 
aforementioned constructs in order to determine the enzyme to be used for our promoter-based 
pathway assembly. For xylose reductases, the enzyme activity was determined using either 0.2 
mM NADPH or NADH as a cofactor. Similarly, for xylitol dehydrogenases, enzyme activity was 
also determined using either 1 mM  NAD+ or NADP+ as a cofactor. The activity of xylulokinases 
was measured using a Glycerol Kit (R-Biopharm, Darmstadt, Germany). Enzyme activities of all 
cloned enzyme homologous are shown in Figure 4.2. Most of the xylose reducases we cloned 
have activity with NADPH as a cofactor. Only psXR from Scheffersomyces stipitis engineered 
for altered cofactor specificity (16) and csXR from Candida shehatae have activity with NADH 
as a cofactor. Therefore, csXR, which exhibited a higher activity when compared to the psXR 
K270R mutant with both NADPH and NADH as a cofactor, was chosen to be the xylose 
reductase in later constructs. Similarly, ctXDH from Candida tropicalis, which displayed the 
highest activity using NAD+ as a cofactor, and ppXKS from Pichia pastoris were also chosen as 
the enzyme in all later constructs. (Notebook #7, page 34) 
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Figure 4.2 Enzyme activities of enzyme homologues. A. Activity of xylose reductase homologues from 
different sources. Blue columns show the activity when NADPH is used as a cofactor, while red columns 
show the activity when NADH is used as a cofactor. B. Activity of xylitol dehydrogenases homologues 
from different sources. Blue columns show the activity when NAD+ is used as a cofactor (primary Y-
axis), while red columns show the activity when NADP+ is used as a cofactor (secondary Y-axis). C. 
Activity of xylulokinase homologues from different sources. All enzyme activity measurements were 
done, at the very least, in duplication. The error bar indicates the standard deviation of replicated samples. 
 
In order to enable the high throughput cloning of enzyme homologues, a homologous 
recombination-based method was used for the construction of plasmids that contained the gene 
expression cassettes which were used for generation of DNA fragments for enzyme-based 
pathway optimization (previously described in Chapter 3). The same plasmids were also used for 
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examination of enzyme activities of these cloned homologues. As one of the advantages of the 
homologous recombination-based DNA assembler method, complete knowledge of the 
sequences of target gene was not necessary for the cloning work. Of note, to speed up the cloning 
of more than sixty enzyme homologues, the resultant constructs were simply checked by 
diagnostic PCR rather than DNA sequencing. Since csXR, ctXDH, and ppXKS were selected as 
enzyme homologues for all the constructs of the promoter-based assembly, they were submitted 
for DNA sequencing prior to the construction of the pathway libraries. As a result, it was found 
that the cloned ctXDH displayed the same sequence as the cDNA sequence in the NCBI 
database. The cloned csXR has one missense mutation (G28D) when compared with the 
reference sequence available online. Surprisingly, the cloned ppXKS shows mutations scattered 
across its gene sequence when compared to the reference sequence. When the cloned gene 
sequence of ppXKS was translated into an amino acid sequence, the resulting protein is of the 
same length (i.e., non-truncated). The amino acid sequence of the cloned ppXKS was aligned 
with its reference sequence from NCBI to compare the sequence similarities (Figure 4.3). 
The cloned ppXKS only shares 93% sequence identity with its reference protein. To 
further verify that the origin of the cloned ppXKS is actually from cDNA isolated from Pichia 
pastoris and not due to contamination, the amino acid sequence of the cloned ppXKS was 
subjected to a BLAST search of the non-redundant protein sequence database at NCBI. The 
result from the BLAST search showed that the top hit with the highest score is indeed the 
xylulokinase from Pichia pastoris, indicating that the ppXKS we cloned is from Pichia pastoris 
cDNA and not contamination. (Notebook #8, page 1-13) 
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Score = 1175 bits (3039),  Expect = 0.0, Method: Compositional matrix adjust. 
 Identities = 575/617 (93%), Positives = 596/617 (97%), Gaps = 0/617 (0%) 
 
Query  1    MVTKEIQNRDSALTESVPNDLYLGFDLSTQQLKITSFEGRSLTHFKTYRVDFDEELSVYG  60 
            MVTKEIQ+R+SA++  VP+DLYLGFDLSTQQLKITSFEGRSLTHFKTYRVDFDEELS YG 
Sbjct  1    MVTKEIQDRNSAMSALVPSDLYLGFDLSTQQLKITSFEGRSLTHFKTYRVDFDEELSAYG  60 
 
Query  61   INNGVYVNEETGEINAPVAMWVEALDLIFSKMQKDKFPFGIVKGMSGSCQQHGSVYWSKD  120 
            I NGVYVNEE GEINAPVAMW+EALDLIFSKMQKDKFPFG VKGMSGSCQQHGSVYWSKD 
Sbjct  61   IKNGVYVNEEIGEINAPVAMWIEALDLIFSKMQKDKFPFGNVKGMSGSCQQHGSVYWSKD  120 
 
Query  121  APDLLSSLSPSKDLKSQLCPKAFTFEKSPNWQDHSTGEELEIFERKAGSPENLSKITGSR  180 
            APDLLSSLSP KDLKSQLCPKAFTFEKSPNWQDHSTGEELEIFERKAGSPENLSKITGSR 
Sbjct  121  APDLLSSLSPLKDLKSQLCPKAFTFEKSPNWQDHSTGEELEIFERKAGSPENLSKITGSR  180 
 
Query  181  AHYRFTGSQIRKLAKRVNPELYKETYRISLISSFLSSLLCGRITKIEESDGCGMNIYDIQ  240 
            AHYRFTGSQIRKLAKRVNPELYKETYRISLISSFLSSLLCG+ITKIEESDGCGMNIYDIQ 
Sbjct  181  AHYRFTGSQIRKLAKRVNPELYKETYRISLISSFLSSLLCGKITKIEESDGCGMNIYDIQ  240 
 
Query  241  NSRYDEDLLAVTAAVDPEIDGATEHERQEGVARLKDKLQDLEPVGYRSIGTIAAYFVEKY  300 
            NSRY EDLLAVTAAVDPEIDGATE ERQEGVARLKDKLQDLEPVGYRSIG+I+AYFVEKY 
Sbjct  241  NSRYSEDLLAVTAAVDPEIDGATEDERQEGVARLKDKLQDLEPVGYRSIGSISAYFVEKY  300 
 
Query  301  GFSEDSKVFSFTGDNLATILSLPLHNDDILVSLGTSTTVLLVTETYWPNSNYHVFKHPTV  360 
            GF +DSK FSFTGDNLATILSLPLHNDDILVSLGTSTTVLLVTETYWPNSNYHVFKHPTV 
Sbjct  301  GFRKDSKFFSFTGDNLATILSLPLHNDDILVSLGTSTTVLLVTETYWPNSNYHVFKHPTV  360 
 
Query  361  PGSYMVMLCYVNGALARNQIKTSLDKKYNVSDPNDWTKFNEILDKSKPLHGKEELGVYFP  420 
            PGSYMVMLCYVNGALARNQIK SLD+KYNVSD NDWTKFNEILDKSKPLHGK+ELGVYFP 
Sbjct  361  PGSYMVMLCYVNGALARNQIKASLDEKYNVSDSNDWTKFNEILDKSKPLHGKKELGVYFP  420 
 
Query  421  KGEIIPNCVAQTKRFSYDAKSKKLVTANWDIEDDVVSIVESQALSCRLRSGPLYHGSDET  480 
            KGEIIPNC+AQTKR+SYDAKS+KLV A+WDIEDD VSIVESQALSCRLRSGPLYHGSDET 
Sbjct  421  KGEIIPNCIAQTKRYSYDAKSRKLVAADWDIEDDAVSIVESQALSCRLRSGPLYHGSDET  480 
 
Query  481  DQEEESEVIQRLSNFPKISADGKDQRLPDLISHPKKAFYVGGASQNVSIVRKFSEVLGAK  540 
            D++EE EV +RLS FPKISADGKDQRL DLISHPKKAFYVGGASQNVSIVRKFSE+LGAK 
Sbjct  481  DEKEEIEVTRRLSIFPKISADGKDQRLADLISHPKKAFYVGGASQNVSIVRKFSEILGAK  540 
 
Query  541  EGNYQINLGDACAIGGAFKAVWSDLCETEKAIPYSDFLRKNFHWKENVKPVEADSSLWLQ  600 
            EGNYQINLGDACAIGGAFKAVWSDLCET+KAI YSDFL KNFHWKENVKPVEADSSLWLQ 
Sbjct  541  EGNYQINLGDACAIGGAFKAVWSDLCETKKAISYSDFLSKNFHWKENVKPVEADSSLWLQ  600 
 
Query  601  YVDGVGILSEIEQTLEK  617 
            YVDGVGILSEIEQTLEK 
Sbjct  601  YVDGVGILSEIEQTLEK  617 
Figure 4.3 Alignment of cloned ppXKS amino acid sequence with its reference sequence from the NCBI 
database 
 
4.2.2 Creation of Promoter Mutants with Varying Strengths 
To create a library of promoters with varying strengths for the optimization of pathways, 
a group of yeast promoters were characterized under different growth conditions (Figure 4.4). 
Promoter TEF1, ENO2, PDC1, TPI1, FBA1, and GPM1 were subjected to nucleotide analogue 
mutagenesis in the presence of 20 μM 8-oxo-2’-deoxyguanosine (8-oxodGTP) and 6-(2-deoxy-β-
D-ribofuranosyl)-3,4-dihydro-8-pyrimido-[4,5-c][1,2]oxazin-7-one (dPTP) using the method 
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described elsewhere (14,17).  
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Figure 4.4 Strength of yeast promoters determined under different aeration conditions. Cite the reference 
or point out it was done by Jie Sun and Zengyi Shao (unpublished data) 
 
To facilitate the cloning and characterization of promoter mutants, a helper plasmid was 
constructed for the promoter engineering work. The PCR products of target promoters were 
cloned into this helper plasmid linearized with XhoI using the DNA assembler method (15). The 
strength of the promoter mutants was determined by measuring the fluorescent intensity of the 
GFP driven by promoter mutants using flow cytometry. Two strategies were used to isolate 
promoter mutants with varying strength. In the first strategy, colonies were randomly picked and 
inoculated into 96-well and fluorescent intensity was measured using a plate reader. The mutants 
were then divided into ten groups representing different promoter strength (i.e. 0~10% of the 
wild type promoter, 10~20% of the wild type promoter, and so on) according to the fluorescent 
intensity. Several mutants from each group were then cultivated in round bottom culture tubes 
and the fluorescent intensity was determined using flow cytometry. This strategy worked very 
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successfully in finding mutants with moderate promoter strength. In order to find promoters with 
very low strength, such as those with strength lower than 20% of wild type promoters, or mutants 
with strength higher than that of the wild type, a mixed culture of promoter mutants was first 
sorted by Fluorescence-Activated Cell Sorting (FACS) to isolate mutants with very high or low 
fluorescent intensity. The cell culture obtained from cell sorting was then spread on SC-Leu 
plates supplemented with glucose. Colonies randomly picked from the plates were inoculated 
into liquid media and their fluorescent intensity was determined by flow cytometry. As expected, 
there is a higher possibility to obtain mutants with either very high or very low strength after the 
library was sorted. For the optimization of the xylose utilization pathway, three promoters mutant 
groups generated from wild type yeast promoters TEF1p, ENO2p, and PDC1p were created. The 
strength of the promoter mutants were then measured using the fluorescent intensity of GFP 
driven by promoter mutants. As shown in Figure 4.5, around ten mutants with varying strength 
were isolated from each promoter. (Notebook #7, page 1-2) 
 
Figure 4.5 Promoter mutants created through nucleotide analogue mutagenesis. Strength of promoter 
mutants was shown using a wild type TEF1 promoter as a reference (relative strength of 100). All 
promoter strengths were determined by measuring the fluorescent intensity of green florescent protein 
driven by promoter mutants. All samples were measured in triplicates. Error bars indicate the standard 
deviation of the replicated samples. 
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4.2.3 Construction of Gene Expression Cassettes with Promoter Mutants 
In order to investigate the efficiency of the pentose utilization pathways consisting of the 
same catalytic enzymes but with different expression profiles, a general scaffold for the three-
gene xylose utilization pathway was designed.  
This scaffold consists of csXR, ctXDH, and ppXKS. Specifically, csXR ORF was flanked 
with a PDC1 promoter and an ADH1 terminator, followed by ctXDH with a TEF1 promoter and 
a CYC1 terminator, and ppXKS with an ENO2 promoter and an ADH2 terminator.  Similar to 
the scaffold in the enzyme-based pathway optimization design described in Chapter 3, the 
scaffold for the pentose utilization pathways, namely the combination of enzymes and 
terminators for each catalytic step, remained consistent throughout this study (Figure 4.6).  
 
Figure 4.6 Scaffold for the promoter-based pathway assembly of xylose utilization pathways. The 
scaffold for pathway assembly consists of a xylose reductase gene from Candida shehatae flanked with a 
PDC1 promoter and an ADH1 terminator, followed by a xylitol dehydrogenase gene from Candida 
tropicalis flanked with a TEF1 promoter and a CYC1 terminator, and a xyulokinase gene from Pichia 
pastoris flanked with an ENO2 promoter and an ADH2 terminator. 
 
To facilitate the cloning of promoter mutants for pathway assembly, helper plasmids were 
constructed for each pathway gene in the xylose utilization pathway. In each helper plasmid, a 
DNA fragment (~400 bp) homologous to the upstream adjacent sequence (usually the terminator 
of the previous pathway gene), a pathway enzyme, and a terminator were assembled into a 
pRS414 single copy plasmid using DNA assembler. A unique KpnI site was engineered between 
the DNA fragment homologous to the previous pathway gene and the target pathway gene to 
facilitate the linearization of the helper plasmids for the cloning of promoter mutants in the 
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assembly of gene expression cassettes (Figure 4.7). To clone promoter mutants into the helper 
plasmids for the construction of plasmids with full gene expression cassettes, the promoter 
mutants were amplified from pRS415-promoter mutant-GFP constructs and then transferred into 
the helper plasmids linearized with KpnI. The transformants were plated on SC-Trp solid media 
supplemented with 2% glucose. Single colonies were inoculated into SC-Trp liquid media 
supplemented with glucose. Yeast plasmids were isolated from the liquid culture and transferred 
into E. coli DH5α. Next, E. coli plasmids were isolated and diagnostic PCR was performed to 
confirm the cloning of promoter mutants using primers that anneal to regions both upstream and 
downstream of the promoter mutants. 
 
Figure 4.7 Assembly of gene expression cassettes on the pRS414 helper plasmids. The helper plasmids 
were first linearized at the unique KpnI site, and then co-transformed into S. cerevisiae with the PCR 
fragments of the promoter mutants. The resulting constructs were used for amplification of gene 
expression cassettes consisting of a promoter, the reading frame of an enzyme homologue, a terminator, 
and the upstream and downstream homologous regions. 
 
To obtain the gene expression cassettes for random pathway assembly, PCR was used to 
amplify the whole gene expression cassette including the homologous region upstream to the 
promoter, the promoter itself, the target ORF, and the terminator. The sizes of the resultant 
fragments were confirmed using agarose gel electrophoresis, and then DNA fragments with the 
correct size were purified using a PCR purification kit. The concentrations of purified DNA 
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fragments were determined using Nanodrop (Thermo Scientific, Wilmington, DE). Similar to 
what was previously described in Chapter 3, the vectors used in the creation of promoter mutants 
(pRS415), gene expression cassettes (pRS414), and the final pathway assembly (pRS416) were 
all different. Since different nutrition markers were used in these vectors, only a simple PCR 
cleanup was performed between different steps. 
4.2.4 Assembly of Libraries Containing the Xylose Utilization Pathways Using DNA 
Assembler 
To create a library of yeast strains containing the three-gene xylose utilization pathway, 
DNA fragments homologous to the adjacent sequences were mixed and transferred into S. 
cerevisiae with the linearized pRS416 shuttle plasmid for the INVSc1 strain. After DNA 
transformation, a small amount of transformants were spread on a SC-Ura plate supplemented 
with glucose to determine the library size. The rest of the transformants were first cultivated 
overnight in liquid SC-Ura medium supplemented with glucose and then washed and spread on a 
SC-Ura plate supplemented with 2% xylose for screening. When 100 ng of each fragment was 
used for the promoter-based pathway library assembly in the INVSc1 strain, a library of 104 to 
105 transformants per transformation could be obtained.  
Eight colonies were randomly picked from the promoter-based pathway library in the 
INVSc1 strain in order to determine the diversity among the resultant pathway mutants. These 
single colonies were inoculated first in SC-Ura medium supplemented with 2% glucose and then 
cultivated at 30 °C with 250 rpm agitation for 2 days. The cultures were then used to inoculate 
125 mL un-baffled flasks containing 25 mL of YP medium supplemented with 2% xylose to an 
initial OD of 0.2. The flask cultures were grown at 30 °C and 100 rpm agitation (in oxygen 
limited conditions). Samples were drawn from the cultures at various time points for the 
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measurement of cell density and the concentration of xylose and ethanol. (Notebook #7, page 
224-225) 
 
Figure 4.8 Xylose fermentation performance of eight colonies randomly picked from the promoter-based 
pathway library in INVSc1. The cell growth of the mutants (indicated by cell density measured using 
optical density at 600 nm), xylose consumption, ethanol production, and ethanol yield from xylose were 
all different for the eight mutants.  
 
As shown in Figure 4.8, when xylose was used as the sole carbon source, randomly 
picked mutants in the pathway library exhibited different fermentation performance in terms of 
overall growth rate, xylose consumption, and ethanol production, which indicates a high degree 
of diversity within the promoter-based pathway library. 
The promoter-based pathway optimization was also performed using industrial S. 
cerevisiae strains as host strains. In this study, Still Spirits (Classic) Turbo Distiller's Yeast 
(which will be referred to simply as the “Classic” strain from here on) and S. cerevisiae ATCC 
4124 were used as two model industrial yeast strains. Due to the lack of auxotrophic markers in 
industrial strains, a new single copy centromeric vector–namely pRS-KanMX, which carries the 
 131 
dominant selection marker of KanMX—was constructed to enable pathway engineering in 
industrial strains (For more detail of the design and construction of pRS-KanMX vector, please 
refer to Chapter 5). The pRS-KanMX vector bears the same homologous region as the pRS416 
vector used in previous assembly. Therefore, the same DNA fragments used for pathway 
assembly in the INVSc1 strain can be directly used for pathway assembly using pRS-KanMX as 
the backbone. After DNA transformation, the transformants need to be recovered in YPAD liquid 
medium overnight to increase their transformation efficiency. After recovery, a small amount of 
transformants were spread on a YPAD plate supplemented with glucose and 200 mg/L G418 in 
order to determine the library size. The remaining transformants were first cultivated overnight 
in liquid SC complete medium supplemented with glucose and 200 mg/L G418 and then washed 
and spread on a SC complete plate supplemented with 2% xylose for screening. The 
transformation efficiency of pathway assembly using industrial strains and the pRS-KanMX 
vector was lower than that of the assembly in the INVSc1 strain. Using 100 ng of each DNA 
fragment, a library size of 103 to 104 was achieved for industrial yeast strains.  
4.2.5 Screening of Libraries of Pathways with Promoter Mutants 
Similar to the screening of the enzyme-based pathway library in Chapter 3, the promoter-
based pathway library was also screened using a size-based colony prescreening followed by 
tube screening and flask screening. Using the INVSc1 strain as the host, the pathway was 
assembled using DNA fragments amplified from helper plasmids. A small aliquot of the 
transformants were plated onto SC-Ura plates supplemented with 2% glucose in order to 
determine the library size. The rest of the transfermants was used to inoculate a 25 mL liquid 
media of SC-Ura supplemented with 2% glucose. Frozen cell stocks were made from the liquid 
culture for later analysis. A small aliquot of the liquid culture was then washed with ddH2O and 
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around 10
5
 cells were plated onto a 24.5 cm by 24.5 cm square agar plate of SC-Ura 
supplemented with 2% xylose. At the same time, around 10
4
 cells harboring a reference pathway 
consisting of csXR driven by a wild type PDC1 promoter, ctXDH driven by a wild type TEF1 
promoter, and ppXKS driven by a wild type ENO2 promoter were plated on a regular 15 cm 
round agar plate with the same media. The library plate and the reference plate were then 
incubated together and examined daily. Colonies on the library plate that had grown to a size 
bigger than that of the largest colonies on the reference plate were then picked for later screening. 
For library screening, eighty colonies that appeared larger than the biggest colonies on 
the reference plate were inoculated into a culture tube containing 1 mL of SC-Ura liquid media 
supplemented with 2% glucose and then grown at 30 ºC with 250 rpm shaking for 36 hours. 
Next, 200 L of culture was then spun down and resuspended in 200 L of YP media 
supplemented with 2% xylose. Next, 120 L of cell suspension was used to inoculate 3 mL of 
YP culture with 2% xylose in a culture tube. This step ensured that the tube cultures would have 
a starting OD of around 0.2. The tube cultures were then grown at 30 ºC with 250 rpm agitation. 
The OD600 of the tube culture was then taken after 24, 36, and 48 hours. The cell density at the 
first two time points were used to determine the specific growth rate while the 48 hour time point 
was taken to show the final biomass productivity of the strain. 
After the tube screening, the top ten strains that displayed a high growth rate were picked 
for later analysis. These fast growers were inoculated into 50 mL un-baffled flasks containing 10 
mL of YP media supplemented with 2% xylose. The flask cultures were then grown at 30 ºC with 
100 rpm agitation to determine the xylose consumption and ethanol production of the mutant 
strains (Figure 4.9). 
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Figure 4.9 Screening strategy based on colony size. The pathway library is spread on an agar plate 
containing 2% xylose as the sole carbon source together with a reference pathway consisting of a xylose 
utilization pathway driven by wild type PDC1, TEF1 and ENO2 promoters. Colonies on the library plate 
that have grown to a size bigger than that of the largest colonies on the reference plate are picked and 
inoculated in media supplemented with 2% and the necessary selection pressure for maintaining the 
pathway bearing plasmids. The seed cultures are then used to inoculate tubes containing YP media 
supplemented with 2% xylose to a similar initial OD. Mutant strains bearing fast xylose utilizing 
pathways are identified by measuring the cell growth rates of the mutant strains. The top ten mutant 
strains identified using tube cultures are screened again in 50 mL flasks containing 10 ml YP media 
supplemented with 2% xylose. Flask cultures are analyzed using HPLC and the top mutant strain with the 
fastest xylose utilization rate and the highest ethanol productivity is identified. 
 
For pathway assembly in the ATCC 4124 stain, eighty large colonies were inoculated into 
SC complete media supplemented with 2% glucose and 200 mg/L G418. The seed tubes were 
grown for 36 hours at 30 °C under 250 rpm of agitation. Next, 200 L of seed culture was spun 
down and resuspended in YP medium supplemented with 2% glucose and 120 L of the cell 
suspension was used to inoculate 3 mL YP media supplemented with 2% xylose in round bottom 
culture tubes. The same procedure was applied for the tube and flask screening of the industrial 
strain as that of the INVSc1 strain. After screening of the promoter-based pathway library, we 
noticed most of the big colonies picked from agar plate grew better when compared to the strains 
harboring the control pathways. As a consequence, a smaller number of colonies (only fifty 
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colonies) were picked for the pathway screening of the Classic strains to reduce the amount of 
required labor. 
To further validate the screening strategy, 36-hour samples of the fifty tube cultures were 
analyzed using HPLC. It was found that the xylose consumption and ethanol production of 
mutant strains correlated well with cell growth rates. This indicated that the screening method is 
not only an effective strategy for finding faster growers, but also a valid method for finding fast 
xylose consumers and ethanol producers. After the shake flask-based screening of the top ten 
faster growers was completed, the top three ethanol producers were identified using shake flask 
cultures under the oxygen limited condition. The tube cultures of the top three ethanol producers 
were highlighted in red in Figure 4.10. The results showed that the top three mutants from the 
shake flask based screening with oxygen limited conditions were also among the highest ethanol 
producers in the tube based screening using aerobic conditions. This result further validated the 
tube based prescreening step, as the growth in an aerobic tube culture is a good indicator of the 
xylose consumption and ethanol production ability of the mutant strains (Figure 4.10). 
(Notebook #8, page 78-79) 
 
Figure 4.10 Correlation between xylose consumption and ethanol production with specific growth rate 
for tube based screening. The 36 hour samples of the fifty largest colonies from the promoter-based 
pathway library in the Classic strain were analyzed using HPLC. The overall xylose consumption and 
ethanol concentration was plotted with the specific growth rate of the mutant strains. The top xylose 
consumer and ethanol producer from flask based screening under oxygen limited conditions are marked in 
red.  
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Figure 4.11 Tube and flask based screening of the promoter-based pathway library in different strain 
backgrounds. Left: Specific growth rates of the eighty or fifty colonies screened using tubes. The top 
mutants selected for later flask screening are marked in red and the strain hosting the control pathway is 
marked in green. Right: Xylose consumption and ethanol yield of the top ten growers in flask based 
screening before xylose depletion. In both cases, the control strain contains pathways driven by wild type 
promoters on a single copy plasmid (PDC1p_wt-csXR-ADH1t-TEF1p_wt-ctXDH-CYC1t-ENO2p_wt-
ppXKS-ADH2t). 
 
Using the screening strategy described above, eighty fast growers were screened from the 
promoter-based pathway assembly in the INVSc1 strain and in ATCC 4124, while fifty faster 
growers were screened again in the Classic turbo yeast. Specific growth rates of the tube cultures 
are shown in Figure 4.11. (Notebook #7, page 201-207,  page 227, page 253-255, page 300; 
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Notebook #8,  page 26-27) 
4.2.6 Characterization of Screened Mutant Strains 
In the whole process of pathway screening, no prolonged incubation of longer than three 
days was used, which should limit the possibility of host strain adaptation. In order to further 
confirm that the improvement of xylose fermentation was indeed due to the pathway on the 
plasmids rather than host strain adaptation, plasmids of the top ten fastest growers from the 
INVSc1 library were isolated and retransferred back into fresh INVSc1 strains. The top ten 
fastest growers before and after retransformation were inoculated into 50 mL shake flasks 
containing 10 mL of YP media supplemented with 2% xylose to an initial OD of 0.2. The xylose 
consumption and ethanol production abilities of the strains before and after retransformation 
were compared. As shown in Figure 4.12, the fermentation ability of the strains hosting the same 
pathways before and after retransformation were very similar, indicating that a minimum extent 
of host adaptation occurred during the screening process. In other words, the better xylose 
fermentation ability of the screened strains was from the plasmids bearing better xylose 
utilization pathways. (Notebook #7, page 301-303) 
 
Figure 4.12 The xylose fermentation ability of the top ten mutant strains in the INVSc1 library before and 
after retransformation. The xylose consumption and ethanol yield after 3 days of fermentation under 
oxygen limited conditions are shown. The xylose consumption and ethanol yield before retransformation 
are shown in blue while those after retransformation are shown in red. 
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After the tube and flask based library screening, the top three fastest growers were 
selected for further analysis. From the promoter-based pathway library screened in the INVSc1 
strain, the top three fastest growing strains were S3, S5 and S7. From the promoter-based 
pathway library screened in the ATCC 4124 strain, the top three fastest growing strains were S4, 
S8, and S9. wIn addition, the top three fastest growing strains screened in the Classic strain were 
S5, S6, and S7 (Figure 4.11). The plasmids bearing the optimized pathways were isolated from 
the selected strains and submitted for DNA sequencing to identify the promoter mutants in these 
pathways. Surprisingly, many of the promoter mutants in the pathways were mutated when 
compared to the sequence of the promoter mutants originally introduced into the pathway library. 
It is difficult to estimate the strength of the mutated promoters. In order to determine the 
expression profiles of the selected strains, the mutated promoters were cloned into the pRS415-
GFP helper plasmid originally used to construct the promoter mutant library. The promoter 
strength of these mutated promoters was determined using flow cytometry (Figure 4.13).  
(Notebook #7, page 243) 
  PDC1 TEF1 ENO2 
  
  PDC1 TEF1 ENO2 
INVSc1 S3 B7 C12 B4 
1~2 
mutations 
 
INVSc1 S3 46 64 150 
INVSc1 S5 B7 C12 B9 
 
INVSc1 S5 49 115 136 
INVSc1 S7 B7 G11 B5 3~5 
mutations  
INVSc1 S7 51 34 53 
ATCC S4 E2 WT WT 
 
ATCC S4 223 148 140 
ATCC S8 E2 F9 WT 6~10 
mutations  
ATCC S8 223 151 145 
ATCC S9 D12 D11 WT 
 
ATCC S9 232 52 161 
Classic S5 C1 C12 E6 
>10 
mutations 
 
Classic S5 132 140 99 
Classic S6 C1 C12  WT 
 
Classic S6 132 140 141 
Classic S7 C1 WT WT 
  
Classic S7 132 30 140 
Figure 4.13 DNA sequencing of the promoters in the fastest xylose utilizing strains. Left: Sequence 
similarity with the reference promoter mutants and number of mutations in the promoters. Right: Relative 
promoter strength of the promoter mutants. The strength of the wild type TEF1 promoter was defined as 
100.The best pathway mutant in each strain background is marked in red. 
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Overall, the optimal xylose utilizing pathways in the INVSc1 strain required a low 
expression level of xylose reductase, a medium to high level of xylitol dehydrogenase, and a 
high level of xylulokinase. On the contrary, the optimal xylose utilizing pathways that consisted 
of the same group of catalytic enzymes preferred a very high expression level of the reductase, 
together with a relatively high expression level of both the dehydrogenase and the kinase when 
Classic turbo yeast was used as a host. The expression profiles of the optimal pathways in the 
ATCC 4124 strain were similar to the ones in the Classic strain, except that a medium high 
xylose reductase expression level was preferred. 
Our previous study showed that integration of the xylose utilization pathway into the 
chromosome would improve the xylose fermentation ability of the mutant strains (Figure 4.14). 
To investigate the effect of its chromosomal integration, the xylose utilization pathway in the 
best mutant of the fastest growing INVSc1 strain (S3) was cloned into a pRS406 single copy 
integrative plasmid and integrated into the URA3 site of the INVSc1 strain. The fermentation 
behavior of the S2 pathway on a single copy centromeric plasmid and a single copy 
chromosomal integration was compared to the wild type pathway (WT) in the INVSc1 strain 
(Figure 4.15). (Notebook #9, page 1-14) 
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Figure 4.14 Comparison of the fermentation performance of the INVSc1 strains harboring the reference 
pathway (psXR-psXDH-psXKS) either on a single copy plasmid (left) or a single copy chromosomal 
integration (right).  
 
 WT S3 plasmid S3 integration Unit 
Xylose consumption rate 0.24 0.40 0.37 g/L/hr 
Ethanol production rate 0.04 0.10 0.09 g/L/hr 
Ethanol yield 0.15 0.25 0.24 g/g xylose 
 
Figure 4.15 Xylose fermentation of the mutant INVSc1 strain S3 on a single copy plasmid (S3 plasmid) 
or single copy integration (S3 integration) compared to the wild type control strain (WT). The 
fermentation was done in duplicates. The error bar indicates the standard deviation of the replicates. 
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Single colonies of INVSc1 strain harboring either a freshly retransferred S3 pathway on a 
plasmid, a confirmed chromosomally integrated S3 pathway, or the control pathway on a single 
copy plasmid were inoculated into 3 mL of SC-Ura liquid media supplemented with 2% glucose 
in round bottom culture tubes. The tube cultures were then grown at 30 °C and 250 rpm for 24 
hours and used to inoculate 125 mL baffled shake flasks containing 25 mL of SC-Ura liquid 
media supplemented with 2% glucose as seed cultures. The seed cultures were grown for another 
24 hours and then used to inoculate 250 mL un-baffled shake flasks containing 50 mL of YP 
media supplemented with 2% xylose to an initial OD of 1. The cultures were grown at 30 °C 
with 100 rpm agitation.  
The control pathway consisting of a xylose utilizing pathway driven by the wild type 
PDC1, TEF1, and ENO2 promoters consumed 40 g/L xylose within 170 hours, while the S3 
mutant strain consumed 40 g/L xylose within 100 hours. The xylose consumption rate, ethanol 
production rate, and ethanol yield were calculated using the 97.5 hour time point in Figure 4.15. 
The S3 mutant strain consumed xylose and produced ethanol at 1.7 times of the rate of the strain 
containing the control pathway. The ethanol yield was also improved by more than 60% in the S3 
mutant strain. Of note, the integration of the S3 pathway did not improve the fermentation 
performance. 
The xylose fermentation ability of the best pathway mutants was also investigated in 
industrial strains. Single colonies of freshly retransformed industrial strains harboring mutant 
pathways were inoculated into 3 mL YPAD media supplemented with 2% and 200 mg/L G418. 
Tube cultures were grown at 30 °C under 250 rpm of agitation for 24 hours and then used to 
inoculate 125 mL baffled shake flasks containing YP media supplement with either 2% of 
glucose and 200 mg/L G418 or 2% xylose. The seed shake flask cultures were grown at 30 °C 
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under 250 rpm agitation for another 24 hours and then used to inoculate 250 mL un-baffled shake 
flasks to an initial OD of 2 or 10. (Notebook #9, page 15-19) 
 
YPD seed culture OD~10 ATCC WT ATCC S8 Classic WT Classic S7 Unit 
Xylose consumption rate 0.10 0.71 0.06 0.74 g/L/hr 
Ethanol production rate 0 0.19 0 0.17 g/L/hr 
Ethanol yield 0 0.26 0 0.24 g/g xylose 
 
 
YPX seed culture OD~2 ATCC WT ATCC S8 Classic WT Classic S7 Unit 
Xylose consumption rate 0.04 0.73 0.03 0.73 g/L/hr 
Ethanol production rate 0 0.20 0 0.17 g/L/hr 
Ethanol yield 0 0.28 0 0.23 g/g xylose 
 
Figure 4.16 (cont. on next page) Xylose fermentation of the industrial strains harboring optimized 
mutant xylose utilizing pathways. 
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YPX seed culture OD~10 ATCC S8 Classic S7 Unit 
Xylose consumption rate 0.92 0.92 g/L/hr 
Ethanol production rate 0.27 0.24 g/L/hr 
Ethanol yield 0.30 0.26 g/g xylose 
 
Figure 4.16 (cont’d) Xylose fermentation of the industrial strains harboring optimized mutant xylose 
utilizing pathways. 
 
In industrial strains, the control pathway consisting of a pathway driven by the wild type 
PDC1, TEF1, and ENO2 promoters consumed less than 5 g/L xylose within 90 hours, while the 
industrial strains harboring the optimized mutant pathways consumed 40 g/L xylose within 60 
hours. When xylose medium was used for seed culture and high initial OD was used, the 
industrial strains harboring the best mutant pathways can consume 40 g/L xylose within 48 
hours. The xylose consumption rate, ethanol production rate, and ethanol yield were calculated 
using the 60 hour point for the fermentation of YPD seed culture with an initial OD of 10 and 
YPX seed culture with an initial OD of 2. Since the xylose was almost depleted at the 47.5 hour 
point of the fermentation with YPX seed culture and an initial OD of 10, the xylose consumption 
rate, ethanol production rate, and ethanol yield were calculated using the 47.5 hour time point. 
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As shown in Figure 4.16 and 4.15, industrial strains with the optimized pathways consumed 
xylose and produced ethanol faster and with a higher yield when compared to the laboratory 
strain INVSc1. 
During the sequence analysis of optimized xylose utilizing pathways, we noticed that the 
optimized expression patterns of pathways with identical metabolic genes in different strain 
backgrounds differed drastically. To investigate whether the pathways with different expression 
patterns are truly optimal for the strain background, the most highly optimized mutant pathways 
found in the laboratory and industrial strains were exchanged. Specifically, fastest xylose-
utilizing pathway optimized in INVSc1 strain (INV-S3), Classic turbo yeast (CTY-S7), and 
ATCC4124 (ATCC-S8) were introduced in to all three yeast hosts. Of note, the plasmid 
harboring the INV-S3 pathway was not the one used for pathway screening in INVSc1 because 
both Classic and ATCC4124 lacks an URA3 auxotrophic mutation for the utilization of pRS416 
based pathway plasmid. The INV-S3 pathway was recloned into a single copy shuttle vector with 
a KanMX selection marker for this experiment. Three optimized pathway constructs were 
transferred into three different host strains and the nine resulted constructs were tested for xylose 
fermentation abilities. As shown in figure 4.17, the resulting pathways showed different 
fermentation performances in a new strain background. In the INVSc1 strain, the pathway 
optimized in INVSc1 strain (S3) outperformed the pathways optimized in ATCC 4124 (S8) or 
Classic strains (S7). Similarly, the pathway optimized in ATCC 4124 strain (S8) also fermented 
xylose better in ATCC 4124 strain comparing to pathways optimized elsewhere (S3 or S7).  
However, the pathway optimized in ATCC 4124 (S8) fermented xylose better in Classic strain 
compared to the pathway optimized in Classic strain (S7) or INVSc1 strain (S3). The fact that the 
pathway optimized in ATCC 4124 strain (S8) outperformed the pathway optimized in Classic 
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strain (S7) might be due to the pathway optimized in Classic strain (S7) and ATCC 4124 (S8) 
performed very similar in all strain backgrounds (Table 4.1). In most of the cases, the strain 
optimized in the target strain background performed equally or better compared to pathway 
optimized elsewhere indicating that the optimized pathways are strain-specific. The dependence 
of pathway optimization on a particular strain may result from differences in expression levels of 
endogenous genes involved in the pathway, the overall availability of cofactors, or stress 
responses. It has been frequently observed that the choice of host strains of the same species can 
affect the behavior of the same heterologous pathway significantly, which poses an obstacle for 
transferring well-established metabolic pathways between different host strains (18). 
Consequently, the ability to tailor-make metabolic pathways rapidly in different strain 
backgrounds presented by the COMPACTER approach is highly desirable in pathway 
engineering. (Notebook #9, page 19-24) 
 
Figure 4.17 (cont. on next page) Xylose fermentation of INVSc1, ATCC4124 and Classic Turbo Yeast 
with pathways optimized in different strain backgrounds. 
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Host strain Optimized pathway 
INVSc1 S3 
Classic S7 
ATCC 4124 S8 
 
Figure 4.17 (cont’d) Xylose fermentation of INVSc1, ATCC4124 and Classic Turbo Yeast with pathways 
optimized in different strain backgrounds. Filled symbols with solid lines: Xylose concentration (g/L). 
Filled symbols with dashed lines: OD. Open symbols with solid lines: Ethanol concentration (g/L). (a) 
INVSc1strain harboring xylose utilizing pathway optimized in INVSc1 strain (S3), in ATCC-4124 strain 
(S8) and in Classic strain (S7). (b) ATCC 4124 strain harboring xylose utilizing pathway optimized in 
INVSc1 strain (S3), in ATCC-4124 strain (S8) and in Classic strain (S7). (c) Classic Turbo Yeast strain 
harboring xylose utilizing pathway optimized in INVSc1 strain (S3), in ATCC-4124 strain (S8) and in 
Classic strain (S7). 
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Table 4.1 Xylose fermentation of INVSc1, ATCC4124 and Classic Turbo Yeast with pathways optimized 
in different strain backgrounds. The pathways optimized in corresponding strains were marked in red. 
 
 
Xylose 
consumption rate 
(g/L/h) 
Ethanol Production 
rate (g/L/h) 
Ethanol Yield 
(g/g xylose) 
INVSc1 S3 0.66 0.18 0.28 
INVSc1 S7 0.52 0.11 0.21 
INVSc1 S8 0.47 0.10 0.23 
Classic S3 0.18 0.01 0.06 
Classic S7 0.79 0.19 0.24 
Classic S8 0.81 0.22 0.28 
ATCC S3 0.47 0.11 0.23 
ATCC S7 0.73 0.16 0.22 
ATCC S8 0.74 0.19 0.26 
 
To further confirm the strain-specific balancing of metabolic pathways at transcriptional 
level, quantitative PCR (qPCR) was performed using RNA isolated from fermentation culture at 
exponential phase to compare the relative expression ratio of XR, XDH and XKS genes in 
optimized pathways and reference pathway. The experiment was performed for the top ten 
growers in INVSc1 strain as well as Classic strain in comparison to the reference pathway under 
the same fermentation conditions. As shown in Figure 4.18, the optimized mutant INV-S3 
exhibited higher expression ratio of XDH/XR and XKS/XR when compared to the reference 
strain (more than one-fold higher XDH/XR ratio and almost four-fold higher XKS/XR ratio). 
Moreover, the top ten mutant isolated from the laboratory strain (INVSc1) all exhibited higher 
relative expression ratio of XKS over XR (4.1 < XKS/XR < 19.3) when compared with the 
reference pathway (XKS/XR ~ 2), while nine out of the top ten mutants also exhibited a higher 
relative expression ratio of XR over XDH. Similarly, the top ten optimized pathway in the 
industrial strain (Classic Turbo Yeast) also exhibited very distinct expression levels of XR, XDH 
and XKS compared to the reference pathway. The top ten mutants all exhibited a much lower 
relative expression ratio of XDH/XR and XKS/XR when compared with the reference strain. 
Specifically, the S7 mutant exhibited a relative expression ratio of XDH/XR almost two orders of 
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magnitude lower when compared with the reference strain and an expression ratio of XKS/XR 
more than eight times lower. Unsurprisingly, the relative expression levels of pathway optimized 
in INVSc1 strain (INV-S3) differed drastically compared to the pathway optimized in Classic 
strain (CTY-S7). The qPCR results together with the fermentation results from pathways with 
switched strain backgrounds confirmed that the pathways optimized using the COMPACTER 
method were indeed strain-specific. (Notebook #9, page 24-26. This experiment was 
performed by Tong Si.) 
 
\  
Figure 4.18 Relative expression levels (normalized toward the expression level of XR as 1) of XR, XDH 
and XKS measured using qPCR in top ten optimized strains and the reference strains in laboratory and 
industrial hosts. (a) Relative expression levels of XR, XDH and XKS in laboratory strain INVSc1 (INV). 
As shown in the figure, compared to the control strain (INV-WT), the top ten selected fast mutants had 
higher relative expression level for XKS. Most (nine out of ten) of the top ten fast growers also exhibited 
higher relatvie expression levels for XDH when compared to the control strain. (b) Relative expression 
levels of XR, XDH and XKS in industrial strain Classic Turbo Yeast (CTY). As shown in the figure, 
compared to the control strain (CTY-WT), the top ten selected fast mutants had lower relative expression 
level for XDH and XKS. Interestingly, comparing to the control strain and the optimized strains in 
laboratory strain which had higher expression level of XDH than XR, all the optimized mutants in 
industrial strain exhibited higher expression level of XR than XDH. 
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4.3 Discussions 
Balancing the metabolic flux of heterologous pathways is one of the key challenges in the 
metabolic engineering of microbial factories for the overproduction of desired compounds. 
Traditional approaches for optimization of metabolic pathways involve the identification of 
bottlenecks and branching points of metabolic pathways, followed by the overexpression and 
deletion of certain genes for either “debottlenecking” or “debugging” the pathways (19-22). 
However, it is sometimes very hard to obtain optimal pathways using these approaches since 
strong overexpression and the deletion of genes only sample two extreme points in the space of 
gene expression. Alper and coworkers showed in their work that the fine-tuning of genetic 
expression for pathway optimization may be more effective, which can be achieved through the 
use of a series of promoters with varying strength (14). In this chapter, three groups of promoter 
mutants with varying strength were created using nucleotide analogue mutagenesis. Around ten 
mutants were isolated for each promoter group and assembled together with a fixed set of 
metabolic enzyme homologues to form gene expression cassettes with varying expression levels. 
These gene expression cassettes were then used as building blocks for the assembly of libraries 
of xylose utilization pathways with different expression profiles in various S. cerevisiae strain 
backgrounds. 
Due to the high degree of homology between the promoter mutants generated from the 
same template, homologous recombination inevitably occurred between different promoter 
mutants during the pathway assembly process. The recombination between promoter mutants 
resulted in the incorporation of mutated or chimeric promoter mutants into the assembled 
pathway library that was not present in the original promoter mutant libraries (Figure 4.13). The 
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existence of these chimeric mutants increased the number of possible combinations in the 
libraries.  
The wide existence of mutated promoters in the top selected pathways indicated that the 
recombination rate between promoter mutants was very high. For example, in the top three 
mutants in the INVSc1 promoter-based library assembly, all three PDC1 promoter mutants were 
mutated. At the same time, some mutated promoters that were found in the top mutants also 
exhibited strengths exceeding the dynamic range of the promoter mutants originally isolated for 
the assembly. For example, in the top three mutants from the promoter-based pathway assembly 
in industrial strains, mutants of the TEF1 promoter with a relative strength of 150 were 
identified, yet the highest recorded strength of the TEF1 promoter mutants in the pre-selected 
library was only around 110.  
It has been previously shown that different S. cerevisiae strains have distinct xylulose 
fermentation abilities due to their inherent capacities for pentose sugar metabolism (18). With 
this in mind, it is not very surprising that the promoter-based pathway optimization yielded 
different combinations of expression levels for xylose reductase, xylose dehydrogenase, and 
xylulokinase under different strain backgrounds. These differences in expression profiles may 
have resulted from the different behavior of promoter mutants under different strain backgrounds, 
the differences in the expression level of endogenous aldose reductases, the activity of 
endogenous xylulokinases, or the capacity of the downstream pentose phosphate pathways in the 
host strains. The different expression profiles may also have arisen from the distinct individual 
capabilities of cofactor regeneration and cell stress response in different types of host cells. The 
strain-specificity of pathway optimized using the COMPACTER method was proven by 
examining the fermentation ability of the top mutant pathway generated from one strain 
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background under a different strain background. The fermentation behavior of the strains with 
switched pathway together with the qPCR data indicated the pathway optimization approach was 
“strain- -specific,” and the optimized pathway mutants can be regarded as pathways “tailor-made” 
for a specific strain. In this sense, the promoter-based pathway assembly method could be used 
to optimize pathways in different strains background as well as the same strain background under 
different fermentation or nutrition conditions.  
It is commonly known that fermentation conditions used in the industrial production of 
biofuels are very different from the ones used in the shake flasks and fermenters of typical 
research laboratories (23). The temperature, pH, inhibitor, and even starvation stress that exist in 
industrial fermentation processes can affect the metabolism of recombinant strains—possibly 
resulting in suboptimal performance of the strains in the industrial biofuel production. In these 
cases, the promoter-based pathway assembly method could be applied to balance the metabolic 
flux within the heterologous pathway in order to manufacture the best possible fit for the 
fermentation conditions in modern-day industrial applications. 
Researchers have been working for decades to improve the fermentation ability of S. 
cerevisiae using xylose as a carbon source. After the introduction of functional xylose utilizing 
pathways from xylose assimilating yeast, such as P. stipitis into S. cerevisiae, numerous efforts 
have been made to modify both the heterologous and endogenous genes to optimize the xylose 
fermentation efficiency (20,21,24,25). In this chapter, the xylose utilization pathway was 
optimized using a combinatorial pathway library consisting of pathway mutants with different 
expression profiles. Using this approach, the xylose utilization ability of the pathway consisting 
of the wild type PDC1, TEF1, and ENO2 promoters was improved two-fold in the INVSc1 strain, 
while the xylose utilization rate was improved six-fold when industrial S. cerevisiae strains were 
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used as the host. Of note, the dramatic improvement in this study was achieved by the 
optimization of the three gene heterologous xylose utilizing pathway in S. cerevisiae within eight 
months that did not rely on any knowledge of the previous metabolic engineering studies on 
xylose utilization (Table 4.2). This method can be further applied to optimize the extended 
xylose utilization pathway, including the xylose transporter, endogenous pentose phosphate 
pathway genes, and other genes that might facilitate xylose utilization in S. cerevisiae. 
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Table 4.2 Xylose fermentation performance of optimized and reference strains compared with top xylose fermenting strains in literature. The 
reference strains are csXR, ctXDH and ppXKS driven by wild type PDC1, TEF1 and ENO2 promoters in corresponding strains.  
 
Host strain 
Laboratory 
strain 
(INVSc1) 
 
Industrial strain (Classic Turbo Yeast) 
 
 
 D452-2 
 
 
IR-2 
 
 
IR-2 
 
 INV-WT INV-S3 CTY-WT CTY-WT CTY-S7 CTY-S7 CTY-S7 DA24-16
5
 
 
MA-R46 
 
MA-R56 
 
Seed culture SCD1 SCD1 YPD2 YPX3 YPD2 YPX3 YPX3 YPD2 YPD2 YPD2 
Initial OD 1 1 10 2 10 2 10 1 
2.8 g 
(dry cell 
weight)/L 
2.8 g 
(dry cell 
weight)/L 
Xylose 
consumption rate 
(g xylose/l/hr) 
0.24 0.40 0.06 0.03 0.74 0.73 0.92 1.064 1.07 1.294 
Ethanol 
productivity 
(g ethanol/l/hr) 
0.04 0.10 0 0 0.17 0.17 0.24 0.354 0.36 0.504 
Yield 
(g ethanol/g xylose) 
0.15 0.25 0 0 0.24 0.23 0.26 
0.31~0.33
4
 
0.34 0.374 
1. SC-Ura supplemented with 2% glucose 
2. YP medium supplemented with 2% glucose 
3. YP medium supplemented with 2% xylose 
4. Calculated approximately according to figure shown in corresponding manuscript 
5. Ha, S.J., Galazka, J.M., Rin Kim, S., Choi, J.H., Yang, X., Seo, J.H., Louise Glass, N., Cate, J.H. and Jin, Y.S. Engineered Saccharomyces cerevisiae 
capable of simultaneous cellobiose and xylose fermentation. Proc Natl Acad Sci USA, 108, 504-509 (2011). 
6. Matsushika, A., Inoue, H., Watanabe, S., Kodaki, T., Makino, K. and Sawayama, S. Efficient bioethanol production by a recombinant flocculent 
Saccharomyces cerevisiae strain with a genome-integrated NADP(+)-dependent xylitol dehydrogenase gene. Applied and Environmental Microbiology, 
75, 3818-3822 (2009).  
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4.4 Conclusions and Outlook 
 
In this chapter, a promoter-based pathway assembly method was developed for the 
optimization of a three gene fungal xylose utilization pathway in S. cerevisiae. First, twenty XR 
homologues, twenty-two XDH homologues), and nineteen XKS homologues of xylulokinase 
were cloned and assayed for enzymatic activity. Enzyme homologues with high activity and 
matching cofactor specificity, namely csXR, ctXDH, and ppXKS, were selected to form the 
scaffold for combinatorial pathway assembly. At the same time, promoter mutants with varying 
strength were created using S. cerevisiae native promoters PDC1, TEF1, and ENO2 as templates. 
Around ten mutants with varying strength were pre-selected and assembled with the same set of 
enzyme homologues in order to generate building blocks for pathway assembly. The gene 
expression cassettes were then assembled into a pathway library of the same pathway enzymes 
with different expression profiles. This pathway library was screened in laboratory yeast strain 
INVSc1 and industrial yeast strains ATCC 4124 and Classic turbo using colony size-based 
prescreening followed by tube and shake flask screening. After the screening, strains harboring 
the best pathway mutant in the INVSc1 strain background consumed xylose and produced 
ethanol at 1.7 times of the rate of the strain containing the control pathway with a more than 60% 
improvement of ethanol yield compared to the control strain harboring the same xylose 
utilization pathway driven by the wild type promoters, while the best pathway mutants identified 
in industrial strains achieved six-fold improvement of xylose fermentation ability compared to 
the control strain. 
Unlike the traditional pathway optimization strategies, which rely on identifying the rate 
limiting step and then optimizing pathways by deletion and strong overexpression of certain 
genes (14), our newly developed combinatorial pathway assembly method provides a novel 
 154 
strategy for balancing metabolic flux in recombinant strains. Instead of overexpression and 
deletion of genes within the metabolic pathway, a series of promoter mutants with varying 
strength were shuffled. This act of promoter shuffling generated a library of pathways with 
different expression profiles. Using this method, thousands of combinations of gene expression 
levels for a multi-step metabolic pathway can be assembled and investigated.  
Many complicated metabolic pathways may be optimized by the strategy presented in 
this chapter given that a proper screening or selection method is available. Moreover, this newly 
developed strategy can also enable host strain-specific pathway optimization for tailor-making 
pathways for special strains with a particular metabolic background or under a specific growth 
condition. 
In the process of optimizing these pathways, a library of xylose utilization pathways with 
diversified behaviors was also generated. Given the well-defined scaffold using fixed catalytic 
enzyme homologues, the diversity of the pathway mutants mainly relies on the different 
expression levels of genes involved in the pathway assembly. In other words, the pathway 
libraries generated using the strategy described in this chapter exhibit a controlled diversity. 
These kinds of libraries are very useful in the understanding of metabolic pathways. Regulation 
and interaction of metabolic pathways can be studied through approaches such as metabolic flux 
analysis and DNA microarrays.  The pathway library consisting of the same pathway enzymes 
with different expression profiles can also be used to study the effect of the perturbation of 
expression level of a certain enzyme on the overall pathway performance. Models of metabolic 
pathways can be generated using the data collected by studying mutants from the pathway library 
to understand and predict the response of the metabolic pathway to varying gene expression 
profiles. 
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4.5 Materials and Methods 
4.5.1 Strains, Media and Cultivation Conditions 
S. cerevisiae L2612 (MATα leu2-3 leu2-112 ura3-52 trp1-298 can1 cyn1 gal+) was a gift 
from Professor Yong-su Jin (5). S. cerevisiae strain INVSc1 (MATa his3D1 leu2 trp1-289 ura3-
52 MATAlpha his3D1 leu2 trp1-289 ura3-52) was purchased from Invitrogen. Still Spirits 
(Classic) Turbo Distiller's Yeast was purchased from Homebrew Heaven (Everett, WA). 
Saccharomyces cerevisiae ATCC 4124 was from ATCC (Manassas, VA).  Escherichia coli 
DH5α (Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, IL) was used 
for recombinant DNA manipulation. Yeast strains were cultivated in either synthetic dropout 
media (0.17% Difco yeast nitrogen base without amino acids and ammonium sulfate, 0.5% 
ammonium sulfate, 0.083% amino acid drop out mix) or YPA media supplemented with sugar as 
carbon source (1% yeast extract, 2% peptone, 0.01% adenine hemisulfate). E. coli strains were 
cultured in Luria broth (LB) (Fisher Scientific, Pittsburgh, PA). S. cerevisiae strains were 
cultured at 30 °C and 250 rpm for aerobic growth, and 30 °C and 100 rpm for oxygen limited 
conditions. E. coli strains were cultured at 37 °C and 250 rpm unless specified otherwise. All 
restriction enzymes were purchased from New England Biolabs (Ipswich, MA). All chemicals 
were purchased from Sigma Aldrich or Fisher Scientific. 
4.5.2 Plasmid and Strain Construction 
Most of the cloning work was done using the yeast homologous recombination mediated 
DNA assembler method (15). DNA fragments flanked with regions homologous to adjacent 
DNA fragments were generated with polymerase chain reaction (PCR) and all the DNA 
fragments were purified and co-transformed into S. cerevisiae along with the backbone. To 
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confirm the correct clones from transformants, yeast plasmids were isolated using a Zymoprep II 
yeast plasmid isolation kit (vendor, city, state) and transferred into E. coli. Plasmids from E. coli 
were then isolated and confirmed using diagnostic PCR. 
4.5.3 Determination of Activity of Enzyme Homologues 
The activities of enzyme homologues were determined using the INVSc1 strain as the 
host strain. Plasmids used as a template for amplification of gene expression cassettes (i.e. 
pRS414-promoter-ORF-terminator) were transformed into INVSc1 using a lithium acetate 
method (26). The resulted transformants were plated on SC-Trp plates supplemented with 
glucose. Single colonies were then used to inoculate round bottom culture tubes containing 3.5 
mL of SC-Trp supplemented with glucose. The culture tubes were then grown at 30 °C at 250 
rpm agitation for 48 hours. Cell pellets were then collected by centrifuging cell cultures at 4000 
rpm for 5 min at 4 °C and washed twice using sterile water. To lyse the cells, cell pellets were 
resuspended in Y-PER Extraction Reagent (Thermal Scientific, Rockford, IL) following the 
manufacturer’s instructions. The cell suspension was then incubated at 25 °C for 20 min under 
700 rpm agitation. The cell debris was precipitated at 14,000 x g centrifugation for 10 min at 
4 °C. The cell lysate was kept on ice for the enzyme activity assay.  
To determine the enzyme activity, the cell lysate was mixed with the proper reagents in a 
96-well plate and the absorbance at 340 nm was measured using a microplate reader. To assay 
the xylose reductase activity, 20 L of crude cell extract was mixed with 100 L of 50 mM 
potassium phosphate at pH 7 and 20 L of 2 mM NADPH or NADH (in 50 mM potassium 
phosphate  buffer at pH 7). The components were mixed and incubated at room temperature for 5 
minutes. After the addition of 60 L of 0.6 M xylose (in 50 mM potassium phosphate buffer at 
pH 7), the change of absorbance at 340 nm was immediately recorded using a Synergy 2 Multi-
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Mode Microplate Reader at 25 °C (BioTek, Winooski, VT). Similarly, to assay the activity of 
xylitol dehydrogenase, 20 L of crude cell extract was mixed with 100 L of 50 mM potassium 
phosphate at pH 7, 20 L of 500 mM MgCl2, and 20 L of 10 mM NAD
+
 or NADP
+
. The 
components were mixed and incubated at room temperature for 5 minutes. After the addition of 
40 L of 1 M xylitol (in 50 mM potassium phosphate buffer at pH 7), the change of absorbance 
at 340 nm was immediately recorded using a Synergy 2 Multi-Mode Microplate Reader at 25 °C 
(BioTek, Winooski, VT). A glycerol kit was used to measure the activity for xylulokinases (R-
Biopharm, Darmstadt, Germany). First, an enzyme/cofactor cocktail was prepared by premixing 
300 L of Solution 1 and 3 L of Solution 2 from the glycerol kit and 600 L of ddH2O. The 
mixture was incubated for 5 to 7 minutes at room temperature before use. Next, 162 L of 
theenzyme/cofactor cocktail was then mixed with 20 L of crude cell extract and the absorbance 
at 340 nm was recorded using a Synergy 2 Multi-Mode Microplate Reader at 25 °C immediately 
after the addition of 18 L of 50 mM D-xylulose. 
4.5.4 Creation of Promoter Mutants  
To facilitate the cloning and characterization of promoter mutants, a helper plasmid was 
constructed for the promoter engineering work. This plasmid consisted of a pRS415 backbone, a 
unique XhoI site, the GFP gene, and a GPM1 terminator. PCR products of promoters were cloned 
into this helper plasmid linearized with XhoI using the DNA assembler method (15). The 
resultant promoter mutant library was then spread out on a SC-Leu plate supplemented with 2% 
glucose. The strengths of the promoter mutants were determined by measuring the fluorescent 
intensity of the GFP driven by promoter mutants via flow cytometry. Two strategies were used to 
isolate promoter mutants with varying strength. In the first strategy, colonies were randomly 
picked and inoculated into 96-well plates containing SC-Leu liquid media supplemented with 
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glucose and fluorescent intensity was measured using a 96-well fluorescence plate reader 
(vendor name, city, state). The promoter mutants were then divided into ten groups representing 
different promoter strength (i.e. 0~10% of the wild type promoter, 10~20% of the wild type 
promoter, and so forth) according to their fluorescent intensity. For each type of promoter, 
several promoter mutants from each group were then cultivated in round bottom culture tubes 
and the fluorescent intensity was determined using flow cytrometry. In order to find mutant 
promoters with very low strength, such as mutant promoters with strength lower than 20% of the 
wild type promoters, or mutant promoters with strength higher than the wild type promoter, a 
mixed culture of promoter mutants was first sorted with FACS to isolate mutant promoters with 
very high or with low fluorescent intensity. The cell culture obtained from cell sorting was then 
spread on SC-Leu plates supplemented with 2% glucose. Colonies randomly picked from the 
plates were inoculated into liquid media and the fluorescent intensity was determined with flow 
cytometry. As we expected, there is a higher possibility to obtain mutant promoters with either 
very high or low strength after the library was sorted. To confirm the variation of  the florescent 
intensity was actually from the plasmid harboring GFP driven by promoter mutants but not the 
variation of the strain background. Plasmids harboring GFP driven by promoter mutants were 
isolated and then retransferred into fresh host cells. All the flow cytometry measurements were 
done at least in triplicates and the florescent intensity were the average of the replicates. Only 
strains exhibited a highly homogenous florescent intensity were used for further analysis of the 
promoter mutants. (Notebook #6, page 225-226) 
4.5.5 Fermentation and HPLC Analysis  
Most shake flask fermentation was performed in un-baffled shake flasks at 30 °C under 
100 rpm agitation. A single colony was inoculated into media with selection (e. g. SC drop-out 
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media or rich media supplemented with antibiotic as a selection pressure) supplemented with 2% 
glucose in 15 mL round bottom culture tubes filled with 3 mL media at 30 °C with 250 rpm 
agitation. If a high initial OD was desired for the fermentation, a secondary seed culture was 
inoculated with the prime seed culture in a 125 mL baffled shake flask at 30 °C under 250 rpm 
agitation. The seed culture was then used to inoculate a fermentation culture to a certain initial 
OD either in a 250 mL un-baffled shake flask filled with 50 mL of media or a 125 mL un-baffled 
shake flask filled with 25 mL media. The media in the shake flask for fermentation was YPA 
media supplemented with xylose at 4% or 2% as the sole carbon source (1% yeast extract, 2% 
peptone, 0.01% adenine hemisulfate). The fermentation cultures were cultivated at 30 °C under 
100 rpm agitation and samples were taken periodically and analyzed. Cell densities of the 
samples were measured using a Cary 300 UV-Visible spectrophotometer (Agilent Technologies, 
Santa Clara, CA) after a proper dilution at a wave length of 600 nm. The samples were then 
centrifuged and the supernatants were diluted 5 to 10 times before HPLC analysis. An HPLC 
system equipped with a reflex index detector (Shimadzu Scientific Instruments, Columbia, MD) 
was used to analyze the concentrations of glucose, xylose, xylitol, ethanol, acetate, and glycerol 
in the broth. To separate all the metabolites mentioned above, an HPX-87H column (BioRad, 
Hercules, CA) was used following the manufacturer’s manual using 5 mM sulfuric acid as the 
mobile phase. The HPLC chromogram was analyzed using the LCsolution Software (Shimadzu 
Scientific Instruments, Columbia, MD). 
4.5.6 Quantitative PCR (qPCR) 
Fresh samples of cell cultures harvested at exponential phase grown under the same condition as 
mentioned above for xylose or cellobiose fermentation were used to determine the relative 
expression ratio of metabolic genes via qPCR. The total RNA was isolated using the RNeasy 
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mini kit (QIAGEN, Valencia, CA) following the manufacturer’s instruction. The RNA samples 
were then reversed transcribed into cDNA using the Transcriptor First Strand cDNA Synthesis 
Kit using oligo-dT primer following the manufacturer’s instruction. The qPCR experiments were 
carried out using LightCycler® 480 system (Roche, Indianapolis, IN) using Cyber Green – based 
method following the manufacturer’s instruction.  
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Chapter 5 Developing Tools for Genetic Engineering in Polyploid 
Industrial Yeasts 
5.1 Introduction 
Laboratory S. cerevisiae strains, which have been simplified and adapted for controlled 
laboratory conditions, are poor ethanol producers when compared to industrial S. cerevisiae 
strains. Industrial S. cerevisiae strains are better ethanol producers than laboratory strains due to 
a superior level of ethanol productivity as well as a higher tolerance to both inhibitors and the 
characteristically strenuous conditions of industrial processing (1). A limited number of pentose-
assimilating industrial S. cerevisiae strains have been constructed in the past few years, and, 
among them, several strains have shown much higher pentose utilization efficiency and ethanol 
productivity when compared to laboratory strains (2-5).  
It was shown that different S. cerevisiae strains have distinct D-xylulose fermentation 
abilities due to their inherent capacities for pentose sugar metabolism (2). Due to the robustness 
of industrial S. cerevisiae strains and the varied pentose metabolic pattern associated with 
different strain background, the ideal strategy appears to be to directly optimize the pentose 
utilization pathway in industrial strains. However, in contrast to the well-defined haploid 
laboratory S. cerevisiae strains, industrial strains are usually either diploid or polyploid. Multiple 
sets of chromosomes and lack of auxotrophic markers make the genetic modification of these 
industrial strains much more challenging (1). 
In order to facilitate the pathway optimization and metabolic engineering in industrial S. 
cerevisiae stains, a series of expression vectors were constructed using positive selection markers. 
These vectors enabled the direct assembly of pathway libraries on a single copy plasmid and 
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stable chromosomal integration of the improved pathways into the genome of industrial strains 
through site-specific single copy integration and multicopy delta integration. Taking advantage 
of the high mobility of the pathway components used in our previous pathway optimization, 
xylose utilization pathways were rapidly re-assembled or re-constructed in an industrial strain 
background using these newly developed vectors. 
The high ploidy level and the lack of nutrition markers also created a great obstacle for 
genome modifications such as site-specific gene insertions, deletions, and point mutations in 
industrial S. cerevisiae strains. Dr. Nikhil Nair, a previous member of the Zhao research group, 
developed a scar-less gene deletion method called MIRAGE (Mutagenic Inverted Repeat 
Assisted Genome Engineering) for gene modification in S. cerevisiae that takes advantage of the 
instability of inverted repeat sequences (6). Using this method, genomic modification of S. 
cerevisiae can be achieved through a single transformation followed by two selection steps. The 
scar-less feature was extremely valuable for gene deletion in industrial strains, as multiple 
deletion attempts might be required to completely delete a single gene due to redundancies that 
may result from the organism’s high ploidy level (Figure 5.1). 
 
Figure 5.1 MIRAGE method for chromosomal gene modification 
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In this chapter, we report our effort in constructing new vectors for genetic engineering in 
industrial yeast strains. In addition, we report our effort in adapting the MIRAGE method for use 
in industrial yeast strains through the creation of URA3 mutants and the design of counter-
selectable markers. 
5.2 Results and Discussion 
 
5.2.1 Construction of Single Copy Expression Vector for Industrial S. cerevisiae Strains 
Unlike the haploid laboratory strains, industrial S. cerevisiae strains lack auxotropic 
mutations for the use of nutritional markers (7). In order to introduce, characterize, and optimize 
pathways in industrial strains, dominant drug-resistant selection markers were investigated in 
several industrial S. cerevisiae strains (Table 5.1). Using pRS416 as a backbone, dominant drug-
resistant markers KanMX (8), AUR1-c (9), CAT (10), and YAP1 (11) were used to construct 
single copy expression vectors. The KanMX cassette was cloned from a pUG6 plasmid, on 
which an E. coli transposon Tn903 was fused to a TEF promoter and a TEF terminator (12). 
Expression of the KanMX cassette in yeast renders the transformants resistant to the 
aminoglycoside antibiotic G418 (12). AUR1-c is a mutational marker in which a single mutation 
in the S. cerevisiae native AUR gene conferred resistance to an antifungal antibiotic called 
Aureobasidin A (AbA) (9). The CAT cassette was constructed by fusion of an E. coli Tn9 with a 
TEF promoter and a TEF terminator. The introduction of the CAT cassette should render the 
transformants resistant to chloramphenicol (10). YAP1 is a newly discovered marker for 
transformation of yeast strains. By overexpression of the native YAP1 gene, the transformants 
gain resistance to two different antibiotics, namely cycloheximide and cerulenin (11). (Notebook 
#6, page 137-144, page 160) 
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Table 5.1 Comparison of different dominant drug-resistant markers 
Marker Drug Gene Origin Notes 
KanMX G418 (200 mg/L) Tn903 Heterologous marker, most widely used 
AUR1-c 
Aureobasidin A  
(0.5 mg/L) 
AUR1-c mutation 
Mutational marker, may result in resistance from mutation 
of the AUR gene in yeast genome 
CAT 
Chloramphenicol  
(1~5 g/L) 
Tn9 Heterologous marker, very high drug concentration 
YAP1 
Cerulenin/Cycloheximide 
 (~5 mg/L) 
YAP1 native Overexpression marker, dual drug resistance 
 
The drug resistance of these markers was tested in Still Spirits Turbo Yeast Classic 
(Classic) and Alcotec Turbo Super Yeast (Super) from Homebrew Heaven (Everett, WA), as 
well as Saccharomyces cerevisiae Type II from Sigma Aldrich (St. Louis, MO). The KanMX, 
YAP1 and AUR1-c markers were all proved to be functional in these strains (Table 5.2). The 
CAT cassette did not work for yeast transformation, because using as high as 5 g/L 
chloramphenicol did not result in growth inhibition in non-transformed yeast cells (10). Among 
the dominant markers tested, the KanMX and YAP1 marker exhibited the highest selection 
efficiency when G418 and cerolenin were used as the selection antibiotic, respectively. The 
KanMX marker was used the most  in this chapter due to the low price of G418. (Notebook #6, 
page 180) 
Table 5.2 Transformation of yeast strains with dominant markers on single copy plasmids.  
3 Hours of recovery after transformation 
Markers 
Strains 
YAP1 on  
Cerulenin 
YAP1 on  
cycloheximide 
AUR1-c KanMX 
L2612 ++++ +++++ +++ +++ 
Classic +++ + - ++ 
Super +++ - + ++ 
Type II + - + + 
Overnight recovery after transformation 
Markers 
Strains 
YAP1 on 
Cerulenin 
YAP1 on 
cycloheximide 
AUR1-c KanMX 
L2612 +++ +++++ ++++ ++++ 
Classic +++ - + ++++ 
Super +++ - ++ ++++ 
Type II - ++ +++ +++ 
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Table 5.2 (cont’d) Transformation of yeast strains with dominant markers on single copy plasmids.  
Wild type cells (no plasmid) on resistant plates 
Markers 
Strains 
YAP1 on 
Cerulenin 
YAP1 on 
cycloheximide 
AUR1-c KanMX 
L2612 + +++++ +++ - 
Classic - + + - 
Super - - + - 
Type II - - + - 
-: no colonies, 
+:1~10 colonies, 
++: 10~100 colonies,  
+++: 100~1000 colonies, 
 ++++: More than 1000 colonies,  
+++++: A lawn 
 
Using dominant drug-resistant markers with confirmed functionality, different expression 
systems were designed for the assembly and validation of pentose utilization pathways in an 
industrial yeast strain. First, single copy plasmid based expression vectors were designed using 
the pRS416 shuttle vector as a template. The uracil auxotrophic marker was replaced with 
different dominant selection markers. The resulting expression vectors retained the pBR322 
origin of replication for propagation in E. coli, the CEN.ARS for maintenance of a single copy 
plasmid in yeast, the multiple cloning sites (MCS) for linearization of the vector, as well as the 
homology region flanking MCS for introduction of the pathway via DNA assembler (Figure 5.2). 
 
Figure 5.2 Single copy vectors with dominant selection markers: single copy vector with positive 
selection markers were constructed by replacing the uracil auxotrophic marker of pRS416 shuttle vector 
with dominant selection markers. The pentose utilization pathway could then be introduced into the 
vectors using DNA assembler.  
 
pMarker pMarker-pathway
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Using these single copy vectors, various xylose utilization pathways were introduced into 
the Classic strain. The fragments of the gene expression cassettes encoding various xylose 
reductases (XR), xylitol dehydrogenases (XDH), and xylulokinases (XKS), previously created 
for the enzyme-based pathway assembly project, were assembled into a single copy vector with a 
KanMX marker (namely pRS-KanMX) for industrial strains using the DNA assembler method 
(Please refer to Chapter 3 for the construction of the gene expression cassettes). The 
transformants were streaked out on the YPAD plates containing 200 mg/L G418 after an 
overnight recovery in the YPAD liquid media. Single colonies were inoculated in the YPAD 
liquid media supplemented with 200 mg/L G418, and then yeast plasmids were isolated using a 
Zymoprep II yeast plasmid isolation kit (Zymo Research, Irvine, CA). The yeast plasmids were 
transferred into E. coli DH5α, and E. coli plasmids were isolated for confirmation of the correct 
constructs using restriction digestion with multiple enzymes. The confirmed constructs were then 
transferred into the Classic strain using a standard lithium acetate method (13). Next, the 
transformants were then streaked out on an YPAD plate containing 200 mg/L G418 after an 
overnight recovery in the YPAD liquid media. Single colonies were picked from the plate and 
inoculated in the YPAD liquid media supplemented with 200 mg/L G418 in a round bottom 
culture tube. After 24 h incubation at 30 °C with 250 rpm agitation, the cultures were used to 
inoculate 25 mL YP liquid media supplemented with 2% xylose to an initial OD of 1. Figure 5.3 
shows the fermentation behaviour of the xylose pathways in the Classic strain. Compared to the 
control strain with a single copy of XR, XDH and XKS from P. stipitis integrated to the URA3 
site of L2612 strain, the Classic strain hosting the xylose utilization pathways on single copy 
plasmid consumed xylose faster and grew to a higher cell density.(Notebook #6, page 286-291) 
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Figure 5.3 Fermentation of xylose using a Classic strain hosting different xylose utilization pathways on 
single copy vectors. 
 
5.2.2 Pathway Optimization in Industrial S. cerevisiae Using Single Copy Vectors 
Taking advantage of the single copy expression vector pRS-KanMX, pathway 
optimization using DNA assembler was directly performed in industrial S. cerevisiae strains. In 
Chapter 4, the promoter-based pathway assembly in polyploid yeast Classic and ATCC 4124 
strains was described. We were able to reuse the gene expression cassettes created for promoter-
based pathway assembly for laboratory strains to directly assemble pathway libraries in industrial 
strains because the pRS-KanMX vector contains the same DNA sequence flanking the multiple 
cloning site for the DNA assembler based pathway assembly. The pathway assembly using the 
pRS-KanMX vector requires an overnight recovery of the transformants in the YPAD liquid 
media for increased efficiency. The resulting library size was around 10
3
 for the Classic strain 
and 10
4
 for ATCC 4124. After screening in the Classic and ATCC 4124 strains, a xylose 
pathway consisting of XR from Candida shehatae (csXR), XDH from Candida tropicalis 
(ctXDH), and XKS from Pichia pastoris with optimized expression profiles were identified. The 
optimized mutants contained different combination of promoter mutants when compared to the 
ones identified in laboratory INVSc1 strains. Due to the superior fermentation ability of the 
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industrial strains, one mutant strain consumed 40 g/L xylose within 48 hours and produced 
ethanol with a yield of 0.3. Please refer to Chapter 4 for the details of the promoter-based 
optimization of xylose utilization pathway in industrial strains. 
 
Figure 5.4 Co-fermentation of cellobiose and pentose sugars by the use of a cellobiose transporter and a 
β-glucosidase. Glucose repression resulted from competition for sugar uptake and inhibition to 
downstream pathways from high intracellular glucose concentration would be relived by introduction of a 
cellobiose transporter and immediate utilization of glucose upon uptake. 
 
Recently, a novel approach was developed to overcome glucose repression in mixed 
sugar utilization by introducing a cellobiose transporter and a β-glucosidase into recombinant 
xylose-utilizing S. cerevisiae strains (14,15) (Figure 5.4). In these strains, cellobiose, an 
incomplete hydrolysis product of cellulose, is fermented instead of glucose in the presence of 
xylose. Since cellobiose enters S. cerevisiae cells through a dedicated cellobiose transporter, the 
competition of glucose and xylose at the sugar uptake step is eliminated. Cellobiose is then 
hydrolyzed into glucose intracellularly and continuously consumed for the production of ethanol. 
The simultaneous hydrolysis and utilization of cellobiose avoids intracellular accumulation of 
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glucose, thus alleviating glucose repression. Using the newly constructed pRS-KanMX vector, 
Dr. Yongbo Yuan from our research group was able to optimize the expression level of the 
cellobiose utilization pathway directly in industrial strains. To optimize the cellobiose utilization 
pathway in the Classic strain, the cellobiose transporter cdt-1 and β-glucosidase gh1-1from 
Neurospora crassa were assembled with promoter mutants of varying strength created from the 
wild type PDC1 and ENO2 promoters, respectively (15). (Please refer to Chapter 4 for the 
creation of promoter mutants of varying strength using nucleotide analogue mutagenesis.) The 
gene expression cassettes were then assembled with a linearized pRS-KanMX vector via the 
DNA assembler method to create a library of two step cellobiose utilization pathways with 
different gene expression levels. Since ten PDC1 promoter mutants and eleven ENO2 promoter 
mutants were introduced into the library along with the linearized pRS-KanMX backbone, 
twenty-two fragments were involved in the pathway assembly. When 200 ng of each fragment 
was used in the pathway assembly, a library size of 10
4
 can be achieved. After screening of the 
pathway library with a colony size-based screening method similar to the ones described in 
Chapter 3 and Chapter 4, mutant strains with improved cellobiose utilization efficiency were 
obtained. 
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Figure 5.5 Promoter-based pathway assembly using a pRS-KanMX vector in the Classic strain. Red 
filled diamond: cellobiose concentration in the optimized mutant, black filled square: Cell density of the 
optimized mutant (measured by optical density at 600 nm), pink filled upside-down triangle: ethanol 
concentration in the optimized mutants, blue triangle: intracellular glucose concentration in the optimized 
mutant. Green open squares: cell density of control strain with the wild type promoters (measured by 
optical density at 600 nm), dark blue open circle: cellobiose concentration of the control strain, purple 
open upside-down triangle: ethanol concentration of the control strain, light blue triangle: intracellular 
glucose concentration in the control strain. 
 
Within 48 hours, the optimized mutant was able to consume 80 g/L cellobiose with an 
ethanol yield of 0.39, while the control strain consisting of the wild type PDC1 and ENO2 
promoters takes more than 200 hours to completely utilize 80 g/L of cellobiose (Figure 5.5). 
5.2.2 Design of Integrative Vectors for Industrial S. cerevisiae Strains 
Single copy centromeric vectors are great platforms for the convenient introduction and 
optimization of pathways in industrial strains. Integrative vectors provide a more stable 
chromosomal integration of heterologous pathways into S. cerevisiae industrial strains for 
laboratory evolutionary engineering or industrial application (16). To facilitate the chromosomal 
integration of heterologous pathways into these industrial strains, single copy and multicopy 
integrative vectors were designed and constructed using dominant selection markers. 
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First, an integrative vector was designed for multicopy integration of pathways into δ-
sequences of S. cerevisiae using the reusable KanMX marker flanked by the loxP sites. The δ-
sequences are the long terminal repeats of the Ty retrotransposon element in S. cerevisiae. The δ-
sequences usually exist in about 150 to 200 copies throughout the genome (16,17). Through the 
use of the loxP sites at the end of the KanMX selection marker, the selection marker can then be 
removed using site-specific recombination via the introduction of the Cre recombinase (18). The 
application of this reusable marker made it possible to remove the marker while repetition of the 
integration process could introduce more copies of the desired pathway into the genome. The 
removal of the marker would also make the strains more suitable for industrial application by 
eliminating the unwanted heterologous antibiotic genes found in the final strain constructs.  
To construct the multicopy integration vector, a yeast CEN.ARS element on the pRS-
KanMX was flanked by spliced δ-sequences, and rare restriction cutting sites were engineered 
between the δ-sequences and CEN.ARS. The resulted expression vectors retained the pBR322 
origin of replication for propagation in E. coli, the CEN.ARS flanked with spliced δ-sequences, 
the MCS for linearization of the vector, and the homology region flanking MCS for introduction 
of the pathway via the DNA assembler method. A full pathway can be introduced into this vector 
using DNA assembler. The pathway on the vector can then be confirmed by restriction digestion 
after isolation of the yeast plasmid and propagation of the plasmid in E. coli.  After confirming 
the correct assembly of the pathway, the plasmid was digested using the restriction enzymes 
corresponding to the rare cutting sites to release the CEN.ARS element. The digestion product 
was then separated with agarose gel electrophoresis, and only the correct large-sized fragment 
was recovered after the digestion. After releasing the CEN.ARS element, the resulting DNA 
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fragment would look like a pathway on a linearized integrative plasmid flanked by δ-sequences 
(Figure 5.6).  
 
Figure 5.6 Vector for multicopy δ-integration in industrial strains. Pentose utilization pathways were first 
introduced into the vectors via DNA assembler. Next, the resultant plasmids were digested using restriction enzymes 
recognizing eight nucleotide sequences (rare cutters) and then integrated into the δ-sequences via homologous 
recombination. Strains with multicopy integration were selected using high drug dosage 
 
The only limitation on the pathway to be integrated is that the pathway should not contain 
the rare cutting site used for the linearization of the vector. To adapt to the need for the 
integration of various pathways, we planned to make a series of this type of multicopy 
integrative vectors using different rare cutting sites (Table 5.3). With a collection of multicopy 
integration vectors with different rare cutting sites, most metabolic pathways could be integrated 
using these vectors. (Notebook #6, page 176-178) 
Table 5.3 List of rare cutting sites 
Name Recognition 
Sequence 
Overhang Price Note 
AscI GG|CGCGCC 
CCGCGC|GG 
5’CGCG 500 units/$61  
AsiSI GCGAT|CGC 
CGC|TAGCG 
3’AT 500 unites/$61 Isoschizomer of 
SgfI (*) 
BbvCI CC|TCAGC 
GGAGT|CG 
5’ TCA 100 units/$58 (*) 
 
  
δ            marker        F1               pentose utilization pathway              Fn              ori AmpR δ                   
δ-CEN
δ-CEN-pathway 
digested with eight cutters
δ-CEN-pathway
 177 
Table 5.3 (cont’d) List of rare cutting sites 
FseI GGCCGG|CC 
CC|GGCCGG 
3’ CCGG 100 units/$66  
NotI GC|GGCCGC 
CGCCGG|CG 
5’GGCC 500 units/$66 Need more for 
supercoiled 
DNA 
PacI TTAAT|TAA 
AAT|TAATT 
3’AT 250 units/$61  
PmeI GTTT|AAAC 
CAAA|TTTG 
Blunt 500 units/$66  
SbfI CCTGCA|GG 
GG|ACGTCC 
3’ TGCA 400 units/$66  
SwaI ATTT|AAAT 
TAAA|TTTA 
Blunt 2000 units/$61  
 
For proof of concept, a multicopy integration vector was constructed using the PmeI site 
at the end of the CEN.ARS element. The vector was constructed by assembling the PCR 
fragments of the final construct together using the DNA assembler method. The correct construct 
of the vector was confirmed using restriction digestion with multiple restriction enzymes. The 
functionality of the multicopy integrative vector was tested by introduction of xylose utilization 
pathways into the INVSc1 strain. The PCR fragments used for promoter-based pathway 
optimization were introduced into the multicopy integration vector linearized at the multiple 
cloning site using the DNA assembler method. After confirmation of the correct assembly of the 
pathway, the CEN.ARS element was released from the plasmid by restriction digestion at the 
PmeI site. The resulted DNA fragment without the CEN.ARS element was used to integrate the 
pathway into the genome of an INVSc1 strain (Figure 5.6). The same control pathway consisting 
of csXR, ctXDH and ppXKS driven by PDC1, TEF1 and ENO2 control promoters respectively 
were introduced into the INVSc1 strain using both a single copy plasmid and a multicopy 
integration vector. The fermentation abilities of these two strains were compared using 
fermentation under oxygen limited conditions in the YP media supplemented with 4% of xylose 
with an initial OD of 2. As shown in Figure 5.7, compared to the single copy plasmid version of 
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the pathway, the multicopy integration resulted in faster xylose utilization and higher ethanol 
production. (Notebook #9, page 27) 
 
Figure 5.7 Fermentation of the control pathway (WT) consisting of csXR, ctXDH and ppXKS driven by 
PDC1, TEF1, and ENO2 wild type promoters, respectively. The blue lines show the xylose consumption 
of the WT pathway on a single copy plasmid. The red lines show the xylose consumption and ethanol 
production of the WT pathway after integration using the multicopy integration vector. 
 
Second, helper plasmids were designed to enable a cloning-free multicopy genomic δ-
integration of pathways using DNA fragments in industrial strains. Of note, chromosomal 
integration of the pentose utilization pathway does not necessarily require a positive selection 
marker since positive selection for growth on pentose sugars can serve as a selection pressure 
(19). DNA fragments containing δ-sequences and homology regions used for homologous 
recombination based cloning can be co-transferred into industrial yeast strains with the pentose 
utilization pathway components in order to introduce multicopy integration of the pathway into 
the genome (Figure 5.8). (Notebook #6, page 197-203) 
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Figure 5.8 Chromosomal integration of multicopies of a target pathway into an industrial yeast strain using DNA 
fragments: fragment 1, 2, and 3 were generated through PCR amplification using helper plasmids δ-helper and δ-
CEN as templates. A. Multicopy integration using the pentose utilization pathway as positive selection; B. 
multicopy integration using dominant markers. 
 
Finally, a number of chromosomal integration vectors for single copy integration were 
also developed to facilitate ligation-free pathway integration into laboratory and industrial yeast 
strains. Usually, integrative vectors lack a yeast origin of replication to increase the efficiency of 
the integration event. Due to the absence of the CEN.ARS element in the integrative vectors, the 
pathway cannot be constructed into integrative vectors via the DNA assembler method. In this 
case, restriction ligation is the most widely used method to clone pathways into integrative 
vectors. This fact limited the size of the pathway to be cloned into an integrative vector due to 
A. 
B. 
fragment 1fragment 2
Fn    δ1 δ2     F1
δ-seq
pentose utilization 
pathway
δ-helper
δ       F1               pentose utilization pathway              Fn       δ                   
fragment 3fragment 2
Fn    δ1 δ2        marker        F1
δ-seq
pentose utilization pathway
δ          marker        F1               pentose utilization pathway              Fn       δ                   
δ-helper δ-CEN
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the availability of restriction sites on the vector. In order to address this issue, single copy 
integration vectors were designed for assembly and integration of pathways via homologous 
recombination. To enable the cloning of pathways into the vectors through DNA assembler, the 
CEN.ARS element of the single copy shuttle vector pRS416 was flanked with a spliced AUR1-c 
gene. To facilitate the linearization of the vector, two rare cutting sites were engineered between 
the CEN.ARS element and the spliced AUR1-c fragments. Similar to single copy expression 
vectors, pathways can be cloned into the integrative vectors using DNA assembler. After 
pathway assembly, the resultant plasmid can be digested using rare restriction enzymes to release 
the CEN.ARS element—yielding linearized DNA fragments with target sequences at both ends. 
Similarly, a single copy integration vector was also constructed for single copy ligation-free 
integration of a pathway into laboratory strains using the URA3 gene as the marker (Figure 5.9). 
These integration vectors can facilitate the integration of large metabolic pathways into 
laboratory and industrial strains. The single copy integration vectors are being applied for 
integration of the xylose utilization pathways. (Notebook #8, page 34-36) 
 
Figure 5.9 From left to right, multicopy delta integration vector, single copy integration vector using 
URA3 as the selection marker and the integration site, single copy integration vector using AUR1-c as the 
selection marker and the integration site for industrial yeast applications using DNA assembler 
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5.2.3 Development of a Gene Deletion Method for Industrial Yeast Strains 
Industrial strains are better host stains for biofuel production because they have higher 
ethanol productivity, a higher tolerance to ethanol, and a higher tolerance to the inhibitors and 
tough fermentation conditions present in typical industrial settings. Unfortunately, genetic tools 
for the engineering of industrial yeast strains are not as well developed as those used for 
laboratory strains due to the higher ploidy level and lack of auxotrophic mutations in industrial 
strains (1). It is especially difficult to introduce genomic modifications such as deletions and 
mutations into industrial strains because of the existence of multiple chromosomal sets. In order 
to facilitate gene deletion and modification in industrial strains, a newly developed scar-less gene 
modification method called MIRAGE (Mutagenic Inverted Repeat Assisted Genome 
Engineering) (insert citation) was investigated in polyploid host strains.  
The MIRAGE method achieves gene modification with one transformation step followed 
by two selection steps. It is based on the counter selectivity of the URA3 marker and the 
instability of the inverted repeat sequences (6). Two strategies were designed to adapt the 
MIRAGE method for genetic modification in polyploid yeast strains. In the first strategy, linear 
DNA fragments flanking the upstream and downstream sequence of the URA3 gene were used to 
disrupt the endogenous URA3 gene in industrial yeast strains. Using this strategy, mutants with a 
URA3
-
 auxotrophic mutation can be created for the gene modification using URA3 as a counter-
selectable marker. In the second strategy, a heterologous counter-selectable marker was designed 
to replace the URA3 cassette used in the original design of the MIRAGE method. If the 
heterologous marker functions well in industrial strains, gene modification can be performed 
using the new marker in polyploid yeast strains without any modification. 
In order to use URA3 as a counter-selectable marker in industrial S. cerevisiae strains, 
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complete deletion need to occur in industrial strains to yield auxotrophic mutants. Complete 
deletion of URA3 is desired when endogenous URA3 is used as a marker since there is a chance 
of homologous recombination between the non-functional URA3 gene in the genome and the 
functional URA3 gene introduced as a marker yielding, which would yield false positive 
transformants. To create URA3- auxotrophic deletion of an industrial strain, URA3 deletion 
strain HZ848 (MATa Δura3 trp1-1) was used to generate a linear DNA fragment for PCR-
mediated deletion of URA3 gene (6). Primers were designed to amplify the DNA fragment from 
~500 bp upstream and downstream of URA3 gene using genomic DNA of HZ848 as a template 
(Figure 5.10). The resulted DNA fragment was used to transform industrial strains using the 
lithium acetate method (13). The transformants were then plated on a synthetic complete plate 
supplemented with 2% glucose and 1g/L 5’-FOA. (Notebook #7, page 108) 
 
Figure 5.10 Scheme for URA3 deletion through homologous recombination. Linear DNA of amplified 
from the genomic DNA of URA3 deletion strain was transferred into industrial strains for deletion of 
URA3 gene through homologous recombination. After selection on 5’-FOA, the positive mutant with a 
clean URA3 deletion could be obtained. 
 
To create URA3- auxotrophic deletion, single colonies were inoculated in the YPAD 
liquid media and genomic DNA was isolated for confirmation of the URA3 deletion. Primers 
annealing to ~500 bp upstream and downstream of the URA3 gene were used as primers to 
confirm the URA3 deletion. As shown in Figure 5.11, the mutants after disruption of the URA3 
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gene showed multiple bands for diagnostic PCR, indicating that there was more than one copy of 
the URA3 gene due to the high ploidy. Among the multiple copies of URA3 genes, some might 
be disrupted and some might remain in the genome. Since we failed to completely delete all 
copies of the URA3 gene from the genome of our industrial strains, the endogenous URA3 gene 
cannot be used as the selection marker for MIRAGE in industrial yeast strains. Fortunately, two 
heterologous URA3 expressing vectors were obtained from Euroscarf (Frankfurt, Germany) 
which would enable the use of a heterologous URA3 as a selection marker. To ensure the ability 
of growth on 5’-FOA was solely from disruption of the URA3 gene and no other gene, a 
complementation study was performed by transforming the strains with pRS416 vectors. As 
shown in Figure 5.11, the URA3 overexpression on pRS416 vectors complemented the mutation 
in the mutant strains Classic C-1, Classic C-3 and ATCC A5-1, indicating the URA3 gene in 
these mutants must have been disrupted. (Notebook #7, page 157, page 186, page 192-193) 
 
Figure 5.11 Deletion of the URA3 gene in an industrial yeast strain. Left: Diagnostic PCR to confirm the 
deletion of the URA3 gene Genomic DNA was used as a template while primers were designed to anneal 
to the DNA sequences 500 bp upstream and downstream of the URA3 gene. M: 1kb DNA ladder. Lane 1: 
HZ848 strain, lane 2 to 5: four colonies of the ATCC 4124 strain with URA3 deletion, lane 6: wild type 
ATCC 4124 strain. Lane 2’-5’: four colonies of the Classic strain with URA3 deletion, lane 6’: wild type 
Classic strain. Right: Complementation study of the URA3 deletion strains. A. Classic C-1 strain 
complemented with pRS416, B. Classic C-1 strain without pRS416 complementation. C. Classic C-3 
strain complemented with pRS416, D. Classic C-3 strain without pRS416 complementation. E. ATCC A5-
1 strain complemented with pRS416, F. ATCC-A5-1 strain without pRS416 complementation. 
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The heterologous URA3 gene from Candida albicans (caURA3) was used as the deletion 
marker for disruption of the GRE3 gene from S. cerevisiae as a proof of concept of gene deletion 
using the MIRAGE method in industrial strains. GRE3 is the endogenous unspecific NADPH-
dependent aldose reductase in S. cerevisiae. The deletion of the GRE3 gene has been shown to 
improve pentose fermentation by reducing xylitol production and increasing ethanol yield 
(20,21).  The GRE3 deletion study using the MIRAGE method was designed by me while the 
actual experiment was carried out by Tong Si. The caURA3 is less likely to recombine with the 
nonfunctional URA3 in the genome due to the relatively low homology between the endogenous 
URA3 (scURA3) and caURA3 (Figure 5.12).  
ALIGN calculates a global alignment of two sequences 
 version 2.0uPlease cite: Myers and Miller, CABIOS (1989) 4:11-17 
caURA3                                              813 nt vs. 
scURA3                                              804 nt 
scoring matrix: DNA, gap penalties: -16/-4 
66.7% identity; Global alignment score: 1546 
 
 
                      10        20        30        40        50        60 
caURA3        ATGACAGTCAACACTAAGACCTATAGTGAGAGAGCAGAAACTCATGCCTCACCAGTAGCA 
              ::: :    ::  ::   :: ::::  ::  : :: :  :::::: :    :: :: ::  
scURA3        ATGTCG---AAAGCT---ACATATAAGGAACGTGCTGCTACTCATCCTAGTCCTGTTGCT 
                         10           20        30        40        50     
 
                      70        80        90       100       110       120 
caURA3        CAACGATTATTTCGATTAATGGAACTGAAGAAAACCAATTTATGTGCATCAATTGATGTT 
                     :::::    : ::: :    ::: :::: :: :: ::::: ::: : :::::: 
scURA3        GCCAAGCTATTTAATATCATGCACGAAAAGCAAACAAACTTGTGTGCTTCATTGGATGTT 
                  60        70        80        90       100       110     
 
                     130       140       150       160       170       180 
caURA3        GATACCACTAAGGAATTCCTTGAATTAATTGATAAATTGGGTCCTTATGTATGCTTAATC 
                :::::: :::::::: :: :: ::: ::::   ::: :::::  :  : :: ::: :  
scURA3        CGTACCACCAAGGAATTACTGGAGTTAGTTGAAGCATTAGGTCCCAAAATTTGTTTACTA 
                 120       130       140       150       160       170     
 
                     190       200       210       220       230       240 
caURA3        AAGACTCATATTGATATAATCAATGATTTTTCCTATGAATCCACTATTGAACCATTATTA 
              :: :: ::: : :::::  : : ::::::::::   ::   :::  :: : ::  ::    
scURA3        AAAACACATGTGGATATCTTGACTGATTTTTCCATGGAGGGCACAGTTAAGCCGCTAAAG 
                 180       190       200       210       220       230     
 
                     250       260       270        280       290          
caURA3        GAACTTTCACGTAAACATCAATTTATGATTTTT-GAAGATAGAAAATTTGCTGATATTGG 
              : : : :: ::  ::   :::::: : : : :: ::::: :::::::::::::: ::::: 
scURA3        GCATTATC-CGCCAAGTACAATTTTTTACTCTTCGAAGACAGAAAATTTGCTGACATTGG 
                 240        250       260       270       280       290    
 
            300       310       320       330       340        350         
caURA3        TAATACCGTGAAGAAACAATATATTGGTGGAGTTTATAAAATTAGTAGT-TGGGCAGATA 
              :::::: :: ::    :: ::   ::  :: :: :: : ::: :: ::  :::::::: : 
scURA3        TAATACAGTCAAATTGCAGTACTCTGCGGGTGTATACAGAAT-AGCAGAATGGGCAGACA 
                  300       310       320       330        340       350   
 
Figure 5.12 (cont. on next page) Alignment of the DNA sequences of URA3 from S. cerevisiae 
(scURA3) and URA3 from C. albicans (caURA3) 
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             360       370       380       390       400       410         
caURA3        TTACTAATGCTCATGGTGTCACTGGGAATGGAGTAGTTGAAGGATTAAAACAGGGAGCTA 
              :::: ::::: :: :::::    ::    ::  : :::   :: :: :: ::::  ::   
scURA3        TTACGAATGCACACGGTGTGGTGGGCCCAGGTATTGTTAGCGGTTTGAAGCAGGCGGCAG 
                   360       370       380       390       400       410   
 
             420       430       440       450       460       470         
caURA3        AAGAAACCACCACCAACCAAGAGCCAAGAGGGTTATTGATGTTAGCTGAATTATCATCAG 
              :::::   :: :      : :: :: :::::  : ::::::::::: ::::: ::::    
scURA3        AAGAAGTAACAA------AGGAACCTAGAGGCCTTTTGATGTTAGCAGAATTGTCATGCA 
                   420             430       440       450       460       
 
             480       490       500       510       520       530         
caURA3        TGGGATCATTAGCATATGGAGAATATTCTCAAAAAACTGTTGAAATTGCTAAATCCGATA 
               ::: ::  :: :   :::::::::: :: :    :::::::: ::::: ::   ::: : 
scURA3        AGGGCTCCCTATCTACTGGAGAATATACTAAGGGTACTGTTGACATTGCGAAGAGCGACA 
               470       480       490       500       510       520       
 
             540       550       560       570       580       590         
caURA3        AGGAATTTGTTATTGGATTTATTGCCCAACGTGATATGGGTGGACAAGAAGAAGGATTTG 
              : :: :::::::: :: :::::::: ::: : :: :::::::::  ::: ::::: :  : 
scURA3        AAGATTTTGTTATCGGCTTTATTGCTCAAAGAGACATGGGTGGAAGAGATGAAGGTTACG 
               530       540       550       560       570       580       
 
             600       610       620       630       640       650         
caURA3        ATTGGCTTATTATGACACCTGGAGTTGGATTAGATGATAAAGGTGATGGATTAGGACAAC 
              ::::: : ::::::::::: :: :: :: :::::::: :: :: :: : ::: :: :::: 
scURA3        ATTGGTTGATTATGACACCCGGTGTGGGTTTAGATGACAAGGGAGACGCATTGGGTCAAC 
               590       600       610       620       630       640       
 
             660       670       680       690       700       710         
caURA3        AATATAGAACTGTTGATGAAGTTGTTAGCACTGGAACTGATATTATCATTGTTGGTAGAG 
              : :::::::: :: ::::: :: ::    :: ::: :::: ::::: :::::::: :::: 
scURA3        AGTATAGAACCGTGGATGATGTGGTCTCTACAGGATCTGACATTATTATTGTTGGAAGAG 
               650       660       670       680       690       700       
 
             720       730       740       750       760       770         
caURA3        GATTGTTTGGTAAAGGAAGAGATCCAGATATTGAAGGTAAAAGGTATAGAGATGCTGGTT 
              :: : ::::  :: ::::: ::: :  :  : :: ::: :: : :: ::: : :: :: : 
scURA3        GACTATTTGCAAAGGGAAGGGATGCTAAGGTAGAGGGTGAACGTTACAGAAAAGCAGGCT 
               710       720       730       740       750       760       
 
             780       790       800       810       
caURA3        GGAATGCTTATTTGAAAAAGACTGGCCAATTA---TAA 
              :: : :: ::::::: ::     :::::   :   ::: 
scURA3        GGGAAGCATATTTGAGAAGATGCGGCCAGCAAAACTAA 
               770       780       790       800     
Figure 5.12 (cont’d)  Alignment of the DNA sequences of URA3 from S. cerevisiae (scURA3) and 
URA3 from C. albicans (caURA3) 
 
To use the caURA3 as a marker, the caURA3 cassette was amplified from a pAG60 
vector purchased from Euroscarf (Frankfurt, Germany) (Figure 5.13). The 25 bp length of DNA 
sequence directly downstream of the GRE3 gene was used as the direct repeat (DR) sequence for 
marker removal. Because of the existence of inverted repeats in the marker used for the 
MIRAGE method, the full marker cannot be amplified using PCR. For construction of the 
marker for deletion of the GRE3 gene, a left DNA fragment of caURA3 in its regular direction 
and a right DNA fragment of caURA3 in an inverted direction were ligated together. (Table 5.4)  
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Figure 5.13 Scheme for construction of caURA3 marker contains inverted repeats 
Table 5.4 List of primers used to amplify the left and right fragments for the construction of a caURA3 
marker with inverted repeats. To create the left fragment, forward primer GRE3-DR-TEFp-for was 
designed to include the 45 bp length of sequence upstream to the GRE3 gene (underlined), the direct 
repeat (bold), and around 20 bp for amplification of the caURA3 cassette from pAG60 (italic), and the 
TEFt-XbaI-rev was designed to include around 20 bp for amplification of caURA3 cassette (italic) and a 
unique XbaI site for ligation (underlined). Similarly, for the right fragment, SpeI-TEFt-for was designed 
to include a unique SpeI (underlined) site and around 20 bp for amplification of the caURA3 cassette 
(italic) in inverted direction, reverse primer was designed to include around 20 bp for amplification of 
caURA3 cassette (italic), the direct repeat (bold) and 27 bp length of sequence downstream to GRE3 gene 
(underlined). 
Primer Name Sequence 
GRE3-DR-TEFp-for 5’-GAAAATACTGTAATATAAATCGTAAAGGAAAATTGGAAATTTTTTA 
AAGTCCAGCCAGTAAAATCCATACTCAACGAGCTTGCCTTGTCCCCGC
CGG-3’ 
TEFt-XbaI-rev 
 
5'-AGTCAGTCTCTAGATCGACACTGGATGGCGGCGTTAG-3' 
SpeI-TEFt-for 
 
5'-CATGACTGACTAGTTCGACACTGGATGGCGGCGTTAG-3' 
TEFp-DR-GRE3-rev 5'-GGAATGAGGGAAATTTGTTCATATCGTCGTTGAGTATGGATTTTAC 
TGGCTGGAAGCTTGCCTTGTCCCCGCCGG-3' 
 
The left fragment was amplified with the primer pair GRE3-DR-TEFp-for and TEFt-
XbaI-rev using pAG60 as a template. The right fragment was amplified using SpeI-TEFt-for and 
TEFp-DR-GRE3-rev using pAG60 as a template. The left fragment was digested with XbaI and 
the right fragment was digested with SpeI, respectively. This digestion created fragments with 
compatible overhangs that could be ligated using a T4 DNA ligase. The ligation product was 
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then digested with XbaI and SpeI to get rid of the self-ligation products of two left fragments or 
two right fragments. The digestion products were separated using electrophoresis to recover only 
the ligation product of a left fragment and a right fragment (Figure 5.14). 
 
Figure 5.14 Scheme of construction of the caURA3 marker containing inverted repeats using restriction 
digestion and ligation. 
 
The resulting DNA fragment was then used to transform industrial yeast strains Classic 
and ATCC4124. Following this, the transformants were spread on a SC-Ura plate supplemented 
with 2% glucose. Single colonies were inoculated into the SC-Ura liquid media supplemented 
with 2% glucose and genomic DNA was isolated to confirm the integration of the marker using 
diagnostic PCR. The positive mutants was then streaked out on a synthetic complete plate 
supplemented with 2% glucose and 1g/L 5’-FOA to facilitate the removal of the marker through 
inverted repeats mediated homologous recombination. The colonies that appeared up on the 5’-
FOA plates were inoculated into the YPAD liquid media and genomic DNA was isolated to 
confirm the removal of the caURA3 marker via diagnostic PCR (Figure 5.15). 
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Figure 5.15 Deletion of the GRE3 gene using a caURA3 inverted repeat via the MIRAGE method. 
(Genomic DNA as template and GRE-up-500 for as the forward primer and GRE-down-500-rev as the 
reverse primer) M: 1kb plus DNA ladder.1. INVSc1 (wild type, expected size ~2 kb), 2. ATCC A5-1 
(URA3
-
 strain, expected size ~2 kb), 3. Classic C-1 (URA3
-
 strain, expected size ~2 kb), 4. ATCC IR-
1(with inverted repeat marker integrated, expected size ~4 kb), 5. ATCC IR-2 (with inverted repeat 
marker integrated, expected size ~4 kb), 6. Classic IR-1 (with inverted repeat marker integrated, expected 
size ~4 kb), 7. Classic IR-1-R (inverted repeat removed, expected size ~1 kb), 8. Classic IR-2-R (inverted 
repeat removed, expected size ~1 kb), 9. ATCC IR-1-R (inverted repeat removed, expected size ~1 kb) 
 
As shown in Figure 5.15, the disruption of the GRE3 gene in polyploid S. cerevisiae 
Classic and ATCC4124 was confirmed by diagnostic PCR. It took only one round of integration 
and removal of the marker to remove all copies of the GRE3 gene in polyploid yeast.  
At the same time, we are also investigating the use of heterologous markers that can be 
directly used in un-modified industrial yeast. The counter-selectivity of the URA3 marker is 
crucial for the success of the MIRAGE method. Due to the counter-selectivity of the URA3 
method, synthetic drop out media can be used to select for strains with URA3 gene integration. 
To confirm the removal of the inverted repeat mediated marker, 5’-FOA can be used to select for 
the loss of the URA3 gene. The URA3 gene cannot be directly used in un-modified industrial 
yeast due to the absence of auxotrophic deletion of URA3 in industrial strains. To be directly 
applicable for gene modification in industrial yeast strains, dominant selection markers such as 
drug-resistant genes are used as positive selection. A literature search was performed in an 
attempt to discover a single dominant marker with counter-selectivity, but no known marker with 
such an attribute was found. In order to create a counter-selectable marker for use in industrial 
strains, a chimeric marker was created by fusing together a dominant selection marker and a 
toxic gene driven by an inducible promoter. In the chimeric marker, the drug-resistance that 
  M      1        2         3         2      4     5    M     3      6      M     2     7     8      3      9 
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results from the existence of the dominant selection marker can be used to select for the correct 
integration of the marker. When the integration of the marker was confirmed, an inducer would 
be added to the medium to activate the toxic gene driven by the inducible marker in order to 
achieve the selection necessary for the inverted repeat mediated marker removal process (Figure 
5.16). 
 
Figure 5.16 Chimeric marker for genetic engineering in un-modified industrial yeast. The chimeric 
marker was constructed by fusing a drug resistant gene with a toxic gene driven by an inducible promoter. 
 
After previous investigation of dominant selection markers in industrial strains, two key 
elements remained to be tested for the construction of this kind of chimeric marker: the inducible 
promoter and the toxic gene. A well-known inducible promoter in S. cerevisiae, the GAL1 
promoter, which can be induced in the presence of galactose, was studied in different strain 
backgrounds for the construction of the chimeric marker (22). To test the behavior of the GAL1 
promoter, the GAL1 promoter was cloned in front of a green florescent protein (GFP) so that by 
comparing the fluorescent intensity of GFP before and after induction, the induction ratio and 
basal expression level of the GAL1 promoter could be studied. The GAL1 promoter was 
amplified from a pSH47 plasmid describe elsewhere (12). The GAL1 promoter-GFP construct 
was made on a pRS-KanMX vector using the DNA assembler method. The resulting construct 
was confirmed using restriction digestion. The confirmed plasmid was then transferred into 
different S. cerevisiae strains. The strains hosting the pRS-KanMX-GAL1p-GFP plasmid were 
grown up overnight in the YPAD liquid media supplemented with 2% glucose and 200 mg/L 
G418 . The culture was then washed and resuspended in YPA liquid media supplemented with 2% 
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galactose and 200 mg/L G418 for three hours. The fluorescent intensities of the strains before 
and after induction were measured using flow cytometry (Figure 5.17). The induction ratio of the 
promoter is very small in this measurement. The experiment was repeated with a longer 
induction time of two days in galactose at 20 °C (data not shown). The induction ratio remained 
low even after two days of induction. Since the functionality of the GAL1 promoter has been 
proven by many other studies (12,23), the low induction ratio of the GAL1 promoter would be 
most likely due to the errors in the GAL1 promoter induced GFP construct. Another proof for 
this assumption is the low induction ratio in widely used laboratory strains such as CEN.pk2 and 
INVSc1. We are now working on trouble shooting the construct using the GAL1 promoter. 
(Notebook #7, page 158, page 208) 
 
Figure 5.17 Induction of a GAL1 promoter in different strains background measured by the fluorescent 
intensity of the GFP driven by GAL1 promoter after three hours of induction in galactose. 
 
An extensive literature search was performed in order to find a suitable toxic gene for 
removal of the selection marker. The E. coli MazF gene was previously reported to be functional 
as a counter-selectable marker for unmarked gene modification in Pichia pastoris (24). MazF is 
an mRNA interferase that mediates programmed cell death in both prokaryotes and eukaryotes 
(25,26). The MazF gene was cloned from the genomic DNA of E. coli K-12 MG1655 and 
assembled with a GAL1 promoter and a GPM1 terminator using DNA assembler. The assembled 
construct was confirmed using restriction digestion. The construct was transformed into different 
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S. cerevisiae strains and tested for cell growth inhibition when galactose was present in the cell 
medium. Unfortunately, no growth inhibition was observed after induction with galactose for 
two days (data not shown). Since the functionality of the GAL1 promoter cloned previously was 
not confirmed, the absence of activity of the MazF gene could also be due to errors in the GAL1 
promoter region. We are now trouble shooting the GAL1p-MazF construct and the GAL1p-GFP 
construct simultaneously. Hopefully, by fixing the possible error in GAL1 promoter cloning, 
both of the elements would be functional for gene disruption in un-modified industrial yeast 
strains. 
5.3 Conclusions and Outlooks 
In this chapter, a variety of genetic tools have been designed to facilitate direct genetic 
engineering of industrial S. cerevisiae strains either on plasmids or on the chromosome. First, 
various dominant selection markers were tested in laboratory and industrial S. cerevisiae strains. 
The KanMX cassette, AUR1-c cassette, and YAP1 overexpression cassette were proven to be 
functional in various host strains. The dominant selection markers were then used to replace the 
URA3 nutritional marker on pRS416 vector to construct single copy expression vectors. These 
vectors were not only functional for expression in industrial strains, but also compatible with 
pathway assembly strategy using the DNA assembler method. Because the single copy 
expression vectors for industrial strains retain the same homology to regions for pathways 
assembly using the DNA assembler method, all of the PCR products of gene expression cassettes 
previously created for enzyme- or promoter-based pathway assembly can all be reused for 
pathway assembly and optimization in industrial strains.  
Second, single copy and multicopy integration vectors were designed for ligation-free 
pathway integration in laboratory and industrial strains. The DNA assembler method is a very 
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robust tool for the rapid creation of large DNA molecules through yeast in vivo homologous 
recombination. In order to construct pathways using the DNA assembler method, a yeast origin 
of replication must be present in the resulting construct for the propagation of the plasmid. 
Unfortunately, the yeast origin of replication is usually eliminated from integrative vectors to 
increase the efficiency of genomic integration. To resolve this problem, rare cutting sites were 
introduced at both ends of the yeast CEN.ARS element in the integrative vectors, enabling the 
rapid assembly of the pathway through DNA assembler as well as linearization and high 
efficiency integration of the pathway after digestion at the rare restriction sites. 
The single copy centromeric expression vector and integration vector compose a useful 
tool box for DNA assembler mediated pathway engineering in industrial and laboratory strains. 
Using these tools, pathways can be rapidly constructed and introduced into industrial yeast, as 
well as assembled and screened while using an industrial strain as the host. 
Third, two strategies were designed for chromosomal modification in industrial strains. In 
the first strategy, industrial strains with the URA3
-
 phenotype were created by PCR mediated 
gene disruption through homologous recombination and counter-selection of the URA3 gene 
with 5’-FOA. Although some copies of the URA3 gene remained in the genome after disruption, 
the URA3
-
 phenotype that could be complemented with the expression of a single copy of URA3 
gene on plasmid indicated that the remaining copies of the URA3 were nonfunctional. The 
resulting URA3- strains were then used to test for the gene’s deletion using a heterologous 
URA3 gene from C. albicans as the selection marker for the removal of the GRE3 gene in 
industrial strains. With a single trial of marker integration and removal mediated with inverted 
repeats, the GRE3 gene was clearly disrupted based on the diagnostic PCR results. Of note, the 
diagnostic PCR results were not completely as expected for the confirmation after integration 
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and removal of the caURA3 inverted repeats. These results might be due to the unusual structure 
of the inverted repeats (for the confirmation after the integration of the marker) and the PCR 
conditions required for diagnostic PCR (for the confirmation after the removal of the marker). 
We are now investigating these abnormal results through diagnostic PCR and qPCR. However, 
despite the unexpected results of the confirmation PCR, one thing we can be sure of is that all the 
copies of the GRE3 genes in the genome of the industrial strains were disrupted. 
Efforts have also been invested to construct chimeric marker cassettes for chromosomal 
engineering in un-modified industrial yeast strains. The counter-selectable markers were 
designed by fusing a dominant selection marker with a toxic gene driven by an inducible 
promoter. The GAL1 promoter and MazF gene were investigated for the use as the inducible 
promoter and the toxic gene, respectively. Unfortunately, the constructs failed to show a good 
induction ratio or growth inhibition when induced with galactose. Reconstruction of the 
expression system, as well as a literature search for other candidates, were performed 
simultaneously in an attempt to resolve the problems as soon as possible.  
With the development of a complete set of expression vectors, integration vectors and 
genetic tools for chromosomal modification that are not only compatible for the application in 
both laboratory and industrial S. cerevisiae but also compatible with the highly efficient DNA 
assembler method (27) would provide great opportunities for metabolic engineering for 
production of value added compounds in yeast. Using the DNA assembler method, large 
metabolic pathways could be rapidly constructed onto the highly mobile expression vectors and 
tested in different strain backgrounds. Libraries of combinatorial pathways could also be 
assembled and optimized specifically in different strain background. With the newly developed 
tools and vectors, it would be possible to optimize the heterologous metabolic pathway and the 
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host strain at the same time, which might lead to rapid advances in metabolic engineering in 
different laboratory and industrial yeasts. 
5.4 Materials and Methods 
 
5.4.1 Strains, Media, and Cultivation Conditions 
 
Saccharomyces cerevisiae L2612 (MATα leu2-3 leu2-112 ura3-52 trp1-298 can1 cyn1 gal+) is a 
gift from Dr. Yong-su Jin (28). S. cerevisiae strain INVSc1(MATa his3D1 leu2 trp1-289 ura3-52 
MATAlpha his3D1 leu2 trp1-289 ura3-52) was purchased from Invitrogen. Still Spirits (Classic) 
Turbo Distiller's Yeast and Alcotec Turbo Super Yeast (Super) were purchased from Homebrew 
Heaven (Everett, WA). S. cerevisiae ATCC 4124 was a gift from Dr. Yong-Su Jin. Escherichia 
coli DH5α (Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, IL) was 
used for recombinant DNA manipulation. Plasmid pUG6 harboring the KanMX cassette and 
pSH47 harboring the Cre recombinase driven by a GAL1 inducible promoter were purchased 
from Euroscarf (Frankfurt, Germany). Yeast strains were cultivated in either synthetic dropout 
media (0.17% Difco yeast nitrogen base without amino acids and ammonium sulfate, 0.5% 
ammonium sulfate, 0.083% amino acid drop out mix) or YPA media supplemented with sugar as 
a carbon source (1% yeast extract, 2% peptone, 0.01% adenine hemisulfate). E. coli strains were 
cultured in Luria broth (LB) (Fisher Scientific, Pittsburgh, PA). S. cerevisiae strains were 
cultured at 30 °C and 250 rpm for aerobic growth, and 30 °C and 100 rpm for the oxygen limited 
condition. E. coli strains were cultured at 37 °C and 250 rpm unless specified otherwise. All 
restriction enzymes were purchased from New England Biolabs (Ipswich, MA). All chemicals 
were purchased from either Sigma Aldrich or Fisher Scientific. 
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5.4.2 Plasmid and Strain Construction 
 
Most of the cloning work was done using the yeast homologous recombination mediated 
DNA assembler method (29). DNA fragments flanked with regions homologous to adjacent 
DNA fragments were generated with polymerase chain reaction (PCR) and all the DNA 
fragments were purified and co-transformed into S. cerevisiae along with the backbone. To 
confirm the correct clones from transformants, yeast plasmids were isolated using a Zymoprep II 
yeast plasmid isolation kit (Zymo Research, Irvine, CA) and transformed into E. coli. Plasmids 
from E. coli were then isolated and confirmed using diagnostic PCR. 
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